Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3011951	s-aspfume	u/ml (u/ml)	1740	2327	16.80%
3011951	s-aspfume	— (—)	1106	1177	100.00%	Distribution not available
3011951	s-hasp�he	u/ml (—)	398	410	100.00%	Distribution not available
3011951	s-aspvere	u/ml (—)	102	102	100.00%	Distribution not available
3011951	s-asfuabe	— (—)	75	78	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormalities of breathing

970

1328

4.39

315.74

1.3

1.13

1.56

u/ml

0.54

449

494

Abnormal findings on diagnostic imaging of lung

539

854

6.27

311.78

1.6

1.2

1.73

1.36

u/ml

0.39

378

391

ILD differential diagnosis

696

310

11.37

307.65

1.4

1.1

1.31

0.19

u/ml

2.65

337

Other pulmonary diagnosis

722

313

11.69

307.65

1.4

1.1

1.30

0.22

u/ml

2.64

352

Asthma-related infections

1371

671

20.95

307.65

1.4

1.2

1.79

0.27

u/ml

8.23

746

209

Obesity related asthma

632

329

19.98

307.65

1.3

1.1

1.06

0.31

u/ml

1.69

320

102

Oral corticosteroids

1532

1327

7.12

307.65

1.4

1.2

1.34

0.67

u/ml

1.90

866

398

Bronchiectasis

365

129.62

307.65

1.7

1.1

1.20

0.04

u/ml

—

266

Cough

541

791

6.70

307.65

1.3

0.47

1.29

u/ml

1.64

275

309

Asthma, unspecified (mode)

1056

271

31.92

307.65

1.3

1.1

1.26

0.20

u/ml

3.02

493

Allergic asthma (mode)

576

175

33.66

307.65

1.5

1.1

2.35

0.07

u/ml

6.67

329

Asthma

1922

308

34.70

307.65

1.3

1.1

1.46

0.20

u/ml

6.36

949

Allergic asthma (mode), excluding more controls

576

176

33.46

307.65

1.5

1.1

2.35

0.06

u/ml

6.69

329

Asthma, unspecified (mode), excluding more controls

1049

271

31.43

307.65

1.3

1.1

1.27

0.20

u/ml

3.04

489

Asthma and allergy, excluding more controls

375

39.44

307.65

1.4

1.0

1.84

0.11

u/ml

—

201

Asthma and opportunity respiratory infection

314

129.07

307.65

2.1

1.2

2.56

0.26

u/ml

5.27

237

1124

511

22.86

307.65

1.4

1.2

1.78

0.31

u/ml

6.01

588

149

Asthma, excluding more controls

1892

306

34.19

307.65

1.3

1.1

1.48

0.20

u/ml

6.36

932

Asthma (only as main-diagnosis)

1966

308

40.15

307.65

1.4

1.1

1.52

0.20

u/ml

6.89

981

Non-allergic asthma (mode)

497

56.25

307.65

1.2

1.0

0.83

0.07

u/ml

—

229

Asthma, including avohilmo

2156

885

14.54

307.65

1.3

1.2

1.51

0.27

u/ml

7.90

1040

274

Asthma (only as main-diagnosis), excluding more controls

1948

306

39.57

307.65

1.4

1.1

1.49

0.20

u/ml

6.68

968

Asthma, hospital admission 2, infections

1371

671

20.95

307.65

1.4

1.2

1.79

0.27

u/ml

8.23

746

209

Asthma/COPD (KELA code 203)

1762

778

16.41

307.65

1.4

1.1

1.61

0.12

u/ml

11.12

985

185

Asthma and allergy

375

41.54

307.65

1.4

1.0

1.84

0.11

u/ml

—

201

COPD

348

212

13.74

307.65

1.5

1.1

2.31

0.13

u/ml

4.39

229

Asthma, hospital admissions , main diagnosis only

2013

1059

17.71

307.65

1.4

1.2

1.51

0.54

u/ml

3.68

997

343

COPD differential diagnosis

696

310

11.37

307.65

1.4

1.1

1.31

0.19

u/ml

2.65

337

Chronic rhinitis, nasopharyngitis and pharyngitis

451

554

8.35

307.65

1.3

1.2

0.90

1.40

u/ml

0.43

261

203

Vasomotor and allergic rhinitis

643

742

8.78

307.65

1.4

1.2

1.21

1.29

u/ml

0.06

283

244

Excluding asthma or asthma-COPD overlap

701

313

11.34

307.65

1.4

1.1

1.30

0.22

u/ml

2.51

339

Asthma, hospital admissions 3, pneumonia

733

320

23.82

307.65

1.5

1.2

1.96

0.30

u/ml

5.47

455

106

Asthma (mode)

1881

310

34.54

307.65

1.3

1.1

1.50

0.19

u/ml

6.50

912

First line medication for Crohn's disease

1280

1293

5.48

307.65

1.4

1.2

1.31

0.50

u/ml

2.73

702

340

Chronic lower respiratory diseases

2124

784

15.03

307.65

1.4

1.1

1.27

0.12

u/ml

10.00

1048

187

Asthma-related pneumonia or sepsis

733

320

23.82

307.65

1.5

1.2

1.96

0.30

u/ml

5.47

455

106

Non-allergic asthma (mode), excluding more controls

497

55.64

307.65

1.2

1.0

0.83

0.06

u/ml

—

229

Asthma-related pneumonia

732

320

23.79

307.65

1.5

1.2

1.96

0.30

u/ml

5.47

455

106

Asthma (diagnoses ohter than nonallergic)

1970

1114

15.68

307.65

1.4

1.2

1.55

0.43

u/ml

5.20

999

350

Suggestive for eosinophilic asthma

266

37.16

307.65

1.6

1.2

2.03

0.06

u/ml

2.96

181

Inflammatory bowel disease treatment related agents

1460

1405

6.00

307.65

1.4

1.2

1.27

0.65

u/ml

1.69

810

413

ILD medications: prednisolone, methylprednisolone, prednisone

1424

1266

6.46

307.65

1.4

1.2

1.33

0.55

u/ml

2.60

802

345

ILD medications

1368

1308

5.83

307.65

1.4

1.2

1.29

0.55

u/ml

2.43

750

355

Allergic rhinitis

568

808

7.18

307.65

1.4

1.2

1.15

0.92

u/ml

0.24

242

314

Chronic sinusitis

719

785

9.42

307.65

1.4

1.2

1.19

1.65

u/ml

0.47

403

297

Other chronic obstructive pulmonary disease

322

207

13.12

302.49

1.5

1.1

2.21

0.13

u/ml

4.12

215

Early onset COPD, excluding more controls

202

26.07

291.70

1.6

1.0

2.14

0.51

u/ml

1.34

129

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

535

926

5.75

284.52

1.4

1.2

1.12

1.24

u/ml

0.10

225

375

Other diseases of upper respiratory tract

972

1257

4.07

273.86

1.4

1.3

0.95

1.59

u/ml

1.01

487

485

Pollen allergy

388

521

7.65

268.97

1.4

1.2

1.02

0.86

u/ml

0.11

152

169

Diseases of the respiratory system

469

254

9.33

264.85

1.4

1.1

1.01

0.22

u/ml

1.61

217

Biological medicines for asthma

143

75.14

259.44

1.6

1.1

0.99

0.17

u/ml

1.71

105

1011

1466

3.68

251.46

1.4

1.2

1.40

0.64

u/ml

1.75

528

511

833

1341

3.94

242.18

1.6

1.1

1.56

0.68

u/ml

1.91

498

438

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

833

1341

3.94

242.18

1.6

1.1

1.56

0.68

u/ml

1.91

498

438

Dyspnoea

861

1852

3.60

237.55

1.3

1.04

1.40

u/ml

0.54

419

804

FESS (DNB20)

273

283

10.12

236.69

1.5

1.3

1.45

0.45

u/ml

1.28

148

118

Ethmoidectomy

277

296

9.80

234.76

1.5

1.3

1.41

0.62

u/ml

0.87

152

125

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

620

1342

4.34

233.92

1.5

1.2

1.62

1.19

u/ml

0.59

410

569

Nasal polyp

260

261

10.24

229.80

1.5

1.2

1.29

1.45

u/ml

0.09

173

107

Other acute lower respiratory infections

567

1285

4.27

211.41

1.5

1.3

1.15

1.28

u/ml

0.14

324

520

Acute bronchitis

441

916

4.79

191.40

1.4

1.3

1.14

1.42

u/ml

0.27

258

378

Acute sinusitis

568

1362

3.94

188.90

1.5

1.2

1.82

1.06

u/ml

1.18

300

534

COPD/asthma related infections

872

1341

3.28

181.46

1.4

1.1

1.01

0.68

u/ml

0.60

472

438

COPD/asthma/ILD related infections

872

1341

3.28

181.46

1.4

1.1

1.01

0.68

u/ml

0.60

472

438

Symptoms and signs involving the circulatory and respiratory systems

868

1336

3.28

180.77

1.3

1.03

1.56

u/ml

0.72

404

496

Pneumonias (Asthma/COPD co-morbidities)

889

2067

3.01

179.73

1.5

1.2

1.52

0.94

u/ml

1.13

531

745

Bronchitis

926

2069

2.96

179.40

1.4

1.2

1.45

1.01

u/ml

0.72

478

834

Influenza and pneumonia

929

2095

2.94

178.10

1.5

1.2

1.65

0.86

u/ml

1.77

550

737

Pneumonia, organism unspecified

795

1835

3.16

177.10

1.5

1.2

1.56

0.87

u/ml

1.42

482

663

All pneumoniae

888

2078

2.98

176.22

1.5

1.2

1.53

0.95

u/ml

1.13

528

748

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

846

2057

2.92

162.96

1.5

1.2

1.56

0.93

u/ml

1.26

514

751

Childhood asthma (age<16)

172

14.06

162.76

1.4

1.0

3.48

0.07

u/ml

—

Childhood asthma (age<16), excluding more controls

172

14.06

162.68

1.4

1.0

3.48

0.07

u/ml

—

Acute upper respiratory infections

868

1922

2.85

155.58

1.4

1.2

1.47

1.06

u/ml

0.58

438

791

Aspergillosis

73.52

154.67

3.9

1.3

9.66

0.08

u/ml

5.63

COPD (mode)

157

14.80

153.00

1.3

1.1

2.11

0.39

u/ml

1.47

107

33.77

147.92

2.0

1.2

2.24

1.18

u/ml

0.37

Later onset COPD, excluding more controls

116

31.57

147.46

1.2

1.1

2.38

0.03

u/ml

—

Any reimbursement code in KELA

525

682

3.89

138.03

1.3

1.2

0.79

0.27

u/ml

1.52

225

168

Bacterial pneumonia (organism specified)

357

751

4.38

136.07

1.8

1.2

1.77

1.13

u/ml

0.52

243

295

Bacterial pneumoniae

336

691

4.36

126.06

1.8

1.2

1.29

1.22

u/ml

0.05

233

262

Asthma mixed form (mode), excluding more controls

37.80

124.36

1.3

1.0

1.36

—

u/ml

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

167

126

10.03

123.88

1.6

1.2

2.13

2.05

u/ml

0.02

110

Asthma mixed form (mode)

36.09

122.81

1.3

1.0

1.36

—

u/ml

—

Bacterial pneumonia, not elsewhere classified

320

651

4.40

121.68

1.8

1.2

1.21

1.30

u/ml

0.07

226

243

Simple and mucopurulent chronic bronchitis

32.59

120.50

1.5

1.1

1.08

0.02

u/ml

—

Non-allergic asthma

143

160

9.25

116.86

1.1

1.4

1.22

1.26

u/ml

0.01

Other chronic obstructive pulmonary disease, including avohilmo

385

863

3.75

116.01

1.5

1.3

1.96

1.06

u/ml

1.18

257

431

ILD, hospital admission 2, with pulmonary infections

113

12.50

114.17

1.7

1.2

1.83

1.65

u/ml

0.04

Atopic dermatitis, strict definition with reimbursement

342

886

3.80

109.40

1.3

1.2

1.54

0.68

u/ml

1.28

145

340

COPD, hospital admission 2, with asthma infections

257

456

4.87

109.00

1.5

1.3

2.50

1.15

u/ml

1.26

176

222

Adverse effects, not elsewhere classified

254

549

4.73

108.93

1.2

1.3

1.26

1.11

u/ml

0.09

227

Acute upper respiratory infections of multiple and unspecified sites

594

1606

2.79

108.27

1.4

1.2

1.47

1.03

u/ml

0.47

288

637

Other respiratory diseases principally affecting the interstitium

184

304

6.18

106.31

1.6

1.3

1.92

1.63

u/ml

0.12

122

147

Infection due to other mycobacteria

31.85

105.50

2.0

1.0

1.61

0.04

u/ml

1.36

COPD, early/later onset

322

698

3.94

104.35

1.5

1.3

2.21

1.04

u/ml

1.40

215

350

COPD, hospital admissions

320

694

3.95

104.08

1.5

1.3

2.23

1.03

u/ml

1.44

213

348

Haemorrhage from respiratory passages

236

455

4.86

103.12

1.6

1.3

1.26

1.64

u/ml

0.28

145

208

Gastro-oesophageal reflux disease

539

1722

2.80

102.69

1.3

0.84

1.32

u/ml

0.97

266

753

Atypical mycobacterium lung infection

42.03

99.22

2.0

1.3

1.80

0.05

u/ml

—

Other respiratory disorders and diseases

189

343

5.61

98.94

1.5

1.3

1.11

1.46

u/ml

0.24

113

166

Other diseases of the respiratory system

189

343

5.61

98.94

1.5

1.3

1.11

1.46

u/ml

0.24

113

166

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

493

1730

2.83

98.23

1.4

1.3

1.26

1.13

u/ml

0.13

225

705

COPD, hospital admissions 3, with asthma pneumonia sepsis

212

355

5.15

95.64

1.6

1.3

2.40

1.06

u/ml

1.19

149

177

Allergic conjunctivitis

504

1837

2.73

93.66

1.4

1.3

1.24

1.02

u/ml

0.25

230

743

Dermatitis and eczema

798

2302

2.29

93.38

1.3

1.53

1.14

u/ml

0.59

354

1005

Voice disturbances

262

656

4.06

92.79

1.6

1.3

1.78

1.21

u/ml

0.34

145

299

Disorders of conjunctiva

644

2234

2.43

91.54

1.3

1.19

u/ml

0.00

289

927

Conjunctivitis

605

2146

2.48

90.19

1.4

1.3

1.27

1.18

u/ml

0.09

269

879

Emphysema

20.19

89.77

1.5

1.1

1.95

0.05

u/ml

—

Urticaria

310

892

3.53

89.70

1.3

1.13

1.04

u/ml

0.06

127

360

Early onset COPD

202

426

4.82

89.17

1.6

1.3

2.14

1.17

u/ml

0.73

129

194

Bronchitis, not specified as acute or chronic

13.39

88.80

1.4

1.1

1.37

0.06

u/ml

2.28

Sleep apnoea, including avohilmo

693

1908

2.37

87.87

1.3

0.62

1.36

u/ml

2.09

293

896

Deviated nasal septum

219

498

4.44

87.78

1.5

1.2

1.92

1.56

u/ml

0.18

129

201

ILD, hospital admissions 3, with pneumonia sepsis

10.98

87.35

1.7

1.2

1.92

1.82

u/ml

0.02

Pain in throat and chest

536

1220

2.70

86.97

1.3

0.93

1.56

u/ml

0.88

248

471

Urticaria and erythema

350

1108

3.20

86.82

1.3

1.02

1.12

u/ml

0.08

144

450

ILD, hospital admissions

153

258

6.06

86.69

1.5

1.3

1.48

1.40

u/ml

0.04

130

Other interstitial pulmonary diseases

153

259

6.04

86.34

1.5

1.3

1.48

1.42

u/ml

0.03

130

Interstitial lung disease

153

260

6.01

86.00

1.5

1.3

1.48

1.41

u/ml

0.03

131

Interstitial lung disease endpoints

153

260

6.01

86.00

1.5

1.3

1.48

1.41

u/ml

0.03

131

Mycoses

247

630

3.98

85.28

2.2

1.2

5.10

0.86

u/ml

4.45

160

274

Sleep disorders (combined)

713

2045

2.30

84.59

1.3

0.62

1.35

u/ml

2.12

304

936

Other and unspecified effects of external causes

282

801

3.58

83.28

1.2

1.3

1.16

1.04

u/ml

0.08

338

Symptoms and signs involving speech and voice

284

817

3.52

82.20

1.5

1.3

1.71

1.36

u/ml

0.20

152

371

Atopic dermatitis

473

1535

2.65

80.81

1.3

1.48

0.96

u/ml

0.80

213

612

Chronic laryngitis and laryngotracheitis

121

174

7.08

79.90

1.5

1.2

0.63

2.43

u/ml

0.75

Other diseases of pleura

294

769

3.42

79.04

1.4

1.3

1.74

1.50

u/ml

0.16

177

389

Dermatitis due to ingested food

11.48

78.93

1.2

1.3

1.37

0.62

u/ml

0.50

Unspecified chronic bronchitis

34.41

78.46

1.6

1.1

2.50

0.02

u/ml

—

Sleep apnoea

642

1891

2.32

78.27

1.3

0.67

1.39

u/ml

1.89

279

886

Atopic dermatitis, strict definition

308

946

3.24

77.44

1.3

1.67

0.86

u/ml

1.02

130

358

COPD, hospital admissions 1, only main diagnosis

236

517

3.93

76.71

1.5

1.3

2.23

1.24

u/ml

0.85

165

255

Vocal cord dysfunction

156

277

5.32

75.30

1.5

1.2

0.57

1.52

u/ml

0.58

110

Diseases of oesophagus, stomach and duodenum

743

2097

2.16

75.05

1.3

0.86

1.36

u/ml

0.85

356

892

ILD, hospital admissions 1, main diag only

132

241

5.60

68.88

1.6

1.3

1.03

1.28

u/ml

0.16

121

ILD medications: immunosuppressive drugs

331

1106

2.89

68.65

1.3

1.2

0.80

0.55

u/ml

0.28

149

309

COPD related to multimorbidity

236

559

3.59

67.34

1.4

1.3

2.38

1.03

u/ml

1.22

159

284

Drug-induced adrenocortical insufficiency

15.85

66.47

2.1

1.1

1.70

0.39

u/ml

0.82

Eosinophilia

17.97

64.99

1.8

1.2

7.17

0.32

u/ml

1.13

Unspecified acute lower respiratory infection

145

309

4.77

63.38

1.7

1.3

0.96

0.98

u/ml

0.01

117

Adrenocortical insufficiency

9.22

61.36

2.2

1.2

1.49

0.87

u/ml

0.34

Codeine

656

1716

2.11

60.87

1.3

1.20

1.11

u/ml

0.10

328

690

Chronic diseases of tonsils and adenoids

431

1114

2.46

59.11

1.3

0.90

1.57

u/ml

0.75

203

394

Codeine or tramadol medication

751

2136

1.96

57.03

1.3

1.19

1.09

u/ml

0.12

381

895

Other disorders of adrenal gland

111

7.61

56.26

2.1

1.3

2.17

0.73

u/ml

0.77

All influenza

176

481

3.70

55.15

1.6

1.2

1.72

1.18

u/ml

0.29

113

161

Other soft tissue disorders, not elsewhere classified

605

1825

2.06

54.27

1.3

1.07

1.19

u/ml

0.11

282

736

Personal history of allergy to analgesic agent

34.90

53.45

1.3

1.1

1.26

0.11

u/ml

—

Desensitization to allergens

157

6.13

52.96

1.2

1.4

0.68

0.49

u/ml

0.24

Immunodeficiencies

124

6.88

52.06

1.9

1.3

0.60

0.80

u/ml

0.17

Fever of other and unknown origin

356

1373

2.42

51.58

1.5

1.3

1.45

1.18

u/ml

0.23

177

598

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

245

384

3.22

50.21

1.3

1.1

0.59

1.82

u/ml

0.86

112

Diagnoses used for exclusion with ILD

184

559

3.33

49.09

1.6

1.3

2.44

1.30

u/ml

0.61

111

259

Examination and observation for other reasons

386

996

2.37

48.40

1.3

1.2

0.75

1.39

u/ml

0.88

190

327

Pain in joint

389

1111

2.33

48.14

1.4

1.2

0.78

1.26

u/ml

0.74

199

456

Pulmonary eosinophilia, not elsewhere classified

21.23

48.11

1.9

1.1

5.33

0.06

u/ml

—

Diseases of the skin and subcutaneous tissue

637

1641

1.95

47.18

1.4

1.3

1.18

1.29

u/ml

0.13

283

707

Polypectomy (DHB20)

131

6.27

46.90

1.7

1.4

1.22

0.61

u/ml

0.42

Personal history of allergy to drugs, medicaments and biological substances

16.19

46.58

1.3

1.0

1.11

0.08

u/ml

—

Lung cancer and mesothelioma

11.11

46.15

1.2

1.0

0.29

0.15

u/ml

—

Tramadol

486

1516

2.07

44.91

1.3

1.27

1.05

u/ml

0.22

248

629

Childhood allergy (age < 16)

147

325

3.78

44.88

1.3

2.29

0.33

u/ml

2.42

Dermatitis

375

1720

2.19

43.96

1.3

1.86

1.01

u/ml

0.79

160

782

Immunodeficiency with predominantly antibody defects

8.59

43.56

1.5

1.3

0.29

0.90

u/ml

0.43

Pain in limb

486

1745

2.02

43.41

1.3

1.37

1.21

u/ml

0.12

220

710

Certain disorders involving the immune mechanism

160

482

3.37

43.40

1.7

1.3

0.68

1.15

u/ml

0.58

213

Opioids

628

1746

1.90

43.21

1.3

0.99

1.12

u/ml

0.17

296

701

Abnormalities of heart beat

191

637

2.99

42.78

1.2

1.3

0.72

1.28

u/ml

0.61

260

Episodal and paroxysmal disorders

690

1936

1.83

42.60

1.3

1.14

1.19

u/ml

0.05

297

839

Viral pneumonia

101

223

4.60

42.39

1.6

1.2

1.57

1.12

u/ml

0.17

Exposure to unspecified factor

604

2539

1.85

42.35

1.3

1.04

1.29

u/ml

0.42

273

1090

Other and unspecified urticaria

170

546

3.15

41.53

1.3

0.81

1.26

u/ml

0.31

223

Other special examinations and investigations of persons without complaint or reported diagnosis

427

1003

2.16

41.44

1.4

1.2

1.26

1.38

u/ml

0.10

219

329

Other specific joint derangements/joint disorders

476

1620

1.98

39.40

1.3

1.04

1.18

u/ml

0.14

232

673

General symptoms and signs

682

1910

1.80

39.27

1.3

1.01

1.31

u/ml

0.43

307

795

Headache

423

1754

2.03

39.09

1.3

1.23

1.26

u/ml

0.02

196

714

Other and unspecified dermatitis

315

1415

2.24

38.99

1.3

1.06

0.97

u/ml

0.07

126

642

Parasetamol

499

1291

1.98

38.70

1.3

0.87

1.32

u/ml

0.61

218

538

Other general symptoms and signs

134

5.54

37.53

1.3

1.2

0.10

0.77

u/ml

0.75

Dermatographic urticaria

195

4.63

36.98

1.4

1.2

2.07

0.59

u/ml

0.45

Implicit fungal Sepsis

7.90

36.74

2.3

1.1

5.98

0.94

u/ml

1.58

Other disorders of white blood cells

128

5.63

36.71

1.7

1.4

5.72

0.65

u/ml

1.02

Other symptoms and signs involving the circulatory and respiratory systems

6.34

36.42

1.2

1.4

0.45

1.76

u/ml

0.65

Fungal Sepsis

7.47

35.78

2.3

1.1

5.82

0.89

u/ml

1.60

Other headache syndromes

276

1240

2.24

34.25

1.3

0.94

u/ml

0.00

118

534

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

570

2323

1.77

33.73

1.4

1.3

1.20

1.30

u/ml

0.09

288

993

COPD-related respiratory insufficiency

169

4.68

33.58

1.5

1.3

1.92

1.06

u/ml

0.41

Persons encountering health services in other circumstances, wide

711

2201

1.68

33.06

1.3

1.23

1.27

u/ml

0.05

333

929

Other and unspecified immunodeficiencies with predominantly antibody defects

12.66

32.88

1.7

1.2

0.33

0.08

u/ml

—

Medical observation and evaluation for suspected diseases and conditions

395

1003

2.03

32.70

1.5

1.2

1.16

1.38

u/ml

0.17

219

329

Non-invasive ventilation

148

471

2.98

32.54

1.8

1.3

0.75

1.76

u/ml

1.01

131

193

Dysphagia

142

488

2.93

30.91

1.2

1.3

0.81

1.33

u/ml

0.45

235

Exclusions for E4_PCOS_BROAD

137

462

3.00

30.87

1.6

1.3

1.31

0.70

u/ml

0.46

183

Disorders of other endocrine glands

273

1257

2.15

30.57

1.6

1.3

0.93

1.04

u/ml

0.11

135

528

Low back pain

424

1757

1.87

30.55

1.4

1.3

1.08

1.34

u/ml

0.27

193

747

Spondylosis

294

1205

2.10

30.37

1.3

1.31

1.53

u/ml

0.16

125

562

Idiopathic pulmonary fibrosis

111

5.41

29.96

1.6

1.3

0.86

1.69

u/ml

0.45

Later onset COPD

120

290

3.27

29.57

1.3

2.31

1.32

u/ml

0.51

149

Persons encountering health services for other counselling and medical advice, not elsewhere classified

640

2196

1.67

29.52

1.3

0.75

1.27

u/ml

1.36

308

928

Congenital malformations of trachea and bronchus

13.86

29.25

1.8

1.3

0.34

0.06

u/ml

—

Neurological diseases

534

1531

1.76

29.14

1.3

1.40

1.30

u/ml

0.08

237

618

Other joint disorders

539

1652

1.74

28.80

1.3

0.86

1.17

u/ml

0.43

227

687

Pulmonary heart disease, diseases of pulmonary circulation

169

661

2.57

28.68

1.6

1.3

1.94

1.39

u/ml

0.33

318

Idiopathic urticaria

7.67

28.65

1.3

0.09

0.37

u/ml

0.51

Soft tissue disorders

603

1860

1.69

28.63

1.3

1.15

1.19

u/ml

0.03

280

745

Dorsalgia

571

1814

1.71

28.62

1.3

0.77

1.33

u/ml

1.10

267

764

Provisional assignment of new diseases of uncertain etiology

279

1361

2.06

28.14

1.4

1.3

1.25

1.22

u/ml

0.02

131

561

Codes for special purposes

279

1362

2.06

28.08

1.4

1.3

1.25

1.22

u/ml

0.02

131

562

Depression or dysthymia

416

1255

1.86

27.85

1.3

0.89

1.38

u/ml

0.76

183

557

Migraine

318

1374

1.98

27.83

1.3

1.68

0.78

u/ml

0.72

140

548

Congenital malformations of the respiratory system

8.32

27.53

1.6

1.5

2.00

0.07

u/ml

0.58

Diseases of the eye and adnexa

515

1482

1.75

27.28

1.3

1.04

1.10

u/ml

0.05

229

556

Other dorsopathies, not elsewhere classified

579

1823

1.68

27.13

1.3

0.76

1.33

u/ml

1.24

276

769

Care involving use of rehabilitation procedures

368

1900

1.85

26.73

1.5

1.3

0.87

1.35

u/ml

0.84

223

793

Persons encountering health services for specific procedures and health care

621

2374

1.63

26.52

1.4

1.3

0.70

1.34

u/ml

1.27

328

958

Hypersensitivity pneumonitis due to organic dust

9.15

26.52

1.5

1.2

0.12

0.08

u/ml

0.24

ILD-related respiratory insufficiency

7.32

26.41

1.6

1.1

0.62

0.88

u/ml

0.13

Sulfasalazine

127

448

2.85

26.40

1.3

1.1

0.37

0.68

u/ml

0.37

139

Irritable bowel syndrome

187

798

2.36

26.37

1.4

1.3

1.19

0.89

u/ml

0.23

350

Covid-19 confirmed case

176

732

2.42

26.28

1.4

1.3

1.77

1.51

u/ml

0.11

301

Pulmonary embolism

155

608

2.57

26.21

1.6

1.3

2.08

1.36

u/ml

0.41

288

Pneumonia due to other infectious organisms, not elsewhere classified

7.17

25.98

2.6

1.1

7.36

1.25

u/ml

0.71

Pulmonary heart disease

155

611

2.55

25.95

1.6

1.3

2.08

1.35

u/ml

0.42

290

Persons with potential health hazards related to communicable diseases

264

1295

2.04

25.68

1.3

0.77

1.00

u/ml

0.31

514

Other disorders of lacrimal gland

204

919

2.24

25.34

1.4

1.3

1.00

1.23

u/ml

0.28

111

423

Somatoform disorder

120

422

2.87

25.19

1.4

1.3

1.47

1.68

u/ml

0.08

175

Other intervertebral disc disorders

455

1604

1.74

25.14

1.4

1.3

1.41

1.33

u/ml

0.07

242

698

Neurological diseases, wide definition

213

461

2.33

24.73

1.3

1.2

0.36

1.43

u/ml

1.60

156

Lung diseases due to external agents

242

3.51

24.61

1.5

1.3

1.89

1.07

u/ml

0.34

120

Persons encountering health services in other circumstances

230

1098

2.11

24.61

1.4

1.3

2.47

1.24

u/ml

0.82

453

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

219

3.67

24.60

1.4

1.2

1.56

0.55

u/ml

0.46

General examination and investigation of persons without complaint and reported diagnosis

354

1003

1.89

24.40

1.4

1.2

0.99

1.38

u/ml

0.42

183

329

Gastrointestinal diseases

377

1022

1.86

24.35

1.3

0.82

1.38

u/ml

0.68

146

397

Bacterial Sepsis

205

829

2.21

24.34

1.6

1.3

1.32

1.34

u/ml

0.01

127

397

Osteoporosis

131

466

2.70

24.31

1.4

1.3

0.79

0.95

u/ml

0.20

249

Abdominal and pelvic pain

565

1732

1.64

24.21

1.3

1.58

1.39

u/ml

0.17

245

747

Functional dyspepsia

155

635

2.46

23.98

1.4

1.3

1.65

1.00

u/ml

0.27

279

Implicit bacterial Sepsis

179

714

2.31

23.76

1.5

1.3

1.27

1.38

u/ml

0.07

115

348

Diseases of the ear and mastoid process

677

2196

1.56

23.71

1.4

1.3

1.11

1.29

u/ml

0.25

319

914

Complications of surgical and medical care, not elsewhere classified

534

2360

1.63

23.69

1.3

0.98

1.29

u/ml

0.46

262

1022

Anxiety disorders

531

2316

1.63

23.65

1.3

0.56

1.34

u/ml

2.29

235

984

Certain infectious and parasitic diseases

568

1749

1.63

23.56

1.4

1.2

1.37

0.80

u/ml

0.97

277

664

Neurotic, stress-related and somatoform disorders

526

2304

1.63

23.34

1.3

0.57

1.34

u/ml

2.24

233

975

Allergic contact dermatitis

106

364

2.95

23.29

1.3

1.28

1.10

u/ml

0.07

160

Candidiasis

100

333

3.04

23.20

1.4

1.2

1.33

0.75

u/ml

0.40

130

Disorders of lacrimal system

238

1179

2.03

23.15

1.4

1.3

1.17

1.19

u/ml

0.02

124

539

Malaise and fatigue

247

1022

2.02

23.06

1.3

0.69

1.23

u/ml

0.69

116

457

Myalgia

144

585

2.48

22.73

1.4

1.3

0.75

1.14

u/ml

0.42

241

Infections, IBD-co-morbidities

100

234

3.14

22.64

1.5

1.2

1.56

1.33

u/ml

0.09

103

Contact with and exposure to communicable diseases

225

1097

2.06

22.63

1.2

1.3

0.90

0.89

u/ml

0.01

421

Disorders of synovium and tendon

298

1440

1.87

22.51

1.3

1.41

1.17

u/ml

0.18

155

597

Recurrent or chronic depression

258

940

1.99

22.44

1.3

0.33

1.38

u/ml

2.59

108

386

Anxiety disorders, excluding more controls

494

2001

1.64

22.40

1.3

0.60

1.42

u/ml

2.07

220

829

Disorders of thyroid, IBD co-morbidities

116

299

2.85

22.31

1.3

1.2

0.25

1.20

u/ml

0.89

109

Spondylopathies

408

1434

1.73

22.21

1.3

0.80

1.37

u/ml

0.92

184

646

Other antidepressants

562

1832

1.61

22.12

1.3

0.98

1.30

u/ml

0.43

248

802

Other arthrosis

272

1007

1.94

21.93

1.3

1.38

1.36

u/ml

0.01

141

471

Selective deficiency of immunoglobulin G [IgG] subclasses

12.60

21.64

1.4

1.3

0.38

0.10

u/ml

—

Any gastric operation

488

1482

1.66

21.59

1.4

1.2

0.96

1.36

u/ml

0.55

213

563

GASTRO-related operations

488

1482

1.66

21.59

1.4

1.2

0.96

1.36

u/ml

0.55

213

563

Venous thromboembolism

260

1319

1.92

21.58

1.5

1.3

1.70

1.22

u/ml

0.40

134

649

Osteopathies and chondropathies

287

1471

1.86

21.41

1.3

1.05

1.28

u/ml

0.24

158

665

Cardiovascular diseases

410

1300

1.72

21.38

1.3

0.80

1.53

u/ml

1.09

183

448

Implicit Sepsis

364

1626

1.75

21.37

1.4

1.3

1.48

1.23

u/ml

0.24

205

735

Symptoms and signs involving the digestive system and abdomen

552

1732

1.60

21.35

1.3

1.59

1.39

u/ml

0.19

239

747

Dorsopathies

570

1840

1.59

21.25

1.2

1.3

0.74

1.33

u/ml

1.27

258

772

Kela reimbursement Agammaglobulinemia (D80-84)

11.79

20.89

1.6

1.1

0.35

0.10

u/ml

—

Hypothyroidism, levothyroxine purchases

190

495

2.22

20.66

1.4

1.3

1.21

1.45

u/ml

0.13

179

Hypothyroidism and >3 levothyroxin purchases

190

495

2.22

20.66

1.4

1.3

1.21

1.45

u/ml

0.13

179

Oedema, not elsewhere classified

156

682

2.29

20.63

1.1

1.3

0.71

1.48

u/ml

0.72

312

Constipation

454

1996

1.63

20.55

1.3

0.82

1.34

u/ml

1.04

210

893

Peritonsillar abscess

101

362

2.81

20.52

1.3

1.2

0.94

1.59

u/ml

0.35

134

Deforming dorsopathies

162

727

2.24

20.43

1.2

1.3

0.60

1.47

u/ml

1.32

316

Lower back pain or/and sciatica

554

2477

1.56

20.33

1.3

0.89

1.34

u/ml

0.74

249

1092

Other bacterial diseases

483

2086

1.61

20.25

1.5

1.3

1.36

1.25

u/ml

0.11

278

887

Suppurative and necrotic conditions of lower respiratory tract

4.73

20.13

1.5

1.3

2.61

0.70

u/ml

0.72

Other symptoms and signs involving the nervous and musculoskeletal systems

237

1234

1.93

20.05

1.3

0.77

1.26

u/ml

0.60

100

541

Implicit viral Sepsis

104

384

2.73

20.00

1.4

1.3

1.68

1.16

u/ml

0.23

167

Viral Sepsis

104

384

2.73

20.00

1.4

1.3

1.68

1.16

u/ml

0.23

167

Hypothyroidism (congenital or acquired)

189

499

2.19

19.87

1.3

1.20

1.44

u/ml

0.13

180

Other diseases of hard tissues of teeth

366

1604

1.71

19.73

1.4

1.3

1.30

1.37

u/ml

0.04

179

678

Rheumatism, unspecified

343

2.83

19.69

1.2

1.3

0.60

1.16

u/ml

0.37

155

Systemic connective tissue disorders

192

935

2.07

19.67

1.3

0.36

1.21

u/ml

2.18

439

Complications of medical and surgical care

376

2140

1.67

19.61

1.4

1.3

0.99

1.26

u/ml

0.38

196

952

D07AA Corticosteroids, weak (group I)

117

463

2.55

19.58

1.5

1.3

1.81

0.98

u/ml

0.71

170

All influenza (not pneumonia)

286

3.00

19.40

1.6

1.2

2.96

1.56

u/ml

0.38

Other complications of surgical and medical care, not elsewhere classified

225

3.29

19.37

1.2

1.3

0.51

0.90

u/ml

0.32

Arthropathies

516

1667

1.58

19.02

1.3

1.17

u/ml

0.00

214

688

DVT of lower extremities and pulmonary embolism

194

960

2.02

18.84

1.6

1.3

2.08

1.32

u/ml

0.54

107

476

Other and unspecified drugs and medicaments

210

3.34

18.72

1.4

1.2

1.63

0.54

u/ml

0.47

Allergic urticaria

220

3.27

18.71

1.4

1.2

0.96

1.11

u/ml

0.08

Diaphragmatic hernia

184

900

2.06

18.65

1.3

0.46

1.55

u/ml

2.54

112

443

Allergic colitis

5.83

18.59

1.5

1.6

1.69

0.70

u/ml

0.48

Diseases of middle ear and mastoid

329

1573

1.72

18.55

1.5

1.3

1.07

1.09

u/ml

0.02

144

644

Osteoporosis with pathological fracture (FG)

110

4.34

18.54

1.1

1.2

0.32

1.24

u/ml

0.57

Lumbar disc prolapse

331

1536

1.72

18.53

1.4

1.3

1.61

1.31

u/ml

0.25

171

677

Symptoms and signs involving the nervous and musculoskeletal systems

300

1722

1.75

18.52

1.3

0.81

1.16

u/ml

0.49

135

777

Other diseases of blood and blood-forming organs, wide

125

525

2.40

18.46

1.5

1.4

3.34

1.20

u/ml

0.68

242

Cardiovascular diseases (excluding rheumatic etc)

412

1454

1.64

18.28

1.3

0.91

1.35

u/ml

0.58

197

522

Vasomotor rhinitis (mode)

165

3.63

18.23

1.3

1.2

0.07

0.22

u/ml

1.65

Viral pneumonia (unknown virus, not influenza)

143

3.83

18.06

1.2

1.3

1.97

0.56

u/ml

0.35

Disorders of eyelid, lacrimal system and orbit

433

2140

1.59

18.00

1.4

1.3

0.94

1.25

u/ml

0.53

233

944

Other diseases of intestines

589

2284

1.50

17.92

1.3

1.22

1.32

u/ml

0.10

262

977

Enthesopathies of lower limb, excluding foot

130

564

2.32

17.84

1.3

1.10

1.56

u/ml

0.28

243

Nonhereditary hypogammaglobulinemia

9.29

17.83

1.7

1.0

0.54

0.05

u/ml

—

Other immunodeficiencies

8.66

17.68

3.0

1.1

1.36

0.05

u/ml

—

Triptan medication for migraine, min. 3 purchases

353

1681

1.66

17.53

1.2

1.3

0.34

0.96

u/ml

2.58

136

661

Occupational exposure to risk-factors

5.06

17.43

1.4

1.2

0.16

0.24

u/ml

0.20

Fibromyalgia

230

3.13

17.40

1.2

0.05

1.66

u/ml

1.08

Exposure to other specified factors

395

2320

1.60

17.34

1.3

0.56

1.25

u/ml

2.13

182

993

Shoulder lesions

382

1426

1.65

17.34

1.3

1.51

1.24

u/ml

0.22

199

624

Temporomandibular joint disorders

103

408

2.54

17.28

1.4

1.2

0.28

0.99

u/ml

0.75

162

Triptan medication for migraine, single purchase ok

452

1963

1.56

17.00

1.2

1.3

0.56

1.31

u/ml

2.43

180

820

Migraine, single triptan purchase ok & required. ICD-code if available is included

452

1963

1.56

17.00

1.2

1.3

0.56

1.31

u/ml

2.43

180

820

Cervical disc disorders

186

947

1.97

16.91

1.4

1.3

1.17

1.39

u/ml

0.13

104

444

Depression medications

205

516

2.01

16.83

1.2

1.3

0.78

1.41

u/ml

0.62

188

Diseases of the musculoskeletal system and connective tissue

313

903

1.74

16.82

1.3

0.76

1.32

u/ml

0.65

118

330

Intestinal infectious diseases

493

2531

1.52

16.74

1.3

0.89

1.30

u/ml

0.70

212

1102

Other noninfective gastroenteritis and colitis

140

644

2.19

16.69

1.3

1.20

1.13

u/ml

0.04

269

Migraine with aura

150

710

2.13

16.67

1.3

2.64

0.71

u/ml

0.82

276

Soft tissue disorders related to use, overuse and pressure

135

613

2.22

16.65

1.4

1.3

0.46

1.16

u/ml

1.19

282

Other heart diseases

289

1097

1.75

16.61

1.4

1.3

1.53

1.45

u/ml

0.05

142

419

Diarrhoea and gastroenteritis of presumed infectious origin

371

2101

1.61

16.58

1.3

1.06

1.23

u/ml

0.17

153

905

Polyarthrosis

375

2.55

16.57

1.3

0.55

0.84

u/ml

0.48

196

Pain (limb, back, neck, head abdominally)

381

1166

1.64

16.43

1.3

1.2

1.66

1.23

u/ml

0.34

159

465

Migraine with aura and triptan purchases

112

473

2.39

16.42

1.2

1.3

0.68

1.06

u/ml

0.25

182

Hypothyroidism, other/unspecified

474

2046

1.53

16.30

1.3

1.14

1.17

u/ml

0.03

192

911

Noninfective enteritis and colitis

248

1400

1.78

16.26

1.3

0.84

1.24

u/ml

0.54

101

614

Cervicalgia

112

477

2.36

16.09

1.2

1.3

0.77

1.51

u/ml

0.70

214

Autoimmune diseases related-to ILD

430

2454

1.55

16.08

1.3

0.40

1.34

u/ml

5.10

182

1071

Other systemic involvement of connective tissue (FG)

140

651

2.15

16.00

1.3

0.19

1.63

u/ml

3.21

300

Complications of procedures, not elsewhere classified

406

2249

1.56

15.99

1.4

1.3

1.32

1.23

u/ml

0.08

208

982

Hypothyreosis and Thyroxine purchase for inclusion criteria

486

2119

1.52

15.96

1.3

1.10

1.13

u/ml

0.03

198

947

Polyarteritis nodosa and related conditions

8.38

15.87

1.8

1.2

0.40

0.08

u/ml

0.92

Sequelae of external causes of morbidity and mortality

127

575

2.22

15.81

1.3

1.03

1.32

u/ml

0.17

270

Hypothyroidism, strict autoimmune

387

1614

1.59

15.71

1.3

1.48

1.34

u/ml

0.10

139

718

Injuries to the knee and lower leg

623

2473

1.45

15.64

1.3

1.37

1.21

u/ml

0.16

300

1055

Conjunctivitis (acute, non atopic)

152

741

2.06

15.51

1.2

1.3

1.83

1.31

u/ml

0.20

300

Autoimmune diseases

591

2066

1.46

15.50

1.4

1.3

0.78

1.38

u/ml

1.27

248

909

Used for control exclusion in common control thyroid runs

565

1946

1.48

15.37

1.4

1.3

0.79

1.46

u/ml

1.30

227

845

Pain, not elsewhere classified

147

713

2.07

15.35

1.2

1.3

0.81

1.14

u/ml

0.30

294

Rotator cuff syndrome

290

1276

1.69

15.33

1.4

1.3

1.57

1.35

u/ml

0.14

149

569

Drug-induced osteoporosis

9.87

15.32

1.2

1.3

0.15

0.07

u/ml

—

Mouth breathing

206

1122

1.84

15.28

1.3

1.57

1.28

u/ml

0.17

497

Antihypertensive medication - note that there are other indications

386

1328

1.60

15.20

1.2

1.3

0.53

1.19

u/ml

1.28

153

511

Nerve, nerve root and plexus disorders

534

2284

1.47

15.04

1.3

0.89

1.32

u/ml

0.69

267

1002

Disturbances of skin sensation

158

794

2.00

15.00

1.2

1.3

0.38

1.06

u/ml

1.29

339

Autoimmune diseases excluding thyroid diseases

542

2047

1.47

14.94

1.3

0.49

1.39

u/ml

3.48

253

904

Other systemic involvement of connective tissue

143

694

2.07

14.94

1.3

0.21

1.15

u/ml

2.28

333

Migraine without aura

129

604

2.15

14.82

1.3

0.76

0.68

u/ml

0.05

225

All anxiety disorders

349

1769

1.59

14.74

1.2

1.3

0.45

1.27

u/ml

2.81

150

722

Dentofacial anomalies [including malocclusion]

166

845

1.95

14.69

1.4

1.3

0.58

0.89

u/ml

0.54

334

Other external causes of accidental injury

457

1502

1.53

14.68

1.4

1.3

1.45

1.40

u/ml

0.03

194

618

Other functional intestinal disorders

223

1199

1.78

14.62

1.3

0.98

1.16

u/ml

0.14

543

Other heart diseases, wide

503

2111

1.48

14.62

1.4

1.3

1.19

1.15

u/ml

0.04

226

887

Factors influencing health status and contact with health services

153

363

2.12

14.58

1.4

1.2

0.79

2.01

u/ml

0.83

118

Symptoms and signs involving the skin and subcutaneous tissue

349

2211

1.58

14.54

1.4

1.3

0.90

1.20

u/ml

0.37

155

982

Pleural plaque

118

3.76

14.48

1.3

1.4

4.09

2.77

u/ml

0.20

Visual disturbances

237

1370

1.74

14.45

1.3

0.91

1.22

u/ml

0.25

109

614

Injuries to the ankle and foot

376

2218

1.55

14.35

1.3

0.95

1.14

u/ml

0.22

187

906

Autoimmune diseases excluding thyroid diseases, strict definition

524

1994

1.47

14.23

1.4

1.3

0.65

1.42

u/ml

2.18

241

873

Other medical care

177

919

1.89

14.17

1.4

1.3

1.99

1.55

u/ml

0.16

418

Other disorders of urethra and urinary system

368

1772

1.56

14.10

1.4

1.3

0.99

1.31

u/ml

0.35

173

759

Drug-induced osteoporosis with pathological fracture

7.26

14.08

1.1

1.2

0.10

1.46

u/ml

0.48

Suppurative and unspecified otitis media

215

1075

1.78

14.02

1.4

1.2

1.09

1.04

u/ml

0.04

405

Bleeding

375

1761

1.55

14.00

1.5

1.3

1.14

1.35

u/ml

0.25

214

795

Acute suppurative otitis media

167

817

1.92

13.91

1.5

1.2

1.24

0.77

u/ml

0.47

296

Endocrine, nutritional and metabolic diseases

470

1602

1.50

13.80

1.4

1.3

0.76

1.36

u/ml

1.06

206

656

Nonsuppurative otitis media

141

603

2.03

13.66

1.7

1.2

0.84

0.91

u/ml

0.06

204

Anaemias

145

473

2.05

13.60

1.3

0.97

1.44

u/ml

0.26

164

Temporomandibular joint disorders, including avohilmo

248

1475

1.69

13.59

1.3

1.23

0.84

u/ml

0.27

103

589

Mood [affective] disorders

538

2467

1.44

13.58

1.2

1.3

0.77

1.35

u/ml

1.38

237

1079

Mood disorders

538

2468

1.44

13.45

1.2

1.3

0.77

1.35

u/ml

1.38

237

1080

Accidents

448

1502

1.50

13.18

1.4

1.3

1.49

1.40

u/ml

0.06

188

618

Pneumonia due to Streptococcus pneumoniae

4.45

13.11

2.2

1.2

1.10

1.03

u/ml

0.02

External causes of morbidity and mortality

365

1173

1.56

13.04

1.4

1.3

1.04

1.42

u/ml

0.38

152

471

Syncope and collapse

188

925

1.81

12.95

1.3

1.36

1.42

u/ml

0.03

432

Hypothyroidism, strict autoimmune, 3 medication purchases required

435

2009

1.48

12.89

1.3

1.32

1.12

u/ml

0.18

157

901

Other arrhythmias

327

1603

1.57

12.84

1.3

1.05

1.23

u/ml

0.14

142

714

Dizziness and giddiness

359

1909

1.53

12.84

1.3

0.85

1.30

u/ml

0.63

182

856

Injury, poisoning and certain other consequences of external causes

310

963

1.62

12.78

1.3

0.63

1.42

u/ml

1.23

115

388

Depression

503

2417

1.44

12.76

1.3

0.81

1.35

u/ml

1.16

223

1045

Sciatica+with lumbago

245

1404

1.66

12.69

1.4

1.3

1.07

1.35

u/ml

0.22

124

610

Coxibs

141

368

2.05

12.55

1.2

1.4

0.66

0.81

u/ml

0.10

170

Persons encountering health services for examination and investigation

319

1003

1.60

12.55

1.4

1.2

1.08

1.38

u/ml

0.24

141

329

Other/unspecified dorsalgia

178

984

1.81

12.50

1.2

1.3

0.68

1.39

u/ml

0.90

439

Selective serotonin reuptake inhibitors

504

1843

1.44

12.47

1.2

1.3

1.41

1.29

u/ml

0.09

229

805

Visual disturbances and blindness

241

1460

1.66

12.42

1.3

0.89

1.17

u/ml

0.23

111

662

Hypertensive diseases (excluding secondary)

301

1094

1.60

12.42

1.2

1.3

0.73

1.51

u/ml

1.03

143

425

Acute bronchiolitis

148

3.14

12.38

1.3

1.22

0.67

u/ml

0.35

Disorders of the thyroid gland

476

2159

1.44

12.36

1.3

0.83

1.21

u/ml

0.62

197

966

Use of hypnotics and sedatives

537

2194

1.42

12.35

1.3

1.02

1.31

u/ml

0.39

274

937

Budesonide

210

2.83

12.33

1.2

0.21

0.86

u/ml

0.50

Acute laryngitis and tracheitis

332

2.42

12.33

1.6

1.2

0.67

0.35

u/ml

0.61

101

5-aminosalicylic acid

356

2.37

12.31

1.2

0.23

0.83

u/ml

0.74

104

Other enthesopathies

154

823

1.88

12.28

1.2

1.3

1.24

1.06

u/ml

0.11

355

Heart failure, not strict

333

1486

1.55

12.26

1.3

0.88

1.46

u/ml

0.90

193

703

Meniscus derangement

262

1097

1.64

12.19

1.4

1.3

2.21

1.29

u/ml

0.51

120

503

Internal derangement of knee

184

1038

1.77

12.19

1.2

1.3

0.99

1.22

u/ml

0.18

472

Anxiety (asthma-related co-morbidities)

338

1745

1.53

12.11

1.2

1.3

0.46

1.32

u/ml

2.87

147

717

Other disorders of patella

101

467

2.18

12.07

1.3

1.2

0.49

0.96

u/ml

0.53

203

Non-selective monoamine reuptake inhibitors

188

1041

1.76

12.02

1.2

1.3

0.86

1.36

u/ml

0.35

485

Nausea and vomiting

124

611

2.00

11.93

1.3

0.80

1.16

u/ml

0.26

259

Open wound of lower leg

326

2.41

11.83

1.6

1.4

2.35

0.79

u/ml

0.94

142

Infections of the skin and subcutaneous tissue

282

1789

1.57

11.83

1.3

0.73

1.21

u/ml

0.97

124

782

Condition for Implicit Sepsis (Organ dysfunction codes)

399

1969

1.48

11.81

1.4

1.3

1.33

u/ml

0.00

212

870

Other nutritional deficiencies

334

2161

1.52

11.75

1.2

1.3

0.66

1.15

u/ml

0.68

153

915

Trochanteric bursitis

287

2.49

11.58

1.4

1.3

0.41

1.34

u/ml

0.82

133

Mood disorders, excluding more controls

487

2087

1.42

11.56

1.3

0.80

1.38

u/ml

1.18

218

893

Symptoms and signs involving cognition, perception, emotional state and behaviour

474

2342

1.42

11.48

1.3

1.12

1.30

u/ml

0.20

244

1012

Other reaction to severe stress, and adjustment disorders

207

1235

1.68

11.38

1.3

0.66

1.02

u/ml

0.53

481

Disorders of vestibular function (Vertigo)

209

1243

1.68

11.31

1.3

1.29

1.36

u/ml

0.04

107

586

Other anxiety disorders

250

1385

1.61

11.25

1.3

0.46

1.11

u/ml

1.49

100

542

ILD medications: azathioprine

233

2.63

11.18

1.2

0.11

1.01

u/ml

0.74

Benzodiazepine use

491

2496

1.40

11.08

1.2

1.3

1.06

1.29

u/ml

0.28

230

1100

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

275

1769

1.55

10.92

1.4

1.3

0.83

1.10

u/ml

0.39

153

805

Transport accidents

227

1244

1.62

10.69

1.3

0.65

1.10

u/ml

0.74

515

342

2.30

10.67

1.7

1.2

1.73

1.04

u/ml

0.26

134

Superficial injury of lower leg

126

662

1.91

10.67

1.2

1.3

1.10

1.13

u/ml

0.02

281

Methotrexate

210

2.68

10.66

1.1

1.2

0.46

0.74

u/ml

0.15

Cardiac arrhythmias

339

1501

1.50

10.65

1.3

0.93

1.34

u/ml

0.44

145

626

Other inflammation of eyelid

293

2.41

10.64

1.4

1.3

0.70

1.06

u/ml

0.32

132

Other diseases of urinary system

520

2115

1.39

10.52

1.4

1.3

1.26

1.30

u/ml

0.04

237

914

Follow-up examination after treatment for conditions other than malignant neoplasms

210

826

1.67

10.50

1.3

1.2

1.38

1.12

u/ml

0.12

107

273

Subjective visual disturbances

121

632

1.92

10.44

1.4

1.3

1.75

1.21

u/ml

0.20

280

Spondylolisthesis/Spondylolysis

403

2.17

10.42

1.3

0.43

1.48

u/ml

1.09

183

Sequelae with surgical and medical care as external cause

436

2.12

10.40

1.3

1.4

1.16

1.06

u/ml

0.04

212

TMD related operations

476

2.07

10.40

1.3

0.28

1.20

u/ml

1.20

193

Other gastritis (incl. Duodenitis)

431

2.12

10.29

1.2

1.3

1.11

1.54

u/ml

0.29

207

Sequelae of injuries, of poisoning and of other consequences of external causes

118

615

1.93

10.25

1.3

0.46

1.57

u/ml

1.74

274

Hypertrophy of (infrapatellar) fat pad

8.03

10.20

1.4

1.1

11.93

0.09

u/ml

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

259

1678

1.55

10.16

1.4

1.3

0.86

1.19

u/ml

0.47

147

768

Abnormal findings on examination of blood, without diagnosis

182

1013

1.69

10.07

1.5

1.3

1.09

1.63

u/ml

0.59

106

482

Presence of other functional implants

223

980

1.62

9.98

1.4

1.3

2.21

1.14

u/ml

0.60

106

504

Achilles tendinitis

212

2.61

9.96

1.4

1.3

1.95

0.97

u/ml

0.31

Pain in thoracic spine

348

2.23

9.83

1.6

1.3

0.89

1.34

u/ml

0.26

150

Arthrosis

329

1217

1.49

9.80

1.3

1.56

1.21

u/ml

0.25

153

549

Obesity

311

2091

1.48

9.80

1.2

1.3

0.69

1.10

u/ml

0.50

142

884

Acute pharyngitis

391

2.15

9.78

1.5

1.2

0.18

0.59

u/ml

1.01

127

Obesity and other hyperalimentation

312

2100

1.47

9.74

1.2

1.3

0.69

1.10

u/ml

0.49

142

887

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

207

823

1.64

9.66

1.3

1.2

0.22

0.91

u/ml

1.38

283

Other obstetric conditions, not elsewhere classified

211

844

1.63

9.64

1.3

1.2

0.21

0.89

u/ml

1.40

289

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

172

1012

1.69

9.64

1.3

0.18

0.84

u/ml

2.03

381

Spinal stenosis

194

924

1.65

9.63

1.3

0.94

1.71

u/ml

0.90

102

460

Falls/tendency to fall

581

2174

1.34

9.39

1.3

1.12

1.25

u/ml

0.12

262

887

Septicaemia

153

853

1.73

9.37

1.6

1.3

0.73

1.05

u/ml

0.48

386

Azathioprine

255

2.40

9.33

1.2

0.11

0.75

u/ml

0.62

Other hammer toe(s) (acquired)

314

2.22

9.32

1.3

0.69

0.61

u/ml

0.06

164

L04AA Selective immunosuppressants

112

594

1.90

9.29

1.2

1.3

0.73

1.22

u/ml

0.36

263

Polyarthropathies

305

1377

1.48

9.16

1.3

0.58

1.18

u/ml

0.95

153

588

Explicit Sepsis

168

964

1.68

9.16

1.6

1.3

0.69

1.38

u/ml

1.13

439

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

145

837

1.74

9.11

1.3

0.34

1.35

u/ml

2.08

348

Erysipelas

213

1236

1.58

9.03

1.3

1.2

1.40

1.15

u/ml

0.19

117

572

Hypokalaemia

235

2.44

9.01

1.3

0.52

0.84

u/ml

0.29

110

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

194

1210

1.61

9.01

1.3

0.21

1.02

u/ml

3.14

476

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

445

2108

1.38

8.99

1.3

1.10

1.26

u/ml

0.19

213

947

Benign paroxysmal vertigo

126

702

1.80

8.95

1.2

1.3

1.23

1.29

u/ml

0.03

342

Finngen Rheumatological endpoints

490

2058

1.36

8.94

1.3

0.96

1.35

u/ml

0.54

221

866

Disorders of oesophagus in diseases classified elsewhere

4.98

8.88

2.1

1.2

0.22

1.04

u/ml

0.41

Disorders of skin appendages

233

1523

1.53

8.86

1.2

1.3

0.99

1.09

u/ml

0.08

102

647

Dislocation, sprain and strain of joints and ligaments at neck level

444

2.02

8.85

1.2

1.3

0.28

0.78

u/ml

0.93

168

Other and unspecified tonsillitis

163

827

1.68

8.78

1.3

1.2

1.18

1.08

u/ml

0.05

293

Postmenopausal osteoporosis with pathological fracture

3.30

8.76

1.2

0.39

1.68

u/ml

0.62

Tuberculosis

3.36

8.76

1.5

1.3

1.65

0.64

u/ml

0.49

Benign neoplasm: Colon

198

1227

1.58

8.70

1.5

1.3

1.24

1.38

u/ml

0.11

118

629

Obesity due to excess calories

226

1477

1.54

8.65

1.2

1.3

0.91

1.13

u/ml

0.16

103

625

Fenamates

253

2.14

8.65

1.4

1.3

0.84

0.51

u/ml

0.23

111

Hypothyroidism, drug reimbursement

290

2.08

8.54

1.3

1.4

0.46

1.51

u/ml

1.05

113

Continuous positive airway pressure

367

2.03

8.53

1.4

1.3

0.66

2.13

u/ml

1.09

151

Common variable immunodeficiency

7.87

8.49

2.8

1.3

0.69

0.07

u/ml

—

Infective dermatitis

248

2.35

8.49

1.1

1.3

5.28

0.52

u/ml

0.99

111

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

241

1002

1.53

8.45

1.3

0.73

1.51

u/ml

1.04

116

393

Dislocation, sprain and strain of joints and ligaments of knee

299

1926

1.45

8.44

1.3

1.69

1.22

u/ml

0.29

134

806

Panic disorder

459

1.97

8.43

1.2

0.44

0.60

u/ml

0.18

154

Diseases of inner ear

228

1469

1.52

8.42

1.3

1.17

1.25

u/ml

0.06

122

695

Migraine without aura and triptan purchases

508

1.92

8.41

1.3

0.94

1.18

u/ml

0.11

193

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

5.94

8.38

1.3

1.2

0.36

0.07

u/ml

—

Oesophagitis

106

3.15

8.38

1.4

1.2

0.17

0.66

u/ml

0.63

Concussion

228

1295

1.53

8.38

1.3

0.42

1.36

u/ml

2.70

528

Trigger finger

313

2.19

8.37

1.3

0.87

1.30

u/ml

0.21

141

Diseases of salivary glands

474

1.95

8.37

1.3

1.58

1.04

u/ml

0.20

208

Viral infections characterized by skin and mucous membrane lesions

193

1226

1.58

8.37

1.5

1.3

1.27

u/ml

0.00

101

521

Other bursopathies

244

2.35

8.32

1.2

1.3

1.32

1.28

u/ml

0.02

115

Other and unspecified nerve root and plexus disorders, also in other diseases

482

1.94

8.32

1.5

1.3

1.17

1.48

u/ml

0.19

216

Other disorders of ear

420

2046

1.37

8.31

1.3

0.69

1.40

u/ml

1.97

214

903

Unspecified privation

257

2.31

8.29

1.5

1.2

0.34

0.90

u/ml

0.58

109

Benign neoplasm of other and ill-defined parts of digestive system

394

2.04

8.27

1.6

1.3

0.37

1.11

u/ml

1.27

195

Hypopituitarism

173

2.63

8.26

1.4

1.3

0.33

0.75

u/ml

0.60

Pyothorax

3.55

8.26

1.3

0.28

0.20

u/ml

0.18

Rosacea

296

2.21

8.23

1.3

1.44

0.98

u/ml

0.16

126

Cervicocranial syndrome

233

2.38

8.23

1.3

0.31

1.04

u/ml

0.78

108

Hypertension, essential

385

1579

1.39

8.23

1.3

0.86

1.56

u/ml

1.00

186

694

Other metabolic disorders

355

2.10

8.21

1.4

1.3

1.34

1.08

u/ml

0.09

156

Bacterial intestinal infections, IBD co-morbidities

395

2.04

8.21

1.4

1.3

0.49

1.14

u/ml

0.82

180

Neuromuscular dysfunction of bladder

180

2.58

8.15

1.9

1.3

1.68

0.59

u/ml

0.52

Other sleep disorders

228

2.38

8.15

1.1

1.3

0.08

1.26

u/ml

1.25

Enlarged lymph nodes

356

2.09

8.14

1.4

1.3

0.45

0.89

u/ml

0.57

151

Injuries to the neck

112

621

1.81

8.13

1.3

0.24

1.03

u/ml

1.83

250

Fall on same level

576

2463

1.31

8.13

1.4

1.3

1.37

1.20

u/ml

0.16

274

1024

Bacterial infection, other or unspecified

194

1119

1.57

8.08

1.5

1.3

1.71

1.17

u/ml

0.37

127

518

Other disorders of fluid, electrolyte and acid-base balance

118

642

1.78

8.03

1.2

1.3

0.77

1.35

u/ml

0.51

317

Disorders of parathyroid gland

414

1.99

7.98

1.1

1.3

0.22

0.80

u/ml

1.20

218

Striking against or struck by other objects

153

931

1.65

7.95

1.3

1.07

1.52

u/ml

0.45

388

Conduction disorders

112

515

1.81

7.94

1.2

1.4

0.67

1.45

u/ml

0.78

243

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

461

2343

1.34

7.94

1.4

1.3

1.57

1.13

u/ml

0.37

214

991

Wegener granulomatosis

4.98

7.93

1.2

0.47

0.08

u/ml

—

Oxicams

101

300

1.92

7.89

1.2

1.3

0.93

0.57

u/ml

0.20

142

Sarcoidosis

321

2.13

7.89

1.5

1.3

0.95

0.89

u/ml

0.03

141

Oter anti-inflammatory and antirheumatic agents, non-steroids

265

1.97

7.88

1.4

1.3

0.33

0.59

u/ml

0.63

135

Other/unspecified synovitis and tenosynovitis

244

2.31

7.88

1.4

5.90

1.46

u/ml

0.72

109

Dental caries

117

657

1.77

7.88

1.4

1.3

0.91

1.20

u/ml

0.18

277

Other extrapyramidal and movement disorders in other diseases

514

1.88

7.81

1.2

1.3

0.93

1.34

u/ml

0.29

246

Other/unspecified enthesopathies of lower limb, excluding foot

161

2.63

7.78

1.1

1.2

0.03

1.30

u/ml

0.98

Preparation and fitting of bite rail to mouth

390

2.01

7.77

1.3

0.20

0.93

u/ml

1.43

155

Scoliosis

209

2.41

7.74

1.1

1.4

0.90

1.36

u/ml

0.23

Excessive, frequent and irregular menstruation

224

817

1.53

7.70

1.3

0.35

1.75

u/ml

2.53

100

322

Rheumatoid arthritis

137

741

1.69

7.67

1.2

1.3

0.90

1.45

u/ml

0.59

344

Urticaria due to cold and heat

6.89

7.66

1.4

0.17

u/ml

—

Congenital malformations, deformations and chromosomal abnormalities

298

2019

1.42

7.64

1.3

1.10

1.14

u/ml

0.03

140

814

Propionic acid derivatives

137

397

1.74

7.62

1.2

1.4

0.73

0.83

u/ml

0.09

183

Hypermobility syndrome

169

2.57

7.60

1.3

1.2

0.10

0.73

u/ml

0.81

Otalgia

199

2.43

7.58

1.2

1.3

0.27

1.20

u/ml

0.72

Pruritus

236

2.30

7.57

1.2

1.98

0.48

u/ml

0.90

100

Paracetamol of NSAID medication

218

2.02

7.55

1.4

1.3

0.41

0.94

u/ml

0.80

Other diseases of oesophagus

176

2.52

7.48

1.4

1.3

2.49

1.02

u/ml

0.46

Dentinal caries

103

569

1.81

7.47

1.4

1.3

0.34

1.32

u/ml

2.37

244

Abnormal findings on diagnostic imaging of other body structures

257

2.23

7.43

1.2

0.98

0.86

u/ml

0.05

105

Stomatitis and related lesions

183

2.48

7.40

1.2

1.3

1.67

1.09

u/ml

0.18

Other specified/unspecified arthritis

113

648

1.75

7.36

1.3

1.32

1.28

u/ml

0.02

287

Oxycodone

120

677

1.72

7.31

1.5

1.3

1.86

1.38

u/ml

0.24

344

Other arthritis (FG)

137

831

1.65

7.27

1.3

1.05

1.55

u/ml

0.29

374

Acetic acid derivatives and related substances

123

365

1.76

7.22

1.3

0.86

0.81

u/ml

0.03

169

Dementia

562

0.38

7.15

1.8

1.3

1.25

1.40

u/ml

0.08

313

Endometriosis

193

744

1.55

7.14

1.2

1.3

0.56

1.79

u/ml

1.62

306

Diseases of pulp and periapical tissues

152

951

1.60

7.13

1.4

1.3

1.24

1.11

u/ml

0.07

421

Other septicaemia

130

767

1.67

7.12

1.7

1.3

0.77

1.10

u/ml

0.42

345

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

155

976

1.59

7.09

1.3

0.27

1.17

u/ml

2.66

421

Irregular menses

268

1525

1.43

7.09

1.3

0.33

0.97

u/ml

2.26

104

588

L04AX Other immunosuppressants

255

1783

1.43

7.05

1.3

0.72

1.10

u/ml

0.38

106

799

Eustachian salpingitis and obstruction

225

2.29

7.03

1.5

1.2

2.90

0.65

u/ml

0.88

Injuries to the wrist and hand

469

2601

1.31

7.01

1.3

0.70

1.36

u/ml

2.00

202

1135

Hypertrophy of breast

100

563

1.79

6.99

1.3

1.2

1.03

1.21

u/ml

0.08

226

Intracranial trauma

259

1350

1.44

6.96

1.3

0.38

1.34

u/ml

3.12

109

549

Gonarthrosis

268

1070

1.44

6.95

1.3

1.34

1.31

u/ml

0.01

118

493

Dementia, including avohilmo

603

0.41

6.92

1.8

1.3

1.18

1.35

u/ml

0.09

333

Polyneuropathies and other disorders of the peripheral nervous system

435

1.89

6.92

1.6

1.3

0.39

1.34

u/ml

1.53

206

Other shoulder lesions

202

2.34

6.88

1.2

1.3

1.20

0.65

u/ml

0.22

Paroxysmal tachycardia

106

512

1.76

6.85

1.3

1.74

1.80

u/ml

0.02

208

Benign neoplasm of colon, rectum, anus and anal canal

229

1421

1.46

6.85

1.4

1.3

1.11

1.46

u/ml

0.36

138

713

Pneumocystosis

4.80

6.73

1.9

1.2

7.91

0.06

u/ml

—

Hypertrophy of breast in women and men

106

614

1.74

6.72

1.3

1.2

0.97

1.08

u/ml

0.05

261

Other and unspecified rosacea

217

2.28

6.71

1.3

1.88

0.78

u/ml

0.33

Dental pulpitis 1, only avohilmo

533

2165

1.29

6.68

1.2

1.3

0.96

1.40

u/ml

0.47

217

978

Otitis externa

101

578

1.76

6.68

1.4

1.3

1.91

1.12

u/ml

0.42

239

Menorrhagia

189

683

1.54

6.67

1.2

1.3

0.42

1.87

u/ml

2.21

286

Unspecific neurodegenerative disorder

503

0.37

6.67

1.3

1.66

1.56

u/ml

0.03

280

Abnormal spermatozoa

174

2.43

6.67

1.5

1.4

1.67

1.95

u/ml

0.11

105

Disorders of continuity of bone

237

2.21

6.65

1.3

0.44

0.53

u/ml

0.10

102

Special screening examination for infectious and parasitic diseases

123

549

1.68

6.65

1.4

1.2

0.76

0.87

u/ml

0.10

158

Radiculopathy

323

2.02

6.64

1.2

1.3

1.30

1.42

u/ml

0.05

157

Other disorders of veins

177

1167

1.52

6.61

1.3

0.83

1.12

u/ml

0.26

543

Nonorganic sleeping disorders, excluding more controls

508

1.80

6.56

1.2

1.3

0.50

1.41

u/ml

0.93

200

Other disorders of skin and subcutaneous tissue

283

1868

1.39

6.56

1.3

1.12

1.32

u/ml

0.20

148

868

Complications of internal orthopaedic prosthetic devices, implants and grafts

429

1.87

6.55

1.2

1.3

0.50

1.22

u/ml

0.97

224

Second line medication for Crohn's disease

259

1842

1.41

6.55

1.3

0.71

1.11

u/ml

0.41

108

822

Dental caries 3 and operation codes

406

1565

1.33

6.54

1.3

1.10

1.44

u/ml

0.33

180

697

Dental pulpitis 4, only avohilmo

531

2162

1.28

6.54

1.2

1.3

0.97

1.40

u/ml

0.46

215

974

Polycystic ovarian syndrome, consortium definition

383

1730

1.34

6.53

1.3

0.48

1.15

u/ml

2.02

163

693

Inflammatory disease of uterus

466

1.84

6.51

1.6

1.2

1.81

1.45

u/ml

0.10

182

Other/unspecified enthesopathies, not elsewhere classified

170

2.43

6.51

1.2

1.3

0.36

0.81

u/ml

0.62

Other and unspecified polyneuropathies, also in other diseases

360

1.95

6.50

1.6

1.3

0.42

1.45

u/ml

1.38

176

Tonsillectomy and adenotomy

305

1543

1.38

6.48

1.4

1.3

0.76

0.94

u/ml

0.25

136

572

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

3.09

6.48

1.5

1.2

0.36

2.27

u/ml

0.88

Reimbursement for rheumatic diseases

259

1842

1.41

6.47

1.2

1.3

0.64

1.27

u/ml

0.81

118

835

Other bacterial intestinal infections

382

1.92

6.45

1.4

1.3

0.62

1.03

u/ml

0.43

177

Pleural effusion

240

2.18

6.45

1.5

1.3

0.80

1.75

u/ml

0.55

119

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

147

2.54

6.43

1.3

1.2

0.12

1.18

u/ml

0.89

Benign neoplasm of other and ill-defined parts of digestive system

432

1.86

6.43

1.6

1.3

0.37

0.95

u/ml

1.08

209

Personality disorders, excluding more controls

130

805

1.62

6.42

1.2

0.83

1.40

u/ml

0.40

315

Inflammatory diseases of female pelvic organs

322

1785

1.36

6.41

1.4

1.3

0.94

1.03

u/ml

0.09

128

734

conjunctival haemorrhage

142

2.56

6.36

1.1

1.2

0.12

1.17

u/ml

0.90

Seropositive rheumatoid arthritis

109

645

1.69

6.36

1.2

1.3

0.97

1.64

u/ml

0.67

316

Chronic periapical parodontitis

470

1.82

6.33

1.6

1.3

0.65

1.36

u/ml

0.85

223

Symptoms and signs concerning food and fluid intake

210

2.25

6.30

1.3

0.47

1.18

u/ml

0.56

Other abnormal uterine and vaginal bleeding

114

484

1.69

6.22

1.3

0.59

1.94

u/ml

1.40

215

128

747

1.62

6.22

1.3

0.94

1.34

u/ml

0.42

409

Dermatitis due to substances taken internally

132

2.60

6.21

1.6

1.2

0.46

0.71

u/ml

0.21

Hernia of abdominal wall, postoperative

367

1.91

6.17

1.1

1.2

0.38

1.34

u/ml

0.97

167

Heart failure,strict

176

842

1.51

6.14

1.2

1.4

0.94

1.68

u/ml

0.89

109

435

Bacterial, viral and other infectious agents

239

2.15

6.13

1.4

1.3

1.31

0.67

u/ml

0.26

Heart failure and antihypertensive medication

101

384

1.74

6.12

1.3

1.4

0.92

1.41

u/ml

0.30

192

Unspecified/other endometriosis

279

2.06

6.11

1.4

1.2

0.48

1.62

u/ml

0.68

110

Reactive arthropathies

195

2.27

6.05

1.5

1.2

0.12

0.42

u/ml

1.74

Cholecystectomy

300

1957

1.36

6.01

1.3

1.07

1.17

u/ml

0.08

136

912

Cutaneous abscess, furuncle and carbuncle

113

688

1.65

6.00

1.3

0.63

1.41

u/ml

1.10

302

Sleep disorders

103

614

1.68

5.94

1.2

1.3

0.44

1.29

u/ml

1.08

248

Supplementary factors related to causes of morbidity and mortality classified elsewhere

130

822

1.59

5.92

1.2

1.4

1.17

1.56

u/ml

0.19

358

Haemorrhoids and perianal venous thrombosis

109

660

1.66

5.90

1.2

1.3

0.96

1.26

u/ml

0.18

333

Other cataract

156

790

1.53

5.89

1.5

1.3

1.40

1.27

u/ml

0.05

389

Otitis media, unspecified

310

1.94

5.88

1.5

1.2

0.42

0.78

u/ml

0.40

Collagenous colitis

204

2.22

5.88

1.2

0.90

1.27

u/ml

0.15

Type of accident

121

755

1.61

5.84

1.2

1.3

1.29

1.47

u/ml

0.07

329

Sequelae of other external causes

119

2.63

5.81

1.5

1.3

1.08

0.68

u/ml

0.21

Other disorders of bone

543

1.72

5.80

1.3

1.44

1.31

u/ml

0.04

227

Other and unspecified anaemias

140

875

1.55

5.79

1.3

1.04

1.31

u/ml

0.15

422

Allergic contact dermatitis due to drugs in contact with skin

3.66

5.78

1.9

1.1

0.84

1.08

u/ml

—

Other necrotizing vasculopathies

143

2.47

5.78

1.5

1.2

0.90

1.13

u/ml

0.10

Ovarian cyst

197

778

1.47

5.76

1.2

1.3

0.45

1.80

u/ml

2.15

311

Postprocedural endocrine and metabolic disorders, not elsewhere classified

320

1.95

5.76

1.5

1.3

1.81

0.96

u/ml

0.25

141

Disorders of adult personality and behaviour

144

939

1.54

5.75

1.2

1.3

0.77

0.95

u/ml

0.12

387

Injury of muscle and tendon at lower leg level

341

1.92

5.75

1.5

1.3

1.24

1.30

u/ml

0.03

148

Seropositive rheumatoid arthritis, wide

109

666

1.64

5.73

1.2

1.3

0.97

1.24

u/ml

0.23

325

Hypertensive diseases

382

1649

1.31

5.72

1.3

0.62

1.56

u/ml

2.05

179

711

Dental caries 1 and operation codes

376

1465

1.32

5.69

1.3

1.18

1.45

u/ml

0.22

163

656

Other anaemias

141

884

1.54

5.68

1.3

1.02

1.30

u/ml

0.16

424

Tinnitus

547

1.71

5.65

1.5

1.3

1.63

1.89

u/ml

0.12

240

Hypertension

381

1647

1.31

5.65

1.3

0.63

1.56

u/ml

2.03

178

711

Conductive and sensorineural hearing loss

317

1642

1.34

5.64

1.4

1.3

0.77

1.47

u/ml

1.53

172

758

Nutritional anaemias

183

1224

1.46

5.63

1.3

0.92

1.11

u/ml

0.14

572

Hyperkinetic disorders, excluding more controls

280

1.99

5.62

1.1

1.3

0.05

0.56

u/ml

2.28

Carpal tunnel syndrome

264

1746

1.37

5.59

1.2

1.3

0.48

1.33

u/ml

2.41

125

771

Nummular dermatitis

158

2.36

5.56

1.5

1.3

2.94

0.58

u/ml

0.83

Other enthesopathy of foot (+metatarsalgia)

222

2.13

5.56

1.3

0.59

1.00

u/ml

0.31

Trigeminal neuralgia

152

2.39

5.56

1.2

0.03

0.74

u/ml

1.36

Respiratory disorders in diseases classified elsewhere

4.58

5.54

1.3

1.2

0.43

0.32

u/ml

—

Enterocolitis due to Clostridium difficile

203

2.18

5.52

1.6

1.3

0.68

1.17

u/ml

0.33

Respiratory tuberculosis, confirmed and not-confirmed

2.86

5.51

1.6

1.3

1.45

0.66

u/ml

0.32

Respiratory tuberculosis

2.86

5.51

1.6

1.3

1.45

0.66

u/ml

0.32

Senile cataract

231

1020

1.41

5.48

1.4

1.3

2.28

1.30

u/ml

0.54

124

498

Diseases of external ear

136

886

1.54

5.47

1.4

1.3

1.79

1.43

u/ml

0.21

381

Other/unspecified seropositive rheumatoid arthritis

107

659

1.63

5.47

1.2

1.3

0.94

1.26

u/ml

0.26

322

Spontaneous rupture of synovium and tendon

153

2.37

5.47

1.7

1.3

1.14

0.56

u/ml

0.31

Diseases of oral cavity, salivary glands and jaws

415

1649

1.29

5.47

1.3

1.68

1.38

u/ml

0.21

197

703

Benign neoplasm: Stomach

204

2.17

5.46

1.8

1.3

0.55

1.11

u/ml

0.47

100

Other diseases of liver

427

1.79

5.44

1.4

1.3

0.36

1.18

u/ml

1.44

196

False labour

182

781

1.47

5.44

1.2

1.3

0.44

0.89

u/ml

0.70

295

Other diseases of intestine

251

2.04

5.43

1.5

1.3

1.38

0.73

u/ml

0.23

128

Heartburn

231

2.09

5.42

1.4

1.2

0.96

0.70

u/ml

0.18

101

Benign neoplasm: Colon

197

1054

1.44

5.42

1.5

1.3

1.25

1.35

u/ml

0.08

117

524

Disorders of gallbladder, biliary tract and pancreas

433

2188

1.28

5.40

1.5

1.3

1.04

1.30

u/ml

0.31

216

979

Adhesive capsulitis of shoulder

363

1.85

5.39

1.3

3.05

1.41

u/ml

0.37

168

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

106

654

1.63

5.39

1.2

1.3

0.96

1.26

u/ml

0.25

319

Fibroblastic disorders

458

1.75

5.37

1.6

1.3

0.78

1.45

u/ml

0.53

219

Cellulitis

533

1.69

5.36

1.3

0.33

1.29

u/ml

1.74

233

Excessive attrition of teeth

215

821

1.43

5.35

1.4

1.2

1.33

1.12

u/ml

0.10

109

331

Fracture of rib(s), sternum and thoracic spine

102

626

1.63

5.30

1.2

1.3

2.69

1.49

u/ml

0.56

288

Non-ischemic cardiomyopathy

491

1.66

5.30

1.2

1.4

0.56

1.52

u/ml

1.25

260

Other and unspecified visual disturbances

220

2.10

5.29

1.2

0.22

0.97

u/ml

0.85

Anti-inflammatory and antirheumatic products, non-steroids

126

397

1.60

5.29

1.2

1.4

0.79

0.83

u/ml

0.03

183

Cluster headache, strict

2.85

5.26

1.1

1.2

0.13

0.70

u/ml

—

Other condition

345

1.86

5.25

1.3

0.42

0.94

u/ml

0.63

139

Disorders of lens

265

1230

1.36

5.21

1.4

1.3

1.99

1.39

u/ml

0.35

148

575

Coagulation defects, purpura and other haemorrhagic conditions

485

1.72

5.21

1.4

1.3

1.31

1.16

u/ml

0.05

196

Tuberculosis, IBD comorbidity

114

2.56

5.21

1.5

1.3

1.32

1.69

u/ml

0.11

Artificial joint operation, meniscal resection

374

1927

1.29

5.20

1.3

1.67

1.30

u/ml

0.26

180

907

Protozoal diseases

3.27

5.19

1.7

1.1

6.16

0.35

u/ml

—

Hallux valgus (acquired)

143

683

1.52

5.19

1.4

1.3

0.79

1.39

u/ml

0.71

312

Atopic conjunctivitis

103

2.65

5.16

1.3

0.06

1.01

u/ml

0.91

Sensorineural hearing loss

291

1527

1.34

5.15

1.4

1.3

0.73

1.46

u/ml

1.62

157

717

Other abnormal findings of blood chemistry

109

2.60

5.15

1.5

1.2

1.44

0.67

u/ml

—

Benign neoplasm of middle ear and respiratory system

164

2.27

5.14

1.3

0.40

0.79

u/ml

0.42

Other necrotizing vasculopathies (FG)

121

2.50

5.12

1.6

1.3

1.00

1.29

u/ml

0.12

Other and unspecified iron deficiency

124

805

1.54

5.09

1.3

0.60

1.26

u/ml

0.95

370

Hypo-osmolality and hyponatraemia

319

1.88

5.09

1.1

1.4

0.23

0.87

u/ml

1.14

168

Extrapyramidal and movement disorders

131

862

1.52

5.07

1.3

0.86

1.48

u/ml

0.63

422

Herpesviral [herpes simplex] infections

293

1.92

5.05

1.9

1.3

3.08

0.96

u/ml

0.81

122

Insomnia

445

1.74

5.04

1.2

1.3

0.58

0.97

u/ml

0.35

169

Noninfectious colitis NAS

343

1.85

5.03

1.2

1.3

1.16

0.92

u/ml

0.12

140

Cervicobrachial syndrome

574

1.64

5.01

1.3

0.51

1.40

u/ml

1.12

241

Use of pramipexole

483

1.70

5.01

1.3

0.90

1.10

u/ml

0.09

232

Benign neoplasm of middle ear and respiratory system

166

2.24

5.00

1.3

0.40

1.42

u/ml

0.79

Other disorders involving the immune mechanism, not elsewhere classified

2.99

5.00

2.5

1.4

0.93

0.29

u/ml

0.31

Other pleural conditions

147

2.32

5.00

1.3

0.28

2.04

u/ml

1.26

Sequelae of injuries of upper limb

239

2.02

4.99

1.4

1.2

0.49

0.79

u/ml

0.31

102

TMD related pain

105

2.60

4.99

1.3

0.10

0.96

u/ml

0.82

Diseases of pulp and periapical tissues, including avohilmo

507

2117

1.25

4.98

1.2

1.3

1.25

1.37

u/ml

0.09

202

947

Endometriosis of pelvic peritoneum

515

1.67

4.97

1.3

1.2

0.28

1.31

u/ml

1.40

211

Female infertility, cervigal, vaginal, other or unspecified origin

151

680

1.49

4.96

1.2

1.3

0.43

1.82

u/ml

1.83

264

Hernia

407

2176

1.27

4.96

1.2

1.3

0.68

1.42

u/ml

1.86

211

956

Dermatophytosis

260

1.97

4.96

1.2

1.3

0.54

0.67

u/ml

0.12

122

Actinic keratosis

111

672

1.57

4.92

1.3

1.04

1.30

u/ml

0.21

374

Other endocrine disorders

167

2.21

4.91

1.8

1.4

0.76

0.80

u/ml

0.02

Pain and other conditions associated with female genital organs and menstrual cycle

109

665

1.58

4.90

1.2

1.3

0.37

1.54

u/ml

1.87

259

Exposure to other and unspecified animate mechanical forces

2.81

4.90

1.1

1.5

3.50

0.62

u/ml

0.67

Other and unspecified injuries of ankle and foot

112

2.53

4.88

1.2

1.3

0.61

0.96

u/ml

0.20

Tuberculosis, wide

118

2.47

4.87

1.5

1.3

1.32

1.65

u/ml

0.10

Nonorganic sleeping disorders

556

1.64

4.86

1.2

1.3

0.50

0.92

u/ml

0.50

213

Papulosquamous disorders

157

1083

1.45

4.84

1.2

1.3

0.48

1.28

u/ml

1.75

513

Iron deficiency anaemia

156

1064

1.46

4.84

1.3

0.51

1.20

u/ml

1.41

491

Skin changes due to chronic exposure to nonionizing radiation

114

695

1.56

4.83

1.3

1.00

1.27

u/ml

0.23

384

Diplopia

277

1.92

4.81

1.2

1.3

0.09

0.80

u/ml

1.20

129

Other disorders of conjunctiva

270

1.93

4.81

1.2

1.3

0.11

1.19

u/ml

1.56

131

Dental pulpitis 1

506

2122

1.24

4.81

1.2

1.3

1.26

1.37

u/ml

0.08

201

950

Disorders of orbit

113

2.50

4.80

1.6

1.3

0.84

0.63

u/ml

0.15

Heart failure, strict

181

916

1.42

4.79

1.2

1.4

0.92

1.58

u/ml

0.82

112

487

Speech therapy

105

667

1.58

4.79

1.4

1.3

0.22

1.45

u/ml

2.72

312

Aplastic and other anaemias

147

950

1.47

4.78

1.3

0.98

1.30

u/ml

0.19

462

Convalescence

144

2.31

4.78

1.2

0.57

1.24

u/ml

0.35

Benign neoplasm: Colon, unspecified

490

1.68

4.77

1.5

1.3

0.44

1.48

u/ml

1.77

246

Restless leg syndrome

278

1.92

4.76

1.2

1.3

0.93

0.98

u/ml

0.02

128

Cluster headache, wide

2.69

4.76

1.1

1.2

0.13

0.64

u/ml

—

Diseases of liver

128

851

1.51

4.75

1.4

1.3

1.04

1.61

u/ml

0.43

405

Lateral epicondylitis

328

1.84

4.75

1.1

1.3

1.74

1.28

u/ml

0.17

143

Streptococcal septicaemia

157

2.24

4.75

1.6

1.3

0.86

1.07

u/ml

0.09

Cholelithiasis, broad definition with cholecystitis

372

2000

1.28

4.74

1.4

1.3

0.92

1.22

u/ml

0.33

180

909

Intracranial injury

227

1617

1.36

4.74

1.3

0.42

1.29

u/ml

3.05

723

Organic, including symptomatic, mental disorders

786

0.57

4.74

1.6

1.3

0.83

1.29

u/ml

0.47

416

Dental pulpitis 4

505

2121

1.24

4.73

1.2

1.3

1.26

1.37

u/ml

0.08

201

949

Hyperparathyroidism

353

1.80

4.72

1.1

1.3

0.04

0.92

u/ml

2.27

184

Behavioural syndromes associated with physiological disturbances and physical factors

152

1047

1.46

4.72

1.2

1.3

0.39

1.00

u/ml

1.25

414

Pneumothorax

114

2.47

4.71

1.6

1.4

5.18

1.11

u/ml

0.72

Chronic gastritis

553

1.63

4.70

1.2

1.3

0.41

1.34

u/ml

1.55

278

Injuries to the abdomen, lower back, lumbar spine and pelvis

145

984

1.47

4.70

1.3

1.11

1.29

u/ml

0.13

449

Superficial injury of abdomen, lower back and pelvis

373

1.78

4.69

1.3

0.57

0.78

u/ml

0.16

144

Dental operations

258

982

1.35

4.68

1.3

0.98

1.56

u/ml

0.56

114

436

Metatarsalgia

204

2.07

4.68

1.3

0.62

1.09

u/ml

0.35

Hypoparathyroidism

2.87

4.67

1.1

1.2

0.67

2.10

u/ml

0.48

Other disorders of teeth and supporting structures

478

1.68

4.67

1.4

1.3

1.50

1.31

u/ml

0.05

216

Obesity, other/unspecified

153

1059

1.45

4.65

1.2

1.3

0.86

1.05

u/ml

0.11

446

Fracture of foot, except ankle

106

680

1.56

4.65

1.5

1.3

1.81

1.23

u/ml

0.26

288

Acute generalized exanthematous pustulosis

115

2.46

4.64

1.7

1.2

0.54

0.58

u/ml

0.02

Thyrotoxicosis with diffuse goitre

382

1.76

4.63

1.4

1.2

0.39

1.33

u/ml

0.97

174

Other CVD

331

1.82

4.61

1.3

0.89

1.45

u/ml

0.36

174

Other viral diseases

139

944

1.47

4.60

1.3

1.62

1.03

u/ml

0.27

368

Sicca syndrome [Sjögren]

213

2.03

4.56

1.4

1.2

0.29

1.08

u/ml

0.77

Other menopausal disorders

136

523

1.50

4.56

1.2

1.3

0.70

2.12

u/ml

1.24

236

Procreative management

151

880

1.45

4.54

1.8

1.3

1.47

1.01

u/ml

0.33

337

Post-traumatic stress disorder

241

1.96

4.53

1.1

1.3

0.06

0.43

u/ml

2.31

Gonarthrosis [arthrosis of knee](FG)

313

1418

1.30

4.53

1.3

1.17

1.53

u/ml

0.31

143

650

Bursitis of shoulder

3.09

4.53

2.1

1.2

1.19

1.17

u/ml

0.01

Other disorders of skin and subcutaneous tissue, not elsewhere classified

326

1.82

4.53

1.3

0.93

0.89

u/ml

0.02

146

Any mental disorder

524

2140

1.23

4.52

1.3

0.81

1.41

u/ml

1.34

259

902

Covid-19 suspected case

103

661

1.56

4.52

1.5

1.3

0.32

1.16

u/ml

1.13

258

Cystitis

392

1900

1.26

4.52

1.3

1.31

1.27

u/ml

0.03

166

807

Superficial injury of ankle and foot

341

1.80

4.52

1.2

1.3

0.09

0.79

u/ml

1.69

123

Other CVD (FINNGEN)

155

2.09

4.51

1.3

1.4

0.92

1.98

u/ml

0.44

Artrosis, including avohilmo

367

1581

1.28

4.50

1.2

1.3

1.58

1.13

u/ml

0.38

163

722

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.55

4.48

1.2

1.3

0.07

0.49

u/ml

1.32

Emotional disorders and disorders of social functioning with onset specific to childhood

134

2.30

4.45

1.3

1.4

0.01

0.77

u/ml

—

Female infertility

164

707

1.44

4.45

1.2

1.3

0.56

1.79

u/ml

1.49

274

Other disorders of eye and adnexa

387

1.74

4.45

1.4

1.3

0.58

1.06

u/ml

0.47

157

Rheumatoid arthritis, including avohilmo

152

1061

1.44

4.44

1.2

1.3

0.87

1.28

u/ml

0.50

498

Metabolic disorders

411

2041

1.25

4.44

1.4

1.3

1.22

1.33

u/ml

0.09

204

915

Explicit bacterial Sepsis

195

2.06

4.43

1.7

1.4

1.12

1.74

u/ml

0.29

Adenomyosis (Endometriosis of uterus)

351

1.77

4.41

1.2

0.46

1.88

u/ml

1.42

163

Generalized anxiety disorder

471

1.66

4.40

1.2

0.27

0.67

u/ml

0.81

160

Dental caries 3

353

1412

1.28

4.40

1.3

1.13

1.49

u/ml

0.33

153

636

Viral and other specified intestinal infections

101

634

1.56

4.40

1.4

1.3

0.45

0.79

u/ml

0.56

220

Zoster [herpes zoster]

366

1.76

4.39

1.3

0.42

1.21

u/ml

1.12

171

Symptoms and signs involving the urinary system

299

1788

1.29

4.37

1.3

1.15

1.22

u/ml

0.06

158

834

Benign neoplasm: Stomach

224

1.98

4.35

1.8

1.3

0.55

1.18

u/ml

0.54

108

Injuries to the thorax

157

1107

1.42

4.34

1.3

2.26

1.24

u/ml

0.72

515

All-cause Heart Failure

175

899

1.40

4.34

1.2

1.3

0.94

1.60

u/ml

0.80

110

480

Recurring oral aphthae

119

2.38

4.33

1.3

2.28

0.80

u/ml

0.42

Benign neoplasm of colon, rectum, anus and anal canal

225

1198

1.34

4.25

1.4

1.3

1.14

1.34

u/ml

0.19

134

573

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

101

595

1.55

4.24

1.3

0.23

0.72

u/ml

1.64

175

Psychiatric diseases

516

2120

1.22

4.24

1.3

0.82

1.46

u/ml

1.43

255

888

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.87

4.24

2.6

1.4

1.00

0.31

u/ml

0.30

Faecal incontinence

172

2.10

4.22

1.6

1.3

2.07

1.12

u/ml

0.20

Fall on same level involving ice and snow

233

1761

1.33

4.20

1.3

0.61

1.21

u/ml

1.53

117

791

Polyuria

485

1.63

4.20

1.4

1.3

0.92

1.39

u/ml

0.28

223

Personality disorders

130

892

1.46

4.19

1.2

1.3

0.83

0.91

u/ml

0.05

365

Car occupant injured in other and unspecified transport accidents

532

1.60

4.18

1.2

1.3

0.74

0.94

u/ml

0.14

206

Primary_lymphoid and hematopoietic malignant neoplasms

487

1.63

4.13

1.3

1.38

1.29

u/ml

0.03

237

Sequelae of injuries of lower limb

250

1.89

4.11

1.2

1.3

0.42

0.77

u/ml

0.37

104

Cholelithiasis

353

1969

1.26

4.10

1.4

1.3

0.96

1.23

u/ml

0.28

170

899

Contact with other hot fluids

2.73

4.10

1.7

1.4

0.36

0.42

u/ml

—

Reactive arthropathies, FINNGEN

181

2.06

4.09

1.5

1.2

0.12

0.65

u/ml

0.91

Any event in cancer register

291

2207

0.78

4.09

1.4

1.3

1.74

1.16

u/ml

0.48

122

986

Other superficial mycoses

3.23

4.07

1.6

1.3

0.61

0.29

u/ml

—

Parodontitis or/and operation codes

199

1589

0.74

4.05

1.2

1.3

1.56

1.04

u/ml

0.25

102

693

Gingivitis and periodontal diseases

392

1622

1.25

4.05

1.3

1.51

1.38

u/ml

0.08

179

702

Inflammatory bowel disease

134

932

1.44

4.04

1.3

0.35

1.36

u/ml

2.40

407

Benign neoplasms

392

1783

1.25

4.02

1.3

0.92

1.36

u/ml

0.64

176

703

Oesophageal obstruction

2.96

4.02

1.2

0.03

2.09

u/ml

—

Specific personality disorders

115

778

1.48

4.00

1.3

0.88

0.98

u/ml

0.05

312

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

156

2.13

3.99

1.5

1.2

0.31

1.39

u/ml

0.80

Generalized skin eruption due to drugs and medicaments

105

2.40

3.99

1.8

1.2

0.59

0.63

u/ml

0.02

Unknown and unspecified causes of morbidity

143

2.18

3.98

1.4

1.2

0.30

1.31

u/ml

0.64

Correction of physiology of bite - demanding therapy visit

204

1.97

3.97

1.2

0.37

0.54

u/ml

0.20

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

844

0.61

3.96

1.3

0.27

1.31

u/ml

4.21

452

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

937

0.62

3.95

1.3

4.03

1.19

u/ml

0.38

424

Keratitis

140

986

1.42

3.95

1.4

1.3

2.57

1.10

u/ml

0.65

437

Endometriosis of rectovaginal septum and vagina

191

2.00

3.92

1.3

1.2

1.30

1.28

u/ml

0.01

Schizophrenia, schizotypal and delusional disorders

949

0.59

3.90

1.1

1.3

0.62

1.27

u/ml

0.71

411

Postprocedural disorders of nervous system

220

1.92

3.87

1.3

2.16

0.59

u/ml

0.65

Other hearing loss

518

1.58

3.86

1.4

1.3

1.50

1.35

u/ml

0.06

255

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

122

1146

0.69

3.86

1.3

2.65

1.06

u/ml

0.38

493

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

942

0.61

3.86

1.3

2.01

1.18

u/ml

0.21

487

Nontoxic multinodular goitre

473

1.61

3.86

1.4

1.3

1.18

0.99

u/ml

0.07

237

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

122

1146

0.69

3.86

1.3

2.65

1.06

u/ml

0.38

493

Disturbance of activity and attention

317

1.75

3.86

1.1

1.3

0.05

0.61

u/ml

2.32

Other diseases of anus and rectum

105

703

1.50

3.84

1.4

1.3

0.41

1.25

u/ml

1.52

340

Palmar fascial fibromatosis [Dupuytren]

249

1.85

3.82

1.8

1.3

1.22

1.45

u/ml

0.11

127

Genitourinary diseases

278

1079

1.29

3.82

1.3

0.89

1.82

u/ml

1.19

110

450

Malignant neoplasm

271

2049

0.78

3.75

1.4

1.3

1.81

1.15

u/ml

0.59

126

925

Benign neoplasms

452

2076

1.22

3.75

1.3

0.99

1.51

u/ml

0.89

212

852

Other diseases of stomach and duodenum

121

2.24

3.74

1.7

1.2

0.89

1.29

u/ml

0.17

Dental caries 3, only avohilmo

354

1449

1.25

3.73

1.3

1.14

1.46

u/ml

0.29

155

653

Schizophrenia or delusion

946

0.60

3.68

1.1

1.3

0.59

1.25

u/ml

0.73

409

Overexertion and strenuous or repetitive movements

267

1.81

3.68

1.9

1.3

0.98

0.74

u/ml

0.15

114

Fall on and from stairs and steps

646

1.51

3.68

1.2

1.3

0.75

1.46

u/ml

0.57

290

Personal history of other diseases and conditions

355

1.69

3.66

1.2

1.3

0.02

0.48

u/ml

1.64

108

Rash and other nonspecific skin eruption

239

1.85

3.64

1.7

1.2

0.55

0.83

u/ml

0.23

Disorders of sclera, cornea, iris and ciliary body

220

1687

1.31

3.64

1.4

1.3

1.86

1.05

u/ml

0.50

105

757

Excessive vomiting in pregnancy

261

1.81

3.63

1.3

2.17

0.55

u/ml

0.34

Ocular pain

225

1.88

3.63

1.3

1.2

0.45

1.05

u/ml

0.50

Erosion of teeth

3.48

3.63

1.3

1.8

0.71

1.89

u/ml

—

Other diseases of lip and oral mucosa

350

1.69

3.63

1.5

1.3

0.75

1.40

u/ml

0.56

158

Other disorders of the musculoskeletal system and connective tissue

321

1.72

3.59

1.4

1.3

1.64

0.61

u/ml

0.34

148

Other disorders of bladder

226

1.87

3.58

1.6

1.3

2.83

1.26

u/ml

0.66

114

Abnormal involuntary movements

292

1.75

3.56

1.4

1.3

1.62

1.02

u/ml

0.22

128

Diverticular disease of intestine

269

1401

1.28

3.55

1.2

1.3

1.52

1.51

u/ml

0.01

124

677

Schizophrenia

469

0.45

3.55

1.0

1.3

0.03

0.79

u/ml

—

191

Nonalcoholic fatty liver disease

234

1.85

3.55

1.4

1.2

0.37

0.67

u/ml

0.38

103

Hallux rigidus

263

1.79

3.54

1.4

1.3

4.07

1.13

u/ml

0.40

139

Malignant neoplasm of breast

128

1293

0.71

3.54

1.3

2.70

1.00

u/ml

0.44

589

Other disorders of cornea

213

1.89

3.53

1.9

1.2

2.36

0.93

u/ml

0.74

Umbilical hernia

644

1.49

3.53

1.2

1.3

0.44

1.46

u/ml

1.97

285

Flat foot [pes planus] (acquired)

192

1.94

3.52

1.6

1.3

1.63

0.54

u/ml

0.41

Dental operations, only avohilmo

269

1076

1.28

3.51

1.3

1.70

1.49

u/ml

0.11

129

481

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

278

2070

0.79

3.51

1.4

1.3

1.51

1.15

u/ml

0.30

139

913

Malignant neoplasm, wide definition for exclusion

278

2070

0.79

3.51

1.4

1.3

1.51

1.15

u/ml

0.30

139

913

Disorders of tooth development and eruption

134

2.12

3.50

1.4

3.78

0.28

u/ml

0.58

Pedestrian injured in transport accident

172

1.99

3.48

1.5

1.2

0.72

1.19

u/ml

0.30

Mixed conductive and sensorineural hearing loss

243

1.82

3.47

1.4

1.3

0.73

1.32

u/ml

0.33

113

Pneumonia derived septicemia

2.91

3.47

2.0

1.2

3.02

0.08

u/ml

—

Other diseases of pericardium

2.49

3.47

1.1

1.3

0.05

1.87

u/ml

—

Otitis externa, unspecified

280

1.76

3.46

1.2

1.18

0.86

u/ml

0.12

110

Other skin changes

363

1.66

3.45

1.4

1.3

0.31

1.05

u/ml

1.10

168

Biological medication for rheuma

464

1.58

3.44

1.2

1.3

0.09

0.78

u/ml

1.84

180

Polymyalgia rheumatica

222

1.85

3.44

1.1

1.3

0.11

1.45

u/ml

1.83

122

Thyrotoxicosis

103

705

1.47

3.44

1.4

1.3

0.44

1.11

u/ml

1.14

314

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

279

2071

0.80

3.44

1.4

1.3

1.49

1.15

u/ml

0.30

140

913

Contusion of ankle

100

2.32

3.44

1.1

1.5

0.04

1.17

u/ml

—

Hypotension

266

1.77

3.42

1.3

0.79

1.67

u/ml

0.52

147

Hernia of abdominal wall

162

1201

1.35

3.42

1.2

1.3

0.47

1.34

u/ml

2.48

571

Gonarthrosis, primary, with knee surgery

187

1153

1.33

3.40

1.3

1.86

1.55

u/ml

0.12

609

Female genital prolapse

134

549

1.41

3.38

1.4

1.3

0.32

2.07

u/ml

2.39

242

Prepatellar bursitis

2.46

3.38

1.4

1.3

0.26

0.35

u/ml

0.22

Coxarthrosis

166

832

1.36

3.38

1.4

1.3

0.87

1.51

u/ml

0.79

412

Normotensive glaucoma

147

2.05

3.36

1.2

1.3

2.09

1.07

u/ml

0.35

Atrial fibrillation and flutter

127

586

1.42

3.35

1.4

1.3

2.04

2.06

u/ml

0.01

263

Benign neoplasm: Colon, unspecified

536

1.53

3.35

1.5

1.3

0.44

1.22

u/ml

1.58

282

Thyroiditis, ILD-related definition

313

1.70

3.34

1.3

1.2

0.23

0.95

u/ml

1.01

127

Injury of muscle and tendon at shoulder and upper arm level

117

825

1.42

3.34

1.3

1.90

1.45

u/ml

0.15

410

Other congenital malformations

283

1.74

3.34

1.2

1.3

2.60

0.58

u/ml

0.46

Correction of physiology of bite - very demanding therapy visit

2.39

3.33

1.2

1.3

0.23

0.41

u/ml

—

Phlebitis and thrombophlebitis (not including DVT)

548

1.52

3.32

1.4

1.3

1.83

1.50

u/ml

0.12

260

Malignant neoplasm of breast, HER-positive

1075

0.65

3.31

1.3

4.20

1.12

u/ml

0.40

510

Episcleritis

148

2.04

3.31

1.1

1.2

0.13

0.57

u/ml

—

Chondropathies

422

1.59

3.30

1.3

1.69

1.03

u/ml

0.18

168

Direct fill therapy

360

1.65

3.30

1.7

1.3

0.39

0.64

u/ml

0.40

146

Retention of urine

571

1.47

3.29

1.4

1.3

1.96

1.47

u/ml

0.21

278

Cluster headache, strict, including avohilmo

135

2.09

3.28

1.1

1.3

0.21

0.39

u/ml

—

Short stature, not elsewhere classified

2.43

3.26

2.4

1.6

0.91

0.52

u/ml

—

Ulcerative colitis

100

689

1.46

3.25

1.4

1.3

0.42

1.43

u/ml

1.70

296

Psoriasis vulgaris

448

1.57

3.23

1.2

1.4

0.10

1.13

u/ml

2.64

207

Other symptoms and signs involving the digestive system and abdomen

401

1.60

3.23

1.4

1.3

1.08

u/ml

0.00

186

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

518

0.50

3.22

1.5

1.3

3.48

0.97

u/ml

0.35

270

Dental caries, including avohilmo

316

1301

1.24

3.22

1.4

1.3

1.25

1.50

u/ml

0.19

139

592

Dental caries 1

316

1301

1.24

3.22

1.4

1.3

1.25

1.50

u/ml

0.19

139

592

Chronic conjunctivitis

2.52

3.22

1.0

1.3

0.12

1.04

u/ml

—

Other specified/unspecified necrotizing vasculopathies

3.62

3.21

2.4

1.2

1.40

0.09

u/ml

—

Other and unspecified nonorganic psychotic disorders

582

0.53

3.19

1.1

1.3

0.01

1.43

u/ml

2.67

226

Misadventures to patients during surgical and medical care

333

1.66

3.18

1.4

1.3

0.91

1.05

u/ml

0.09

148

Benign neoplasm: Rectum

356

1.63

3.18

1.3

2.33

1.37

u/ml

0.36

183

Psoriasis

106

742

1.43

3.18

1.2

1.3

0.27

1.46

u/ml

2.68

347

Right bundle-branch block

2.75

3.16

1.1

1.3

0.06

2.22

u/ml

—

Examination and encounter for administrative purposes

2.48

3.13

1.5

1.2

1.69

1.26

u/ml

—

Emotional disorders starting during childhood or adolecense, excluding more controls

115

2.14

3.12

1.3

0.01

0.29

u/ml

—

Injury of muscle and tendon at hip and thigh level

230

1.79

3.11

1.1

1.3

0.08

1.10

u/ml

1.32

107

Other contact dermatitis

201

1.85

3.11

1.3

1.2

0.76

0.54

u/ml

0.14

Other coagulation defects

194

1.87

3.11

1.3

1.2

2.87

0.58

u/ml

0.43

Tumor necrosis factor alpha inhibitors

429

1.57

3.10

1.1

1.3

0.05

0.84

u/ml

2.08

166

Respiratory conditions due to other external agents

3.11

3.10

1.2

5.08

0.95

u/ml

—

Scleritis and episcleritis

166

1.94

3.09

1.2

0.13

0.52

u/ml

—

Other nonscarring hair loss

3.52

3.07

1.1

1.2

3.29

0.10

u/ml

—

Early lumbar disc prolapse, operated

291

1.69

3.06

1.3

1.2

1.92

1.21

u/ml

0.15

101

Other disorders starting during childhood or adolecense, excluding more controls

128

2.05

3.01

1.8

1.3

0.91

0.22

u/ml

—

Cluster headache, wide,, including avohilmo

140

2.01

3.01

1.1

1.2

0.21

0.38

u/ml

—

Myocarditis

2.31

3.00

1.9

1.3

1.07

0.24

u/ml

0.74

Endometriosis ASRM stages 1,2

603

1.46

2.98

1.3

1.2

0.27

1.22

u/ml

1.50

236

Superficial injury of shoulder and upper arm

256

1.73

2.97

1.2

1.3

0.91

1.19

u/ml

0.12

101

292

1.66

2.95

1.4

1.3

1.28

1.15

u/ml

0.04

161

Scabies

114

2.12

2.95

1.8

1.4

0.30

0.48

u/ml

0.40

Disorders of mineral metabolism

169

1.90

2.94

1.4

1.3

0.12

1.10

u/ml

0.97

Vertigo of central origin

3.38

2.92

1.1

1.2

0.02

0.08

u/ml

—

Monoamine oxidase A inhibitors

265

1.70

2.91

1.2

1.3

0.05

1.16

u/ml

1.75

122

Adalimumab

243

1.74

2.90

1.1

1.3

0.05

0.83

u/ml

1.48

Ganglion

574

1.47

2.89

1.3

0.46

1.02

u/ml

0.80

234

Malignant neoplasm of breast, HER2-negative

127

1261

0.74

2.89

1.3

2.76

1.02

u/ml

0.44

576

Superficial injury of hip and thigh

296

1.66

2.88

1.3

1.06

1.11

u/ml

0.02

136

Pericarditis

2.52

2.87

1.4

1.2

0.28

0.73

u/ml

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

2.26

2.87

1.3

1.2

0.42

0.76

u/ml

—

Hyperkinetic disorders

354

1.60

2.86

1.1

1.3

0.05

0.58

u/ml

2.51

103

Heart failure and bmi 25plus

104

506

1.42

2.86

1.2

1.3

0.78

0.87

u/ml

0.06

268

Contact with heat and hot substances

136

2.00

2.85

1.7

1.3

0.22

0.71

u/ml

0.69

Extreme obesity with alveolar hypoventilation

2.20

2.84

1.5

1.2

0.40

0.74

u/ml

—

Benign neoplasm: Rectum, anus and anal canal

407

1.55

2.83

1.3

2.15

1.28

u/ml

0.35

207

Transplanted organ and tissue status

215

1.77

2.83

1.7

1.3

2.59

0.81

u/ml

0.42

Other facial nerve disorders

2.36

2.83

1.4

1.2

1.33

0.89

u/ml

—

Any operation in hilmo

2.84

2.83

1.1

0.06

0.02

u/ml

—

Other neurological diseases

254

1646

1.24

2.82

1.3

1.32

1.25

u/ml

0.06

135

795

Unspecified fall

179

1377

1.29

2.82

1.3

0.84

1.23

u/ml

0.52

609

Purpura and other haemorrhagic conditions

306

1.64

2.81

1.5

1.3

0.25

0.99

u/ml

1.07

132

Nonspecific lymphadenitis

172

1.87

2.81

1.2

1.3

0.17

0.23

u/ml

0.22

Ulcer of oesophagus

123

2.04

2.81

1.4

1.3

1.15

1.17

u/ml

0.00

Other viral diseases, not elsewhere classified

561

1.46

2.78

1.2

1.3

1.86

1.30

u/ml

0.15

210

Medicines for HER+ breast cancer

1135

0.69

2.77

1.3

3.94

1.09

u/ml

0.43

533

Other specified/unspecified inflammatory spondylopathies

124

2.03

2.76

1.2

0.03

0.76

u/ml

—

Seropositive rheumatoid arthritis, strict definition

386

1.56

2.76

1.3

0.56

1.02

u/ml

0.49

179

Psoriatic arthropathies

217

1.76

2.75

1.2

1.3

0.02

0.53

u/ml

3.17

Dental caries 1, only avohilmo

319

1341

1.22

2.75

1.3

1.25

1.47

u/ml

0.17

139

614

Gout

380

1.54

2.75

1.2

1.3

1.31

1.70

u/ml

0.13

220

Open wound of wrist and hand

164

1250

1.30

2.74

1.3

0.79

1.63

u/ml

1.49

552

Noninflammatory disorders of female genital tract

213

843

1.27

2.72

1.2

1.3

0.62

1.72

u/ml

1.35

332

Benign neoplasm of mouth and pharynx

248

1.70

2.71

1.4

1.3

0.32

1.04

u/ml

0.87

117

Other ulcerative colitis

160

1.89

2.71

1.3

0.37

0.64

u/ml

0.31

Primary_lymphoid and hematopoietic malignant neoplasms

541

1.46

2.71

1.3

1.38

1.00

u/ml

0.14

269

Fissure and fistula of anal and rectal regions

624

1.43

2.70

1.3

0.61

1.13

u/ml

0.44

283

Postprocedural musculoskeletal disorders, not elsewhere classified

153

1.91

2.70

1.7

1.2

0.45

0.55

u/ml

0.10

Other degenerative diseases of the nervous system

448

0.57

2.69

1.2

1.3

1.06

1.43

u/ml

0.14

213

Benign neoplasm of eye and adnexa

219

1.74

2.68

1.3

1.11

1.06

u/ml

0.02

108

Benign neoplasm of eye and adnexa

219

1.74

2.68

1.3

1.11

u/ml

0.00

107

Abnormal results of function studies

175

1.84

2.68

1.1

1.3

0.48

0.41

u/ml

0.06

Coxarthrosis [arthrosis of hip](FG)

183

1033

1.28

2.66

1.4

1.3

0.98

1.64

u/ml

0.82

516

Lichen simplex chronicus and prurigo

147

1.92

2.65

1.1

1.2

1.23

0.52

u/ml

0.44

Thyrotoxicosis, other and/or unspecified

536

1.46

2.65

1.3

0.24

1.19

u/ml

1.54

245

Other benign neoplasm of uterus: Other parts/unspecified

2.40

2.63

1.3

1.1

0.17

2.20

u/ml

—

Other benign neoplasm of uterus: Other parts/unspecified

2.40

2.63

1.3

1.1

0.17

2.78

u/ml

—

Bruxism

2.58

2.63

1.1

1.2

0.03

0.07

u/ml

—

Drug-induced cataract

2.57

2.62

1.7

1.1

1.03

1.10

u/ml

—

Lung transplant status

4.77

2.61

2.7

1.3

0.95

0.66

u/ml

—

Lung transplantation

4.77

2.61

2.7

1.3

0.95

0.66

u/ml

—

Acute gastritis

141

1.92

2.60

1.1

1.3

0.21

1.12

u/ml

0.81

Anorexia

2.93

2.59

1.7

1.1

2.41

0.09

u/ml

—

Injury of muscle and tendon at wrist and hand level

329

1.59

2.59

1.4

1.3

0.33

0.79

u/ml

0.85

148

Dissociative [conversion] disorders

107

2.07

2.57

1.2

0.05

1.12

u/ml

—

Other specified/unspecified hearing loss

149

1.89

2.56

1.4

1.3

0.22

1.49

u/ml

0.98

Speech and linguistic disorders, excluding more controls

202

1.73

2.55

1.4

1.3

0.97

0.33

u/ml

—

Spondyloarthritis

442

1.50

2.55

1.4

1.3

0.60

1.13

u/ml

0.56

197

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

2.14

2.55

1.3

1.2

0.42

0.67

u/ml

—

Injuries to the hip and thigh

147

1031

1.31

2.55

1.2

1.3

0.44

1.43

u/ml

2.37

494

Emotional disorders starting during childhood or adolescence

134

1.94

2.54

1.3

1.5

0.01

0.56

u/ml

—

Disorders of breast

222

1660

1.24

2.54

1.3

0.75

1.06

u/ml

0.37

699

Small fibre neuropathy

2.52

2.54

1.4

1.2

1.27

0.95

u/ml

—

Missing teeth due to accident, extraction or parodontitis

223

1.71

2.53

1.4

1.3

2.74

1.94

u/ml

0.11

108

Gastroduodenal ulcer

450

1.49

2.52

1.2

1.3

0.15

1.45

u/ml

2.82

236

Neoplasms

377

1706

1.19

2.50

1.3

0.76

1.30

u/ml

0.89

168

636

Erosion of teeth, including avohilmo

645

1.40

2.49

1.3

1.17

0.93

u/ml

0.14

258

Subacute thyroiditis

2.12

2.49

1.2

1.1

0.01

0.17

u/ml

—

Schizophrenia or delusion, excluding more controls

849

0.66

2.48

1.1

1.3

0.59

1.57

u/ml

1.13

348

Weight loss

217

1.71

2.48

1.4

1.3

0.60

1.13

u/ml

0.37

104

Endometriosis diagnosis and infertility diagnosis occurring together

381

1.53

2.47

1.2

0.14

1.32

u/ml

1.30

149

Primary gonarthrosis, bilateral

164

1121

1.28

2.46

1.3

0.79

1.55

u/ml

1.22

587

Lesion of plantar nerve

137

1.91

2.46

1.6

1.2

1.48

0.65

u/ml

0.26

Contusion of toe(s) without damage to nail

2.48

2.45

1.4

1.5

0.24

0.74

u/ml

—

Injuries to the elbow and forearm

282

2115

1.21

2.45

1.4

1.3

2.04

1.12

u/ml

0.70

138

913

Heterophoria

233

1.68

2.45

1.3

0.42

0.55

u/ml

0.12

423

1.47

2.45

1.4

1.3

2.03

0.95

u/ml

0.41

231

Benign neoplasm: Rectum

382

1.52

2.44

1.3

2.33

1.17

u/ml

0.47

195

Congenital malformations and deformations of the musculoskeletal system

278

1.62

2.44

1.5

1.3

0.20

0.66

u/ml

0.97

Other and unspecified follicular disorders

103

2.05

2.42

1.1

1.3

1.54

0.44

u/ml

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

647

1.39

2.42

1.2

1.3

0.39

1.23

u/ml

1.45

302

Urethral stricture

2.18

2.41

1.4

1.3

1.21

0.64

u/ml

—

Glaucoma suspect

114

852

1.34

2.40

1.1

1.3

0.77

1.49

u/ml

0.98

440

Other specified and unspecified personality disorders

250

1.65

2.39

1.2

1.76

0.51

u/ml

0.33

Injuries to the shoulder and upper arm

321

2265

1.19

2.38

1.3

1.31

1.29

u/ml

0.01

152

1037

Other symptoms and signs involving cognitive functions and awareness

136

978

1.31

2.38

1.5

1.3

1.12

1.52

u/ml

0.31

477

Perforation of tympanic membrane

235

1.67

2.38

1.7

1.3

0.94

1.17

u/ml

0.11

Pedestrian injured in collision with pedal cycle

2.22

2.38

1.4

1.2

1.21

0.89

u/ml

—

Atypical facial pain

132

1.91

2.36

1.2

3.34

0.77

u/ml

0.34

Persistent mood disorders

508

1.44

2.36

1.1

1.3

0.95

1.10

u/ml

0.08

214

Non-small cell lung cancer

251

1.64

2.35

1.2

1.4

0.38

1.51

u/ml

1.09

133

Varicose veins

234

1445

1.22

2.34

1.2

1.3

0.64

1.37

u/ml

1.32

111

678

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

101

745

1.36

2.33

1.3

0.39

1.63

u/ml

2.43

328

Squamous cell neoplasms and carcinomas of the skin

176

1.77

2.33

1.4

1.3

1.61

1.53

u/ml

0.02

101

Gonarthrosis,primary

330

1749

1.19

2.33

1.2

1.3

0.96

1.41

u/ml

0.56

159

846

Iron deficiency

2.33

2.32

1.5

1.2

0.33

0.57

u/ml

—

Other strabismus

659

1.38

2.32

1.2

1.3

0.55

1.26

u/ml

0.80

263

Olecranon bursitis

2.05

2.31

1.1

1.3

1.11

0.70

u/ml

0.25

Other otitis externa (chronic)

162

1.80

2.31

1.7

1.3

1.52

0.58

u/ml

0.33

Disorders of synovium and tendon in diseases classified elsewhere

2.88

2.31

1.0

1.3

0.02

1.40

u/ml

—

Prurigo nodularis

2.40

2.30

1.0

1.1

1.28

0.98

u/ml

—

Carbimazole or st.post thyroidectomy, condition for graves disease

586

1.40

2.30

1.2

1.3

0.24

1.29

u/ml

1.90

260

Other and unspecified disorders of skin and subcutaneous tissue

155

1.82

2.30

1.1

1.2

1.57

1.28

u/ml

0.08

Ankylosing spondylitis

192

1.72

2.29

1.4

1.3

0.22

0.74

u/ml

0.86

Non-rheumatic valve diseases

148

839

1.29

2.29

1.4

1.3

1.69

1.31

u/ml

0.19

409

Ventral hernia

553

1.41

2.29

1.2

1.4

0.43

1.69

u/ml

2.07

254

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

545

1.42

2.28

1.2

1.3

0.18

1.29

u/ml

1.69

211

Intermittent heterotropia

185

1.74

2.28

1.2

1.4

1.38

0.77

u/ml

0.26

Other pulmonary heart/vessel disease

2.23

2.27

1.6

1.0

0.53

0.64

u/ml

0.06

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

256

1731

1.21

2.27

1.3

0.76

1.06

u/ml

0.39

724

Insulin, fast-acting

127

973

1.31

2.26

1.5

1.3

1.36

1.42

u/ml

0.03

435

Etanercept

178

1.75

2.26

1.0

1.2

0.06

0.62

u/ml

1.08

Medical treatment for female infertility

110

825

1.33

2.26

1.1

1.2

0.57

0.75

u/ml

0.17

300

Seronegative rheumatoid arthritis

278

1.59

2.25

1.1

1.3

0.05

0.92

u/ml

1.57

132

Vulvovaginal ulceration/inflammation in other diseases

186

1.73

2.24

1.1

1.2

1.34

0.74

u/ml

0.19

Psoriatic and enteropathic arthropathies

286

1.58

2.24

1.2

1.3

0.07

1.30

u/ml

1.87

127

Other (seronegative) rheumatoid arthritis, wide

456

1.45

2.23

1.2

1.3

0.16

1.07

u/ml

2.22

221

Presbycusis

163

1.77

2.23

1.4

1.3

3.76

2.16

u/ml

0.28

Other fall from one level to another

598

1.39

2.22

1.5

1.3

1.36

1.42

u/ml

0.02

228

Von Willebrand disease

2.81

2.21

1.4

1.1

0.48

0.08

u/ml

—

Mandibular retrognathia

209

1.68

2.21

1.3

1.4

0.44

0.75

u/ml

0.39

Glaucoma

176

1236

1.25

2.21

1.2

1.3

0.99

1.38

u/ml

0.46

639

Lesion of ulnar nerve

319

1.54

2.21

1.1

1.3

0.33

0.74

u/ml

0.65

146

Deposits [accretions] on teeth

173

1.74

2.20

1.6

1.4

0.83

0.57

u/ml

0.17

Pedestrian injured in collision with car, pick-up truck or van

2.43

2.20

1.6

1.2

0.25

0.29

u/ml

—

Malignant neoplasm of digestive organs

761

0.67

2.20

1.3

0.18

1.33

u/ml

3.98

406

Emotionally unstable personality disorder

384

1.49

2.20

1.3

0.33

0.68

u/ml

0.47

129

2.14

2.19

1.4

1.3

0.42

0.40

u/ml

—

Benign neoplasm: Sigmoid colon

360

1.50

2.18

1.4

1.3

3.05

1.08

u/ml

0.71

178

Recurring oral aphthae, including avohilmo

344

1.52

2.18

1.3

1.29

1.03

u/ml

0.11

145

Fentanyl

143

1.82

2.18

1.7

1.4

1.24

1.20

u/ml

0.01

Special screening examination for other diseases and disorders

173

1.74

2.16

1.8

1.3

0.44

1.62

u/ml

0.83

Mental and behavioural disorders due to tobacco

211

1.67

2.16

1.4

1.3

2.28

0.57

u/ml

0.57

Contact with nonpowered hand tool

2.03

2.16

1.4

1.3

0.25

0.78

u/ml

—

Cerebral palsy and other paralytic syndromes

281

1.57

2.16

1.1

1.3

0.12

1.07

u/ml

1.36

117

Bitten or struck by other mammals

313

1.54

2.16

1.1

1.2

0.48

0.66

u/ml

0.15

119

Benign neoplasm of mouth and pharynx

266

1.58

2.14

1.4

1.3

0.32

0.79

u/ml

0.61

124

Diseases of the digestive system

146

1147

1.27

2.14

1.3

0.40

1.34

u/ml

2.87

547

Graves disease, strict definition

298

1.55

2.13

1.3

1.2

0.20

0.76

u/ml

0.82

113

Benign neoplasm: Rectum, anus and anal canal

436

1.45

2.13

1.3

2.15

1.10

u/ml

0.46

226

Smoking dependency

212

1.66

2.13

1.4

1.3

2.28

0.57

u/ml

0.57

Disorders of muscles

212

1.66

2.12

1.3

0.61

0.70

u/ml

0.06

Foreign body in respiratory tract

130

1.86

2.12

1.1

1.3

0.28

0.75

u/ml

0.54

Dental pulpitis 2, only avohilmo

278

1189

1.20

2.12

1.3

1.30

1.59

u/ml

0.19

118

547

Embedded teeth, including avohilmo

267

1.58

2.11

1.5

1.3

0.63

0.33

u/ml

0.41

Other and unspecified coagulation defects

145

1.80

2.11

1.3

1.2

4.10

0.74

u/ml

0.41

Maternal care related to the fetus and amniotic cavity and possible delivery problems

225

1088

1.22

2.11

1.3

0.64

0.98

u/ml

0.30

422

Abnormalities of gait and mobility

228

1.63

2.11

1.3

1.4

0.46

1.42

u/ml

0.92

115

Other disorders of nervous system

145

1.80

2.10

1.2

1.3

0.23

0.91

u/ml

0.79

Supervision of high-risk pregnancy

115

527

1.32

2.10

1.2

1.3

0.31

0.78

u/ml

0.87

191

Acute renal failure

364

1.49

2.09

1.3

1.57

1.66

u/ml

0.02

185

Vestibular neuronitis

198

1.67

2.08

1.3

2.43

0.97

u/ml

0.50

Atrial fibrillation and flutter with reimbursement

395

1.38

2.08

1.5

1.3

1.46

1.95

u/ml

0.21

187

Disorders of ocular muscles, binocular movement, accommodation and refraction

190

1535

1.23

2.07

1.2

1.3

0.44

1.12

u/ml

1.79

624

Type 2 diabetes, wide definition

303

1673

1.18

2.07

1.3

1.53

1.39

u/ml

0.10

161

799

Cardiac murmurs and other cardiac sounds

196

1.67

2.07

1.5

1.3

0.75

1.49

u/ml

0.40

Intussusception

2.34

2.05

1.9

1.2

3.88

1.08

u/ml

—

Insulin, fast-acting or short human

127

988

1.29

2.05

1.5

1.3

1.36

1.47

u/ml

0.06

443

Pneumococcal septicemia

2.19

2.05

2.0

1.3

3.02

0.82

u/ml

—

Fracture at wrist and hand level

121

936

1.29

2.05

1.2

1.3

1.14

1.64

u/ml

0.35

410

Sulfonylureas

599

0.68

2.04

1.2

1.3

0.90

1.28

u/ml

0.27

341

Other/unspecified reactive arthropathies

184

1.69

2.04

1.5

1.2

0.12

0.55

u/ml

0.93

Spondylopathies (FG)

366

1.48

2.04

1.3

0.16

1.07

u/ml

1.49

151

Autoimmune hyperthyroidism

154

1.76

2.04

1.3

1.1

0.07

0.85

u/ml

0.65

Benign neoplasm: Ascending colon

246

1.59

2.03

1.6

1.3

1.10

1.37

u/ml

0.11

128

Superficial injury of wrist and hand

575

1.38

2.03

1.4

1.3

0.71

1.05

u/ml

0.35

229

Glomerular diseases

408

1.45

2.02

1.4

1.3

0.28

1.31

u/ml

1.42

178

Intestinal malabsorption

118

1.88

2.02

1.2

1.3

0.26

0.73

u/ml

0.54

Crohn disease

359

1.48

2.01

1.2

1.3

0.13

0.61

u/ml

1.20

143

Other disorders of pigmentation

104

1.93

2.00

1.8

1.1

0.34

1.62

u/ml

0.65

L04AD Calcineurin inhibitors

287

1.54

2.00

1.3

0.40

0.60

u/ml

0.22

121

Crohn's disease of small intestine

193

1.67

1.99

1.3

0.08

0.56

u/ml

—

Contraceptive management

187

1070

1.23

1.99

1.2

1.3

2.25

0.99

u/ml

0.52

423

Colonic or urogenital fistula

706

1.33

1.98

1.3

0.59

1.55

u/ml

1.06

322

Other diseases of jaws

148

1.76

1.98

1.2

1.3

0.04

0.55

u/ml

0.97

Chronic pancreatitis

240

1.59

1.98

2.7

1.3

2.12

1.62

u/ml

0.14

117

Disorders of refraction and accommodation

107

816

1.31

1.98

1.2

1.3

0.35

1.18

u/ml

1.50

324

Secondary hypertension

154

1.74

1.97

1.1

1.4

0.04

1.72

u/ml

0.92

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

119

1.86

1.97

1.1

1.3

1.56

0.91

u/ml

0.21

Other erythematous conditions

2.09

1.97

1.1

1.2

0.06

0.99

u/ml

—

Ischemic heart diseases

283

1500

1.18

1.96

1.4

1.3

1.65

1.41

u/ml

0.14

139

739

Calculus of kidney and ureter

690

1.34

1.96

1.3

0.77

1.50

u/ml

0.53

335

Mixed and other personality disorders

225

1.61

1.96

1.1

1.2

0.03

0.55

u/ml

—

Valvular heart disease excluding rheumatic fever

147

853

1.26

1.96

1.4

1.3

1.71

1.31

u/ml

0.21

412

Other local infections of skin and subcutaneous tissue

241

1.58

1.95

1.4

1.3

1.03

1.11

u/ml

0.04

102

Certain conditions originating in the perinatal period

255

1.53

1.95

1.7

1.3

1.17

0.59

u/ml

0.31

Sequelae of injuries of neck and trunk

2.20

1.95

1.5

1.2

0.15

0.27

u/ml

—

Injuries to the head

466

2670

1.14

1.94

1.3

0.89

1.31

u/ml

0.84

214

1148

Diseases of male genital organs

164

663

1.25

1.94

1.5

1.3

2.92

1.41

u/ml

0.88

305

Obsessive-compulsive disorder

164

1.71

1.94

1.1

1.3

0.34

0.44

u/ml

0.12

Benign neoplasm: Caecum

187

1.66

1.93

1.3

1.01

1.18

u/ml

0.07

Localized swelling, mass and lump of skin and subcutaneous tissue

107

822

1.30

1.93

1.4

1.3

1.87

1.39

u/ml

0.19

360

Benign neoplasm of major salivary glands

218

1.61

1.93

1.6

1.3

1.87

1.09

u/ml

0.30

105

Urolithiasis

735

1.32

1.93

1.3

0.79

1.42

u/ml

0.47

362

Impingement syndrome of shoulder

589

1.36

1.93

1.5

1.3

1.23

1.28

u/ml

0.03

272

Angina pectoris

187

1031

1.23

1.93

1.3

1.22

1.25

u/ml

0.02

548

Other deformities of toe(s)

2.13

1.92

1.4

1.2

7.28

0.30

u/ml

—

Ischaemic heart disease, wide definition

276

1462

1.18

1.92

1.4

1.3

1.62

1.38

u/ml

0.15

140

722

Anisometropia and aniseikonia

2.01

1.90

1.2

0.03

1.17

u/ml

—

Chondrocostal junction syndrome [Tietze]

1.93

1.90

1.6

1.3

1.11

0.69

u/ml

—

Other secondary gonarthrosis

128

1.81

1.90

1.3

1.2

1.54

0.31

u/ml

0.46

Kela-code for severe mental illness

1129

0.75

1.89

1.1

1.3

2.19

1.33

u/ml

0.30

495

Inhalation and ingestion of food causing obstruction of respiratory tract

3.23

1.89

1.1

1.8

—

0.09

—

Convulsions, not elsewhere classified

567

1.36

1.89

1.3

0.40

0.99

u/ml

0.96

219

Unspecified urinary incontinence

204

1.62

1.89

1.6

1.3

0.79

0.98

u/ml

0.11

Erythema multiforme

2.33

1.88

1.3

1.1

0.36

0.30

u/ml

—

Anankastic personality disorder

114

1.85

1.87

1.2

1.3

0.30

0.39

u/ml

0.12

Coeliac disease

308

1.50

1.87

1.3

0.47

1.14

u/ml

0.72

127

Crossbite

211

1.59

1.86

1.9

1.3

0.58

0.51

u/ml

0.08

Lichen planus

284

1.52

1.86

1.3

1.11

1.20

u/ml

0.04

143

Early lumbar disc prolapse operation

341

1.47

1.86

1.3

1.2

1.83

0.40

u/ml

0.41

121

Viral warts

260

1.54

1.86

1.7

1.3

0.54

1.16

u/ml

0.50

103

Embedded and impacted teeth

115

761

1.29

1.86

1.4

1.3

0.77

0.72

u/ml

0.06

259

Algoneurodystrophy

100

1.91

1.86

1.2

1.3

0.09

0.91

u/ml

—

Abrasion of teeth

122

702

1.28

1.86

1.4

1.2

1.39

1.11

u/ml

0.11

298

Burns and corrosions

366

1.45

1.85

1.4

1.3

1.06

0.73

u/ml

0.25

144

Other and unspecified local infections of skin and subcutaneous tissue

229

1.58

1.84

1.4

1.3

1.07

1.14

u/ml

0.03

Persons encountering health services for specific procedures, not carried out

190

1.64

1.84

1.5

1.3

0.21

1.41

u/ml

—

Other disorders of kidney and ureter

261

1.54

1.83

1.5

1.3

0.18

0.96

u/ml

1.14

127

Thyroiditis

198

1.62

1.83

1.1

1.2

0.03

1.18

u/ml

1.18

Sudden idiopathic hearing loss

198

1.62

1.83

1.3

0.30

1.16

u/ml

0.83

Anomalies of pupillary function

2.28

1.81

1.2

1.63

0.12

u/ml

—

Abnormal serum enzyme levels

588

1.34

1.81

1.2

1.3

1.68

1.63

u/ml

0.02

305

Leisure time condition

443

1.40

1.81

1.1

1.3

0.41

0.79

u/ml

0.56

186

Complications of genitourinary prosthetic devices, implants and grafts

2.28

1.81

1.1

1.2

0.07

1.18

u/ml

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.07

1.81

1.1

1.2

0.09

1.57

u/ml

—

L02BG Aromatase inhibitors

856

0.72

1.80

1.2

1.3

5.52

0.98

u/ml

0.46

416

Iridocyclitis

588

1.35

1.80

1.4

1.3

1.45

1.12

u/ml

0.15

263

Gluteal tendinitis

2.01

1.80

1.9

1.3

1.34

1.03

u/ml

—

Open wound of head

171

1382

1.22

1.79

1.3

1.31

1.42

u/ml

0.08

642

Plantar fascial fibromatosis

223

1.57

1.78

1.2

1.3

0.04

1.54

u/ml

1.16

100

Other noninflammatory disorders of uterus, except cervix

422

1.34

1.78

1.3

1.25

2.32

u/ml

0.62

197

Salpingitis and oophoritis

555

1.35

1.78

1.6

1.2

1.59

1.23

u/ml

0.12

253

Radial styloid tenosynovitis [de Quervain]

146

1.72

1.77

1.5

1.2

0.11

0.82

u/ml

1.02

DVT of lower extremities

395

1.42

1.76

1.4

1.3

2.98

1.36

u/ml

0.54

197

Open wound of forearm

216

1.58

1.76

1.4

1.3

0.46

0.76

u/ml

0.26

Other and unspecified disorders of vitreous body

136

1086

1.25

1.76

1.2

1.3

0.76

1.31

u/ml

0.66

545

Molar incisor enamel hypoplasia

1.91

1.76

2.2

1.4

0.60

0.66

u/ml

—

Prolonged pregnancy

531

0.67

1.75

1.1

1.3

0.04

0.98

u/ml

1.69

206

Haemorrhage, not elsewhere classified

2.23

1.74

1.4

1.2

0.19

1.00

u/ml

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

193

1.61

1.74

1.4

1.3

1.61

1.21

u/ml

0.14

108

Tooth eruption problems

451

1.39

1.73

1.3

0.52

0.56

u/ml

0.05

137

Pediculosis, acariasis and other infestations

155

1.69

1.72

1.7

1.3

0.64

0.39

u/ml

0.26

Other disorders of penis

178

1.63

1.72

1.3

1.4

0.30

1.16

u/ml

0.88

Fracture of lower leg, including ankle

199

1658

1.20

1.72

1.3

0.56

1.22

u/ml

1.60

733

Corneal ulcer

473

1.38

1.72

1.4

1.3

2.91

0.95

u/ml

0.35

197

Speech disturbances, not elsewhere classified

155

1.68

1.72

1.1

1.3

0.15

1.37

u/ml

—

Other benign neoplasms of uterus

103

1.85

1.71

1.3

1.1

0.16

2.26

u/ml

1.00

Hydatidiform mole

0.00

1.70

0.0

1.1

—

0.13

—

Ulcerative colitis, NAS

373

1.42

1.70

1.3

0.23

0.90

u/ml

1.09

150

Ulcer of lower limb, not elsewhere classified

242

1.53

1.70

1.2

1.3

1.05

1.23

u/ml

0.09

129

Seborrhoeic keratosis

466

1.38

1.69

1.5

1.3

0.91

1.13

u/ml

0.18

237

Other female pelvic inflammatory diseases

492

1.37

1.69

1.6

1.2

2.42

1.32

u/ml

0.32

219

Brachial plexus disorders

283

1.49

1.69

1.3

1.2

0.99

0.77

u/ml

0.12

110

Adjustment and management of implanted device

324

1.45

1.68

1.3

1.4

0.26

1.90

u/ml

2.17

161

Benign neoplasm: salivary glands, exclude unknown (D119)

195

1.60

1.68

1.6

1.2

1.77

1.20

u/ml

0.18

Stenosis and insufficiency of lacrimal passages

195

1.59

1.68

1.2

1.3

0.09

1.13

u/ml

1.23

Synovial cyst of popliteal space [Baker]

141

1.71

1.68

1.3

2.73

0.61

u/ml

0.42

Other problems related to primary support group, including family circumstances

381

1.41

1.67

1.3

0.32

0.49

u/ml

0.33

117

Strabismus

101

787

1.28

1.67

1.2

1.3

0.51

1.19

u/ml

0.95

321

Other disorders starting during childhood or adolescence

163

1.65

1.66

1.8

1.3

0.91

0.45

u/ml

—

Diseases of tongue

119

1.77

1.66

1.4

1.3

0.88

1.63

u/ml

—

Haemorrhage in early pregnancy

128

1004

1.25

1.65

1.2

1.3

0.37

0.84

u/ml

0.83

405

Abnormal weight loss

188

1.60

1.65

1.2

1.3

0.23

1.25

u/ml

1.05

Diseases of appendix

306

2423

1.15

1.65

1.3

1.28

1.21

u/ml

0.06

133

1064

Chronic kidney disease

534

1.34

1.65

1.3

0.24

1.31

u/ml

2.52

267

Barrett oesophagus

1.90

1.65

1.4

1.3

0.06

0.67

u/ml

0.79

Vitamin B12 deficiency anaemia

196

1.59

1.65

1.2

1.3

3.05

1.34

u/ml

0.24

104

Glomerulonephritis

236

1.53

1.64

1.6

1.4

0.48

1.19

u/ml

0.54

104

Hypoplasia of dental enamel , including avohilmo

1.94

1.64

2.2

1.4

0.69

0.66

u/ml

—

Recurrent dislocation of patella

142

1.70

1.64

1.1

1.2

0.16

0.46

u/ml

—

Other symptoms and signs involving general sensations and perceptions

1.98

1.64

1.1

1.2

3.41

0.16

u/ml

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

503

1.35

1.64

1.3

0.71

1.02

u/ml

0.25

250

Other disorders of eyelid

133

1038

1.24

1.64

1.2

1.3

1.06

1.35

u/ml

0.17

522

Deep endometriosis

285

1.48

1.64

1.3

1.2

1.15

0.90

u/ml

0.08

102

Nontoxic goitre/thyroid nodule

106

835

1.27

1.63

1.5

1.3

1.09

1.07

u/ml

0.01

417

Renal failure

115

835

1.26

1.63

1.3

0.93

1.30

u/ml

0.21

427

Dental pulpitis 2

267

1170

1.17

1.63

1.3

0.72

1.53

u/ml

1.25

109

535

Dental pulpitis 3, only avohilmo

279

1.42

1.62

1.2

1.4

1.22

0.78

u/ml

0.21

Bus occupant injured in other and unspecified transport accidents

3.63

1.62

1.2

1.1

0.17

0.05

u/ml

—

Chronic ulcer of skin, not elsewhere classified

135

1.71

1.62

1.7

1.3

0.39

1.48

u/ml

0.80

Viral hepatitis, IBD co-morbidity

1.84

1.61

1.2

1.1

0.03

0.72

u/ml

—

Other noninflammatory disorders of vagina

174

1.61

1.60

1.1

1.2

0.19

2.61

u/ml

1.25

Appendicitis, broad definition

303

2413

1.15

1.60

1.3

1.29

1.21

u/ml

0.06

130

1060

Hyperlipidaemia, other/unspecified

108

809

1.26

1.60

1.3

1.4

1.49

1.44

u/ml

0.02

437

Chronic Coagulation defects

2.02

1.59

1.3

1.2

0.31

0.08

u/ml

—

Alopecia areata

2.01

1.59

1.3

1.2

0.61

1.24

u/ml

—

Other and unspecified erythematous conditions

2.01

1.59

1.1

1.2

0.03

0.99

u/ml

—

Other specified/unspecified systemic involvement of connective tissue

159

1.64

1.59

1.2

0.16

0.55

u/ml

0.59

Other benign neoplasms of uterus

106

1.80

1.59

1.3

1.1

0.16

1.76

u/ml

0.79

Other specified/unspecified soft tissue disorders

1.83

1.57

1.2

0.03

0.83

u/ml

—

Primary open-angle glaucoma, strict

506

1.34

1.57

1.2

1.3

1.37

u/ml

0.00

278

Dental caries 2 and operation codes

327

2276

1.14

1.57

1.3

0.57

1.08

u/ml

0.92

142

941

Benign neoplasm: Skin of other and unspecified parts of face

239

1.51

1.57

1.3

1.2

1.27

0.86

u/ml

0.15

111

Artificial joint re-operation

129

1.71

1.56

1.3

1.2

1.25

1.26

u/ml

0.01

Polyarthritis, unspecified

1.86

1.56

1.3

1.2

0.03

0.30

u/ml

—

Speech and linguistic disorders

245

1.49

1.56

1.4

1.3

0.97

0.81

u/ml

—

Other encephalitis

2.04

1.54

1.0

1.2

0.20

0.41

u/ml

—

Anterior Iridocyclitis

509

1.34

1.54

1.4

1.3

1.51

1.08

u/ml

0.16

227

IBD patients in KELA-register

675

1.29

1.53

1.2

1.3

0.44

1.24

u/ml

1.14

286

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

0.00

1.53

0.0

1.2

—

1.35

—

Myocardial infarction, without ST-elevation

679

1.28

1.52

1.6

1.3

1.90

1.28

u/ml

0.32

369

Other diseases of peritoneum

115

1.75

1.52

1.1

1.2

0.11

0.68

u/ml

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

1.52

0.0

1.2

—

1.06

—

MS-disease / Multiple Sclerosis

219

0.50

1.52

1.0

1.2

0.04

0.59

u/ml

—

Disorders of vitreous body and globe

163

1324

1.20

1.52

1.2

1.3

1.48

1.52

u/ml

0.02

655

Demyelinating diseases of the central nervous system

258

0.54

1.52

1.1

1.2

0.04

0.52

u/ml

—

Cysts of oral region, not elsewhere classified

1.84

1.51

2.0

1.3

0.24

0.68

u/ml

—

Palindromic rheumatism

2.89

1.51

1.2

—

0.08

—

Other peripheral vertigo

201

1.55

1.51

1.2

1.33

0.96

u/ml

0.12

Varicose veins of other sites

146

1.65

1.50

1.3

2.58

0.94

u/ml

0.36

Other benign neoplasms of skin

121

980

1.24

1.50

1.2

1.3

0.76

1.23

u/ml

0.54

468

Follicular cysts of skin and subcutaneous tissue

443

1.36

1.49

1.2

1.3

1.04

1.17

u/ml

0.05

202

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.96

1.49

1.4

1.2

0.07

0.81

u/ml

—

Disorders of vitreous body

159

1296

1.20

1.49

1.2

1.3

1.52

1.48

u/ml

0.02

641

Psychotic depression

131

1.68

1.49

1.1

1.3

3.44

1.07

u/ml

—

Carrier of infectious disease

2.01

1.49

1.8

1.3

1.24

0.45

u/ml

—

Hyperhidrosis

1.96

1.49

1.4

1.2

0.68

1.13

u/ml

—

Other follicular disorders

194

1.55

1.48

1.3

1.16

0.88

u/ml

0.09

Seborrhoeic dermatitis

202

1.54

1.48

1.1

1.3

0.26

0.55

u/ml

0.40

Benign neoplasm: Sigmoid colon

393

1.38

1.47

1.4

1.3

3.05

1.17

u/ml

0.67

200

Impetigo

132

1.67

1.46

1.1

1.3

0.87

0.43

u/ml

—

Migraine without aura, drug-induced

2.52

1.45

1.0

—

0.06

u/ml

—

Premature rupture of membranes

103

602

1.26

1.45

1.1

1.3

0.13

0.99

u/ml

1.67

232

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

202

0.49

1.45

2.0

1.3

0.16

1.25

u/ml

—

106

Diseases of arteries, arterioles and capillaries (FINNGEN)

400

1.31

1.43

1.3

4.34

1.59

u/ml

0.78

181

Benign neoplasm: Ascending colon

269

1.45

1.43

1.6

1.3

1.10

u/ml

0.00

135

Other symptoms and signs involving the urinary system

228

1.50

1.43

1.4

2.03

1.17

u/ml

0.32

111

Anomalies of dental arch relationship, including avohilmo

573

1.29

1.42

1.3

1.63

0.80

u/ml

0.29

201

Disorder of lipoprotein metabolism, unspecified

245

1.47

1.42

1.2

1.3

0.14

1.19

u/ml

1.34

126

Benign neoplasm of major salivary glands

237

1.48

1.41

1.6

1.2

1.87

1.07

u/ml

0.30

113

Benign neoplasm of bone and articular cartilage

221

1.50

1.41

1.3

0.22

0.51

u/ml

0.56

Benign neoplasm: Conjunctiva

1.86

1.40

1.4

1.2

2.52

0.92

u/ml

—

Other abnormal products of conception

163

909

1.20

1.40

1.3

1.2

0.32

0.80

u/ml

1.00

342

Disorders of calcium metabolism

126

1.67

1.40

1.6

1.3

0.12

1.34

u/ml

0.92

Benign neoplasm: Parotid gland

173

1.57

1.40

1.6

1.2

1.70

1.30

u/ml

0.11

Congenital malformations of the circulatory system

393

1.36

1.39

1.2

1.3

2.45

0.99

u/ml

0.45

142

Gout, FINNGEN

484

1.32

1.38

1.2

1.3

1.31

1.52

u/ml

0.07

263

Cholecystitis

263

1.45

1.38

1.2

1.3

0.51

1.36

u/ml

0.87

130

Pain associated with micturition

280

1.43

1.37

1.1

1.4

0.11

0.84

u/ml

1.10

117

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

385

0.65

1.37

1.2

1.3

0.22

1.15

u/ml

1.63

194

Medial epicondylitis

1.81

1.37

1.0

1.2

0.32

0.82

u/ml

—

Panniculitis affecting regions of neck and back

1.81

1.37

1.3

0.03

0.82

u/ml

0.88

Diseases of the myoneural junction and muscle

247

1.46

1.37

1.2

1.4

0.47

1.09

u/ml

0.62

114

Thoracic aortic aneurysm

247

1.46

1.37

1.3

4.70

0.88

u/ml

0.62

128

Other/unspecified rheumatoid arthritis

272

1.44

1.37

1.5

1.2

0.31

1.05

u/ml

0.95

130

Pedal cyclist injured in transport accident

590

1.29

1.36

1.3

0.55

0.99

u/ml

0.44

237

Hyperplasia of prostate

398

1.28

1.36

1.7

1.3

2.21

1.66

u/ml

0.21

217

Mucosal proctocolitis

348

1.38

1.36

1.3

0.57

0.71

u/ml

0.12

139

Benign neoplasm of other and unspecified sites

1.84

1.36

1.1

0.04

1.88

u/ml

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

172

1.55

1.35

1.8

1.4

0.91

0.60

u/ml

—

Impotence

1.84

1.35

1.1

1.4

0.05

1.08

u/ml

—

Acute and subacute iridocyclitis

486

1.32

1.35

1.4

1.3

0.54

1.10

u/ml

0.62

213

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.76

1.35

1.2

1.4

0.29

0.51

u/ml

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

0.00

1.35

0.0

1.2

—

1.26

—

Adenocarcinoma of pancreas

0.00

1.34

0.0

1.2

—

0.28

—

L02BA Anti-estrogens

466

0.69

1.34

1.3

0.58

1.36

u/ml

0.58

209

Disorder of the sleep-wake schedule

2.15

1.34

1.4

1.3

0.02

0.09

u/ml

—

Acute nasopharyngitis (common cold)

255

1.45

1.34

1.4

1.3

0.33

0.73

u/ml

0.56

104

Burns and corrosions of external body surface, specified by site

282

1.42

1.33

1.5

1.3

1.54

0.75

u/ml

0.47

115

Herpesviral keratitis and keratoconjunctivitis

105

1.72

1.33

2.2

1.2

4.67

0.64

u/ml

0.96

Other/unspecified disorders of vestibular function

1.79

1.33

1.2

1.1

0.07

1.16

u/ml

0.62

Inflammatory diseases of prostate (prostatitis)

224

1.48

1.33

1.5

1.3

1.01

1.83

u/ml

0.47

113

Dissocial personality disorder

0.00

1.33

0.0

1.3

—

0.38

—

Acute appendicitis, no complications

225

1947

1.15

1.33

1.3

1.31

1.12

u/ml

0.14

839

Chronic suppurative otitis media, including avohilmo

208

1.49

1.32

1.4

1.03

1.06

u/ml

0.01

Neuralgia and neuritis, unspecified

113

1.69

1.32

1.1

1.2

0.56

0.75

u/ml

0.12

Benign neoplasm: Conjunctiva

1.82

1.31

1.4

1.1

2.52

0.85

u/ml

—

Transient ischemic attack

147

1020

1.20

1.31

1.3

1.57

1.38

u/ml

0.10

531

Hypertrophic disorders of skin

168

1.55

1.31

1.4

1.2

0.14

0.68

u/ml

0.84

Other neurotic disorders

121

1.66

1.30

1.3

1.2

0.01

0.68

u/ml

—

Inflammatory bowel disease, strict (require KELA)

692

1.26

1.30

1.2

1.3

0.44

1.18

u/ml

1.05

293

Inflammatory diseases of the central nervous system

217

1.48

1.30

1.0

1.3

0.19

0.53

u/ml

0.75

Other and unspecified injuries of lower leg

201

1.50

1.29

1.5

1.3

0.44

0.63

u/ml

0.20

Muscle strain

1.89

1.28

1.3

1.2

0.03

1.12

u/ml

—

Benign neoplasm of bone and articular cartilage

226

1.46

1.28

1.3

0.22

0.52

u/ml

0.59

Struck by thrown, projected or falling objec

114

1.67

1.28

1.1

1.4

0.78

0.37

u/ml

—

Ascites

133

0.45

1.28

1.0

1.2

—

0.80

u/ml

—

Benign neoplasm of other and unspecified sites

1.80

1.27

1.1

1.2

0.04

0.76

u/ml

—

Other and unspecified disorders of white blood cells

1.73

1.27

1.1

1.3

0.16

0.61

u/ml

—

Meralgia paraesthetica

1.80

1.27

1.3

7.69

0.89

u/ml

—

Benign neoplasm: Descending colon

122

1.64

1.27

1.1

1.3

0.03

0.93

u/ml

—

Unspecified misadventure during surgical and medical care

130

1.62

1.26

2.0

1.2

1.38

0.56

u/ml

0.40

Lichen planus, including avohilmo

422

1.33

1.26

1.3

0.85

0.91

u/ml

0.03

211

Mixed connective tissue disease

178

1.52

1.26

1.3

1.2

0.17

0.59

u/ml

0.66

Other specified/unspecified bacterial intestinal infections

146

1.58

1.26

1.2

0.07

0.56

u/ml

0.98

Graves ophthalmopathy

1.83

1.26

1.4

1.2

0.07

0.94

u/ml

—

Dental caries 2

328

2299

1.12

1.25

1.3

0.70

1.06

u/ml

0.51

143

949

Cramp and spasm

115

1.66

1.25

1.7

1.3

0.18

0.66

u/ml

0.61

Gout, idiopatic and unspecified

423

1.33

1.24

1.2

1.3

1.45

1.56

u/ml

0.03

218

Leiomyoma of uterus

176

1159

0.85

1.24

1.3

0.46

1.11

u/ml

1.23

487

Female infertility, associated with anovulation

253

1.43

1.24

1.1

1.2

1.14

1.43

u/ml

0.09

Bipolar affective disorders

573

1.28

1.23

1.2

1.3

1.17

1.11

u/ml

0.02

229

Monoarthritis, not elsewhere classified

108

1.67

1.22

1.0

1.2

0.06

0.28

u/ml

—

Unspecified nephritic syndrome

2.05

1.22

2.2

1.3

1.50

1.12

u/ml

—

Other congenital malformations of skin

124

1.62

1.21

1.1

1.5

0.03

0.92

u/ml

—

Parodontitis and operation codes

260

2286

0.88

1.20

1.2

1.3

1.30

u/ml

0.00

138

1045

Calcific tendinitis of shoulder

132

1.60

1.20

1.3

2.66

0.64

u/ml

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

481

0.71

1.20

1.2

1.30

1.17

u/ml

0.04

227

Volume depletion

140

1.57

1.20

1.2

1.4

3.50

1.19

u/ml

—

Acute appendicitis

280

2345

1.13

1.20

1.4

1.3

1.35

1.15

u/ml

0.18

121

1027

Acute and transient psychotic disorders

336

0.65

1.19

1.1

1.2

0.03

0.54

u/ml

—

136

Encephalitis

1.84

1.19

1.0

1.2

0.20

0.38

u/ml

—

Outcome of delivery

419

0.75

1.19

1.2

1.3

0.36

0.85

u/ml

0.67

149

Polyp of the female genital tract

128

620

1.20

1.19

1.3

0.65

1.87

u/ml

1.17

271

Presence of other devices

444

1.31

1.18

1.6

1.2

1.18

1.22

u/ml

0.01

215

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

222

1.45

1.18

1.4

1.3

1.53

0.50

u/ml

0.31

101

Parodontitis or operation codes

278

2304

0.89

1.18

1.2

1.3

1.28

1.32

u/ml

0.02

143

1055

Congenital deformities of feet

1.89

1.18

1.5

1.4

0.30

0.34

u/ml

—

Benign neoplasm: Parotid gland

181

1.50

1.18

1.6

1.2

1.70

0.97

u/ml

0.22

Duodenal ulcer

173

1.51

1.17

1.4

1.3

0.19

1.51

u/ml

1.09

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

231

1.43

1.17

1.3

2.20

0.94

u/ml

0.26

Maternal care for other conditions predominantly related to pregnancy

800

1.22

1.17

1.2

1.3

0.08

0.83

u/ml

1.99

304

Malignant neoplasm of other and unspecified female genital organs

0.00

1.16

0.0

1.1

—

1.89

—

Anogenital herpesviral [herpes simplex] infection

190

1.48

1.16

1.6

1.2

0.67

0.37

u/ml

0.29

Hypothermia

0.00

1.16

0.0

1.2

—

0.08

—

Sequelae of infectious and parasitic diseases

190

1.48

1.16

1.2

2.31

0.47

u/ml

0.55

Parodontitis

278

2302

0.89

1.16

1.2

1.3

1.28

1.30

u/ml

0.01

143

1053

Benign neoplasm: Caecum

215

1.45

1.15

1.3

1.01

1.18

u/ml

0.07

109

Open wound of hip and thigh

1.81

1.15

1.2

0.37

0.26

u/ml

—

Psoriatic arthropathies, ICD10

274

1.39

1.15

1.2

0.02

0.61

u/ml

1.45

121

Stroke, including SAH

137

1196

0.85

1.14

1.2

1.3

1.08

1.39

u/ml

0.24

612

Malignant neoplasm of bronchus and lung

280

1.37

1.14

1.2

1.3

0.36

1.86

u/ml

1.58

154

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

0.00

1.14

0.0

1.2

—

0.35

—

Chronic periodontitis, including avohilmo

277

2300

0.89

1.14

1.2

1.3

1.28

1.30

u/ml

0.01

143

1051

Fracture of femur

432

0.72

1.13

1.1

1.3

0.18

1.20

u/ml

2.01

223

Other embolism and thrombosis

275

1.38

1.13

1.5

1.4

0.93

0.79

u/ml

0.07

134

Dependent personality disorder

1.91

1.12

1.5

1.2

0.30

0.34

u/ml

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

136

1095

0.85

1.12

1.4

1.3

1.89

1.30

u/ml

0.31

553

Pathological resorption of teeth

1.91

1.12

1.5

1.4

0.47

0.97

u/ml

—

Other psoriatic arthropathies

267

1.39

1.12

1.2

0.02

0.62

u/ml

1.43

118

Malignant neoplasm of respiratory system and intrathoracic organs

324

1.34

1.12

1.2

1.3

0.35

1.74

u/ml

1.67

175

Other infective otitis externa

151

1.53

1.11

1.2

1.65

0.66

u/ml

0.26

Dental caries 2, only avohilmo

320

2267

1.11

1.3

0.71

1.06

u/ml

0.45

135

946

Other noninfective disorders of lymphatic vessels and lymph nodes

1.71

1.11

1.3

0.16

0.37

u/ml

—

Cardiomyopathy, other and unspecified

151

1.53

1.11

1.3

3.43

1.14

u/ml

0.39

Congenital iodine-deficiency syndrome/hypothyroidism

1.79

1.11

1.3

1.1

3.06

1.63

u/ml

—

Unspecified mental disorder

109

1304

0.83

1.11

1.2

1.3

1.62

1.25

u/ml

0.16

560

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

284

1.36

1.11

1.2

1.3

0.38

1.06

u/ml

0.78

149

Other Crohn's disease

184

1.47

1.10

1.0

1.3

0.08

0.63

u/ml

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

209

1.44

1.10

1.3

1.2

0.20

0.94

u/ml

0.76

Cardiomyopathy

345

1.34

1.10

1.3

1.4

2.09

1.77

u/ml

0.08

163

Preterm labour and delivery

112

936

1.20

1.09

1.3

1.2

0.24

0.71

u/ml

1.43

383

Other and unspecified mood [affective] disorders

201

1.45

1.09

1.3

0.23

0.57

u/ml

0.44

Disorders of psychological development

344

1.32

1.09

1.4

1.3

0.93

0.72

u/ml

0.08

102

Event of undetermined intent

160

1.50

1.09

1.2

1.3

0.30

0.71

u/ml

0.55

Effects of foreign body entering through natural orifice

629

1.24

1.08

1.2

1.3

2.04

1.37

u/ml

0.16

257

Other osteochondropathies

185

1.46

1.08

1.3

3.28

0.57

u/ml

0.38

Epilepsy

763

1.22

1.07

1.3

0.20

1.22

u/ml

3.29

333

Impacted teeth

569

1.24

1.07

1.4

1.3

0.99

0.72

u/ml

0.26

183

Emergency coronary revascularization (for ACS)

842

0.83

1.07

1.3

2.04

1.42

u/ml

0.26

461

Open wound of ankle and foot

244

1.40

1.07

1.3

1.4

2.33

0.76

u/ml

0.52

102

Glomerular disorders in diseases classified elsewhere

244

1.40

1.07

1.2

1.3

0.04

1.07

u/ml

1.47

112

Other and unspecified disorders of psychological development

2.17

1.07

1.6

1.7

—

0.65

u/ml

—

Somnolence

2.14

1.06

1.1

1.3

—

0.09

u/ml

—

Vitamin deficiency, wide

113

1.60

1.05

1.2

1.3

0.14

0.77

u/ml

—

Vitamin deficiency

113

1.60

1.05

1.2

1.3

0.14

0.77

u/ml

—

Benign neoplasm: Small intestine

1.71

1.05

1.4

1.1

0.09

1.71

u/ml

—

Unspecified haematuria

110

789

1.20

1.05

1.2

1.3

1.03

1.47

u/ml

0.39

394

Multiple delivery

271

1.37

1.04

1.3

0.13

0.83

u/ml

1.49

108

Ankylosing spondylitis, ICD10

237

1.40

1.04

1.4

1.2

0.22

0.77

u/ml

0.79

Injury of nerves at wrist and hand level

1.67

1.04

1.5

1.3

0.35

1.37

u/ml

—

Thrombocytopenia, unspecified

162

1.49

1.04

1.5

1.2

0.39

0.83

u/ml

0.42

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

187

1.45

1.03

1.1

1.3

0.10

0.63

u/ml

—

Arthropathic psoriasis

280

1.36

1.03

1.2

1.3

0.02

0.60

u/ml

1.53

127

Ovarian dysfunction

246

1.39

1.03

1.1

1.2

0.06

0.20

u/ml

1.27

Female infertility, tubal origin

146

1.51

1.03

1.1

1.2

0.59

2.40

u/ml

—

Generalized epilepsy

130

1.54

1.02

1.2

1.4

0.21

0.83

u/ml

—

Caught, crushed, jammed or pinched in or between objects

130

1.54

1.02

1.2

1.4

0.73

0.39

u/ml

0.23

Retinal breaks without detachment

350

1.32

1.02

1.2

1.3

0.98

1.10

u/ml

0.05

169

Gastric ulcer

298

1.34

1.02

1.1

1.3

0.13

1.47

u/ml

1.75

150

Impacted cerumen

188

1.44

1.01

1.5

1.3

2.91

1.00

u/ml

0.60

Graves ophthalmopathy, strict

1.78

1.01

1.4

1.2

0.07

1.08

u/ml

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

450

1.27

1.01

1.3

2.25

0.96

u/ml

0.42

163

Other/unspecified soft tissue disorders related to use, overuse and pressure

1.77

1.00

2.3

1.4

0.28

1.13

u/ml

—

Dental pulpitis 3

308

1.29

1.00

1.2

1.4

1.22

0.83

u/ml

0.18

Primary coxarthrosis, bilateral

582

1.24

1.00

1.6

1.3

0.99

1.43

u/ml

0.33

315

Melanocytic naevi of trunk

308

1.33

0.99

1.9

1.3

2.34

0.62

u/ml

1.06

129

Lesion of lateral popliteal nerve

115

1.57

0.99

1.2

1.3

0.59

0.82

u/ml

—

Nail disorders

214

1.41

0.99

1.2

0.03

0.58

u/ml

1.41

Schizoaffective disorder

225

0.62

0.99

1.2

0.03

0.54

u/ml

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.72

0.99

1.1

1.4

0.04

0.61

u/ml

—

Fracture of forearm

196

1618

1.14

0.99

1.4

1.3

2.44

1.07

u/ml

0.77

707

Chronic suppurative otitis media

164

1.47

0.99

1.3

1.26

u/ml

0.00

Urethritis and urethral syndrome

1.81

0.98

1.5

1.2

1.48

1.29

u/ml

—

Labour and delivery complicated by fetal stress [distress]

117

660

1.18

0.98

1.3

0.40

0.62

u/ml

0.39

226

Diabetes, varying definitions

427

2339

1.09

0.98

1.4

1.3

1.38

1.25

u/ml

0.12

202

1032

Suppurative otitis media, unspecified

1.81

0.98

1.2

1.3

0.06

0.37

u/ml

—

Valvular operations

261

0.65

0.98

1.1

1.4

0.07

2.30

u/ml

—

124

Shoulder region

0.00

0.98

0.0

1.2

—

0.08

—

Anorexia (incl.atypical)

181

1.44

0.98

1.2

0.95

0.72

u/ml

—

Diabetic retinopathy, strict definition

353

0.72

0.98

1.1

1.4

1.11

1.35

u/ml

0.11

172

Open wound of thorax

0.00

0.98

0.0

1.2

—

0.49

—

Malignant neoplasm of testis

0.00

0.98

0.0

1.2

—

0.46

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

1.67

0.98

1.2

1.1

0.04

0.72

u/ml

—

Brain glioblastoma and astrocytoma

0.00

0.97

0.0

1.2

—

0.09

—

Ingrowing nail

132

1.52

0.97

1.2

1.3

0.02

0.78

u/ml

—

Ulcer of vagina/vulva

1.75

0.96

1.2

0.03

1.26

u/ml

—

Hereditary retinal dystrophy

0.00

0.96

0.0

1.2

—

2.01

—

Other disorders of glucose regulation and pancreatic internal secretion

211

0.61

0.96

1.2

1.3

0.05

0.54

u/ml

—

Other noninflammatory disorders of vulva and perineum

224

1.39

0.96

1.3

0.60

2.10

u/ml

0.71

Glucosamine medication

142

978

1.16

0.96

1.4

1.3

0.99

1.47

u/ml

0.55

502

Other and unspecified psoriasis

157

1.47

0.96

1.3

0.83

0.84

u/ml

—

Fibrosis and cirrhosis of liver

157

1.47

0.96

1.3

1.43

1.42

u/ml

0.00

Other disorders of the genitourinary system

293

1.33

0.95

1.4

1.3

1.30

1.09

u/ml

0.10

138

Retinal detachments and breaks

804

1.20

0.95

1.3

0.87

1.18

u/ml

0.28

402

Unspecified visual impairment (binocular)

0.00

0.95

0.0

1.5

—

1.27

—

Substance use, excluding alcohol

541

1.24

0.95

1.3

1.66

0.79

u/ml

0.36

218

Postmenopausal atrophic vaginitis

454

1.21

0.94

1.4

1.3

0.89

2.35

u/ml

0.96

211

Primary open-angle glaucoma

598

1.22

0.94

1.3

1.28

1.30

u/ml

0.01

330

Benign neoplasm: Skin of other and unspecified parts of face

268

1.35

0.94

1.3

1.27

1.18

u/ml

0.03

126

Stroke, excluding SAH

125

1081

0.86

0.93

1.2

1.3

0.71

1.39

u/ml

1.13

559

Appendectomy

260

2255

1.11

0.93

1.3

0.99

1.09

u/ml

0.10

111

974

Fitting and adjustment of other devices

664

1.21

0.93

1.4

1.3

0.91

1.49

u/ml

0.39

323

Other diseases of blood and blood-forming organs

150

1.47

0.93

1.6

1.2

0.42

0.85

u/ml

0.37

Statin medication

255

1591

0.90

0.92

1.3

0.60

1.37

u/ml

1.44

128

692

Insulin, combination of fast acting with intermediate-acting or long-acting

195

1593

1.13

0.92

1.5

1.3

1.32

1.26

u/ml

0.04

763

Abnormalities of forces of labour

385

0.73

0.92

1.3

1.2

0.51

0.45

u/ml

0.06

150

Injury of eye and orbit

365

1.29

0.92

1.4

1.3

1.74

0.73

u/ml

0.39

142

Dystonia

142

1.48

0.92

1.2

1.3

0.05

0.63

u/ml

1.04

Lesion of radial nerve

1.63

0.91

1.1

1.2

5.47

0.88

u/ml

—

Pre-eclampsia or poor fetal growth

133

1148

1.16

0.90

1.3

1.2

0.41

0.84

u/ml

0.84

441

Campylobacter enteritis

1.75

0.90

1.0

1.2

0.26

u/ml

—

Benign neoplasm: Descending colon

135

1.49

0.89

1.1

1.3

0.03

1.10

u/ml

—

Hemiplegia

119

1.52

0.88

1.1

1.2

0.05

0.61

u/ml

—

Bilateral sagittal split ramus osteotomy operation

111

1.54

0.88

1.4

1.3

0.25

0.50

u/ml

0.49

LSIL lesion of the cervix uteri

404

0.74

0.88

1.1

1.2

0.13

0.66

u/ml

—

147

Atrophic disorders of skin

377

1.28

0.87

1.5

1.3

0.22

1.05

u/ml

1.47

166

Cardiodefibrillation

719

1.20

0.87

1.3

1.4

0.31

1.52

u/ml

3.52

398

Ectopic pregnancy

611

1.21

0.87

1.2

0.22

0.97

u/ml

1.26

257

Diabetes mellitus

427

2352

1.08

0.87

1.4

1.3

1.38

1.27

u/ml

0.09

203

1038

Other and/or unspecified nontoxic goitre

203

1.38

0.87

1.5

1.2

0.34

0.86

u/ml

—

Cerebrovascular diseases

185

1492

0.89

0.87

1.4

1.3

1.31

1.30

u/ml

0.01

112

743

KRA_PSY_EATING, excluding more controls

254

1.34

0.86

1.2

0.47

0.43

u/ml

0.05

Left bundle-branch block

136

1.47

0.86

1.0

1.3

0.19

1.55

u/ml

1.02

Benign neoplasm: Transverse colon

195

1.39

0.86

1.7

1.3

1.31

1.18

u/ml

0.04

Recurrent dislocation and subluxation of joint

195

1.39

0.86

1.3

1.2

0.21

0.57

u/ml

0.84

Use of disulfiram, acamprosate or naltrexone

216

0.65

0.85

1.1

1.3

1.25

0.69

u/ml

—

Superficial injury of head

558

1.22

0.85

1.2

1.3

0.06

1.12

u/ml

2.77

230

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.68

0.85

1.4

1.2

0.13

0.52

u/ml

—

Other appendicitis

230

1.35

0.84

1.1

1.3

0.44

0.71

u/ml

0.27

Persons encountering health services in circumstances related to reproduction

235

1434

1.11

0.84

1.5

1.3

1.87

1.19

u/ml

0.45

575

Contusion of other and unspecified parts of foot

137

1.46

0.84

1.1

1.4

0.06

0.45

u/ml

—

Chronic periodontitis

300

1.30

0.84

1.4

1.3

0.12

1.69

u/ml

2.59

148

Paralytic ileus and intestinal obstruction

542

1.22

0.83

1.4

1.3

1.40

1.17

u/ml

0.10

266

Other benign neoplasms of skin

121

1029

1.15

0.82

1.2

1.3

0.76

1.30

u/ml

0.66

493

Phobic anxiety disorders

381

1.26

0.82

1.1

1.3

0.50

0.87

u/ml

0.35

129

UC patients in KELA-register (code 208), prior to 1994

105

1.53

0.81

1.3

1.2

0.27

0.29

u/ml

—

Other acute skin changes due to ultraviolet radiation

1.61

0.81

1.1

0.04

0.84

u/ml

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

189

1.38

0.81

1.3

0.44

0.34

u/ml

0.17

Pedal cyclist injured in noncollision transport accidents

302

1.29

0.81

1.1

1.3

0.21

0.73

u/ml

1.10

123

Other infectious diseases

172

1.40

0.80

1.6

1.3

4.36

1.37

u/ml

0.69

Foreign body in alimentary tract

122

1.48

0.80

1.2

1.3

0.11

0.69

u/ml

—

Benign neoplasm: Spinal cord

1.83

0.79

1.5

0.57

0.38

u/ml

—

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.2

—

1.36

—

Amyloidosis, other/unspecified

0.00

0.79

0.0

1.3

—

2.15

—

Other juvenile arthritis

106

1.51

0.79

1.3

1.4

0.18

0.58

u/ml

—

Varicella [chickenpox]

106

1.51

0.79

1.1

1.5

0.19

0.58

u/ml

—

Melanocytic naevi of trunk

321

1.28

0.79

1.9

1.3

2.34

0.74

u/ml

0.92

129

Hereditary ataxia

0.00

0.78

0.0

1.2

—

0.11

—

Hereditary corneal dystrophies

1.63

0.78

2.0

1.2

2.42

0.87

u/ml

—

Benign neoplasm: Other and unspecified parts of mouth

1.59

0.78

1.2

0.04

0.83

u/ml

—

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

0.00

0.77

0.0

1.3

—

1.55

—

Late syphilis

0.00

0.77

0.0

1.2

—

0.42

—

Operations for atrial fibrillation

0.00

0.77

0.0

1.2

—

0.37

—

Presbyopia

165

1.40

0.77

1.2

0.28

0.52

u/ml

0.33

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

0.00

0.77

0.0

1.2

—

1.09

—

Ménière disease

208

1.35

0.77

1.3

0.10

0.92

u/ml

1.01

102

Crohn's disease NAS

174

1.38

0.76

1.1

1.3

0.21

0.65

u/ml

0.72

Brain glioblastoma

0.00

0.76

0.0

1.2

—

0.09

—

Chronic myeloproliferative disease

0.00

0.76

0.0

1.2

—

1.37

—

Assault by blunt object

0.00

0.76

0.0

1.3

—

0.44

—

LSIL lesion of the cervix uteri, vagina or vulva

505

0.79

0.75

1.2

0.08

1.06

u/ml

1.51

199

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

421

1.22

0.75

1.1

1.3

0.28

1.29

u/ml

1.84

225

Aortic aneurysm

379

1.25

0.75

1.3

3.85

1.11

u/ml

0.52

204

Polycystic ovarian syndrome, broad definition

404

1.24

0.75

1.1

1.2

0.74

0.31

u/ml

0.32

126

Lactose intolerance

1.61

0.75

1.2

1.17

1.06

u/ml

—

Abnormal blood-pressure reading, without diagnosis

1.60

0.75

1.4

1.2

3.45

2.70

u/ml

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

218

1.33

0.75

1.3

1.2

0.18

0.51

u/ml

0.92

Crohn disease (strict definition, all UC cases excluded)

141

1.42

0.74

1.2

1.3

0.01

0.39

u/ml

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

289

1.28

0.74

1.3

1.2

0.60

1.40

u/ml

0.39

104

Other puerperal infections

289

1.28

0.73

1.3

1.2

0.21

0.49

u/ml

0.50

Maternal care for known or suspected abnormality of pelvic organs

111

665

1.15

0.73

1.2

1.3

1.12

1.05

u/ml

0.03

256

Dislocation, sprain and strain of joints and ligaments of elbow

167

1.38

0.73

1.3

0.91

0.38

u/ml

0.39

Memory loss

167

1.38

0.73

1.5

1.3

0.30

1.54

u/ml

1.14

Pacemaker

562

1.19

0.73

1.3

1.4

0.28

1.57

u/ml

3.13

307

Benign neoplasm of other and unspecified intrathoracic organs

2.01

0.73

1.4

1.2

0.06

0.07

u/ml

—

Type 2 diabetes

392

2162

1.08

0.73

1.3

1.44

1.28

u/ml

0.14

188

980

Coxarthrosis, primary

165

1280

1.12

0.73

1.4

1.3

0.69

1.41

u/ml

1.38

675

Crohn's disease of large intestine

142

1.41

0.72

1.2

1.3

0.11

0.73

u/ml

—

Crushed, pushed or stepped on by crowd or human stampede

211

1.33

0.72

1.2

1.4

0.03

0.58

u/ml

2.07

Benign neoplasm: Skin of eyelid, including canthus

344

1.25

0.71

1.1

1.3

0.10

1.25

u/ml

2.33

176

Torticollis

1.76

0.71

1.1

1.4

—

0.13

u/ml

—

Maltreatment syndromes

134

1.42

0.71

1.1

1.3

0.28

0.49

u/ml

—

Intracerebral haemorrhage

206

0.68

0.71

1.3

1.4

0.30

1.61

u/ml

—

104

Other or unspecified ileus, impaction or obstruction

362

1.24

0.71

1.2

1.3

0.53

1.30

u/ml

0.68

177

Fall involving playground equipment

1.94

0.71

1.2

1.5

—

0.17

—

Benign neoplasm of other and unspecified intrathoracic organs

1.94

0.71

1.4

1.2

0.06

u/ml

—

Residual foreign body in soft tissue

109

1.47

0.71

1.2

1.3

0.25

0.84

u/ml

—

Crohn disease (strict definition, require KELA)

177

1.36

0.70

1.2

1.3

0.11

0.66

u/ml

—

Myopia

381

1.24

0.70

1.2

1.3

0.55

0.67

u/ml

0.09

140

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

388

0.77

0.70

1.2

1.3

0.16

0.98

u/ml

1.90

202

Superficial injury of thorax

336

1.25

0.70

1.1

1.3

1.67

0.96

u/ml

0.39

143

Other maternal disorders predominantly related to pregnancy

262

1509

1.09

0.70

1.2

1.3

1.10

u/ml

0.00

607

Problems related to lifestyle

256

1.29

0.70

1.0

1.2

0.26

0.73

u/ml

0.57

Major coronary heart disease event excluding revascularizations

180

1118

1.11

0.69

1.5

1.3

1.69

1.45

u/ml

0.15

103

590

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

118

1.45

0.69

1.1

1.2

0.20

0.32

u/ml

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

195

1.34

0.69

1.2

0.60

1.05

u/ml

0.24

Diseases of peritoneum

230

1.31

0.69

1.1

1.3

0.10

1.07

u/ml

1.21

106

Type1 diabetes, definitions combined, early onset

227

0.70

0.69

2.3

1.3

0.52

0.62

u/ml

—

Benign neoplasm: Other and unspecified parts of mouth

1.54

0.69

1.2

0.04

0.76

u/ml

—

Other congenital malformations of nervous system

1.86

0.68

1.0

—

0.10

u/ml

—

Attention to artificial openings

1.60

0.68

1.1

1.2

0.06

0.74

u/ml

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

187

1.34

0.68

1.3

1.2

0.23

1.00

u/ml

0.70

malignant neoplasm of female genital organs

341

0.76

0.67

1.2

1.3

1.80

0.87

u/ml

0.21

160

Wet age-related macular degeneration

244

1.29

0.67

1.4

1.3

4.39

0.81

u/ml

0.66

138

Oral lichen ruber planus, including avohilmo

153

1.38

0.67

1.2

1.08

0.58

u/ml

—

Benign neoplasm: Small intestine

1.49

0.67

1.4

1.2

0.09

1.53

u/ml

—

L04AC Interleukin inhibitors

136

1.40

0.66

1.4

1.3

0.20

0.38

u/ml

—

Crowding of teeth, including avohilmo

249

1.26

0.66

1.5

1.3

1.57

0.63

u/ml

—

Other sexually transmitted chlamydial diseases

191

0.68

0.66

1.2

0.20

0.43

u/ml

—

Other and unspecified corneal deformities and disorders

1.52

0.66

2.5

1.2

2.79

0.75

u/ml

—

Melanocytic naevi

855

1.15

0.66

1.5

1.3

1.67

1.26

u/ml

0.25

357

Hyperprolactinaemia

111

1.45

0.66

1.3

1.2

0.13

0.25

u/ml

—

Insulin medication

195

1515

1.10

0.65

1.5

1.3

1.32

1.20

u/ml

0.08

721

Spinal instabilities

1.58

0.65

1.3

1.2

0.01

0.99

u/ml

—

Other aneurysm

103

1.46

0.65

1.1

1.3

2.02

0.61

u/ml

—

Coronary revascularization (ANGIO or CABG)

730

0.87

0.65

1.3

2.13

1.34

u/ml

0.33

401

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

201

0.69

0.64

1.1

1.3

2.75

1.25

u/ml

—

112

Amenorrhoea

224

1.30

0.64

1.3

0.10

2.01

u/ml

1.09

L01XE Protein kinase inhibitors

120

1.42

0.64

1.5

1.2

0.30

1.05

u/ml

—

Melanocytic naevi of other and unspecified parts of face

166

0.66

0.64

1.1

1.2

0.04

1.25

u/ml

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

270

0.74

0.64

1.8

1.2

3.49

0.78

u/ml

0.38

100

Type 2 diabetes, definitions combined

369

2054

1.07

0.64

1.3

1.43

1.27

u/ml

0.13

180

941

Scleritis

1.73

0.64

1.2

—

0.09

u/ml

—

Cerebrovascular diseases (FINNGEN)

104

652

1.14

0.64

1.3

1.03

1.93

u/ml

0.60

279

All dysplastic lesions of the cervix uteri

987

0.87

0.64

1.2

0.14

0.94

u/ml

2.33

371

Orchitis and epididymitis

146

1.37

0.63

1.2

1.5

1.20

1.19

u/ml

—

Chronic iridocyclitis

129

1.40

0.63

1.4

1.3

4.04

0.68

u/ml

—

Osteonecrosis

129

1.40

0.63

1.1

1.2

0.08

1.24

u/ml

—

Iron deficiency anaemia secondary to blood loss (chronic)

332

1.24

0.63

1.1

1.3

0.17

1.18

u/ml

1.72

158

Colorectal cancer, excluding all cancers (controls excluding all cancers)

571

0.83

0.63

1.2

1.3

0.20

1.18

u/ml

3.02

307

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

360

1.21

0.62

1.2

1.3

0.29

1.16

u/ml

1.37

193

Unspecified lump in breast

442

1.20

0.62

1.5

1.3

0.45

1.46

u/ml

1.08

192

Gout, strict definition

288

1.25

0.62

1.2

1.3

0.09

1.75

u/ml

2.41

158

Malignant melanoma of skin

234

0.73

0.62

1.5

1.3

0.26

1.31

u/ml

—

116

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

114

887

0.89

0.61

1.3

2.10

1.23

u/ml

0.39

468

Melanocytic naevi of other and unspecified parts of face

164

0.67

0.61

1.1

1.3

0.03

0.66

u/ml

—

Benign neoplasm: Choroid

130

1.39

0.61

1.2

0.49

1.30

u/ml

0.46

Malignant neoplasm of endocrine gland

191

1.31

0.61

1.3

1.2

2.45

0.60

u/ml

0.37

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.1

—

0.09

—

Drug-induced systemic lupus erythematosus

0.00

0.60

0.0

1.1

—

0.05

—

Other other unspecified disorders of the circulatory system

1.48

0.60

1.5

1.2

1.26

0.83

u/ml

—

Palatinal maxillary canine

0.00

0.60

0.0

1.9

—

0.65

—

Marginal zone B-cell lymphoma

0.00

0.60

0.0

1.3

—

0.09

—

Other nutritional anaemias

0.00

0.60

0.0

1.3

—

0.09

—

Colitis, primary sclerosing, strict definition

0.00

0.60

0.0

1.1

—

0.03

—

Haemorrhagic disorder due to circulating anticoagulants

0.00

0.60

0.0

1.3

—

0.09

—

Alcohol induced polyneuropathy

0.00

0.60

0.0

1.3

—

0.44

—

Unstable angina pectoris

644

1.15

0.60

1.3

1.09

1.50

u/ml

0.19

356

Other chromosome abnormalities, not elsewhere classified

0.00

0.60

0.0

1.8

—

0.06

—

Congenital malformations of heart and great arteries

368

1.21

0.60

1.2

1.3

2.74

1.05

u/ml

0.46

131

Postprocedural disorders of digestive system, not elsewhere classified

1.50

0.59

1.2

0.12

0.85

u/ml

—

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

0.00

0.59

0.0

1.3

—

0.38

—

Use of dimethyl fumarate

0.00

0.59

0.0

1.2

—

0.10

—

Gout, unspecified

344

1.22

0.59

1.3

1.77

1.74

u/ml

0.01

177

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.00

0.59

0.0

2.1

—

1.12

—

Disorders of optic nerve and visual pathways

254

1.26

0.59

1.5

1.3

1.35

1.24

u/ml

0.03

Benign neoplasm: Choroid

131

1.38

0.59

1.2

0.49

0.59

u/ml

0.08

Other and unspecified glaucoma

114

1.41

0.58

1.4

1.3

0.03

1.27

u/ml

—

Neuroendocrine tumor and carcinoma of small intestine

0.00

0.58

0.0

1.2

—

0.08

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.58

0.0

1.3

—

1.30

—

Type 2 diabetes, definitions combined, including avohilmo

373

2070

1.07

0.58

1.3

1.43

1.27

u/ml

0.13

180

944

Single spontaneous delivery

130

772

0.90

0.58

1.1

1.3

0.17

1.20

u/ml

4.23

343

Benign neoplasm: Spinal cord

1.72

0.58

1.5

0.57

1.36

u/ml

—

Exposure to other and unspecified inanimate mechanical forces

184

1.31

0.57

1.5

1.3

0.75

0.60

u/ml

—

Separation of retinal layers (serosa)

106

1.42

0.57

1.0

1.2

0.05

0.58

u/ml

—

Cerebral cysts

149

1.35

0.57

1.2

1.3

0.22

0.65

u/ml

—

Amblyopia ex anopsia

106

1.42

0.57

1.3

1.5

0.50

0.94

u/ml

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

401

1.20

0.57

1.3

0.69

0.62

u/ml

0.06

156

Benign neoplasm: Transverse colon

211

1.28

0.57

1.7

1.3

1.31

1.24

u/ml

0.02

105

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

331

0.78

0.57

1.1

1.3

1.29

1.13

u/ml

—

160

Crohn disease (strict definition, require KELA, min 2 HDR)

176

1.31

0.56

1.2

1.3

0.11

0.66

u/ml

—

Specific development disorders of scholastic skills

114

1.39

0.55

1.3

1.4

0.01

0.63

u/ml

—

Pustular psoriasis

124

1.37

0.55

1.1

1.2

0.22

0.75

u/ml

—

Toxic liver disease

1.63

0.55

1.0

1.2

—

0.08

u/ml

—

Myeloproliferative diseases

168

1.31

0.55

1.8

1.3

2.96

1.25

u/ml

0.27

Spontaneous abortion

198

1238

1.09

0.54

1.2

1.3

0.61

1.13

u/ml

0.78

507

Pregnancy hypertension

179

1479

1.09

0.54

1.3

0.44

0.93

u/ml

1.21

593

Uterine polyps

249

1.25

0.53

1.6

1.2

0.63

2.08

u/ml

0.91

113

Bullous disorders

125

1.36

0.53

1.2

0.55

0.59

u/ml

—

Other orthopaedic follow-up care

125

1.36

0.53

1.2

0.08

1.29

u/ml

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

122

929

0.90

0.53

1.4

1.3

2.11

1.20

u/ml

0.49

488

Contact with sharp glass

108

1.39

0.53

1.1

1.3

0.42

0.48

u/ml

—

LeFortI or BSSRO operation

134

1.35

0.53

1.3

0.25

0.43

u/ml

0.34

Nontoxic single thyroid nodule

187

1.29

0.52

1.5

1.1

0.55

0.78

u/ml

—

Other dialysis

1.52

0.52

1.1

1.3

0.01

0.23

u/ml

—

Coronary atherosclerosis

200

1188

1.09

0.52

1.2

1.3

1.82

1.23

u/ml

0.33

102

612

Type 2 diabetes, strict (exclude DM1)

368

2069

1.06

0.52

1.3

1.44

1.26

u/ml

0.14

179

947

Postmenopausal bleeding

436

1.14

0.52

1.1

1.3

0.73

2.42

u/ml

1.25

203

Complications following abortion and ectopic and molar pregnancy

1.45

0.52

1.0

1.2

0.10

0.23

u/ml

—

Oesophageal varices

1.45

0.52

1.3

0.20

0.22

u/ml

—

Cirrhosis of liver, NAS

100

1.40

0.52

1.4

2.48

1.03

u/ml

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

687

0.87

0.51

1.3

0.94

1.24

u/ml

0.16

322

Degeneration of macula and posterior pole

109

806

1.12

0.51

1.4

1.3

3.07

1.14

u/ml

0.87

431

Fracture of lumbar spine and pelvis

415

1.18

0.51

1.6

1.3

1.78

0.89

u/ml

0.35

196

Colectomy operation

342

1.20

0.51

1.3

0.99

1.23

u/ml

0.10

169

Infectious mononucleosis

260

1.23

0.51

1.4

1.3

0.42

0.60

u/ml

0.19

Other diseases of spinal cord

1.47

0.50

1.2

0.52

0.88

u/ml

—

Traumatic subdural haemorrhage

194

1.27

0.50

1.5

1.3

0.13

2.29

u/ml

2.10

Pregnancy examination and test

398

1.15

0.50

1.3

0.11

0.87

u/ml

1.57

136

Acute lymphadenitis

162

1.30

0.50

1.4

1.3

2.39

0.69

u/ml

—

Congenital malformations of aortic and mitral valves

101

1.39

0.49

1.4

5.15

0.28

u/ml

—

Transient global amnesia

180

1.28

0.49

1.6

1.3

4.11

1.39

u/ml

—

Use of antiglaucoma preparations and miotics

127

1.34

0.49

1.2

0.43

1.60

u/ml

—

Insulin, intermediate and long-acting

162

1459

1.09

0.49

1.4

1.3

1.22

1.30

u/ml

0.05

700

Other disorders of breast

362

1.19

0.49

1.3

0.37

1.20

u/ml

1.04

150

AV-block

270

1.21

0.49

1.2

1.4

0.13

1.71

u/ml

1.87

135

Myositis

1.56

0.49

1.0

1.2

—

1.23

u/ml

—

Hypertrophic scar

154

1.30

0.48

1.3

1.2

0.16

0.73

u/ml

0.81

Other acquired deformities of musculoskeletal system and connective tissue

119

1.35

0.48

1.3

1.2

4.01

0.60

u/ml

0.39

Alcohol abuse, main dg

388

0.82

0.48

1.3

0.17

0.76

u/ml

1.73

158

Benign neoplasm of other and unspecified endocrine glands

308

1.20

0.48

1.2

1.3

0.38

0.91

u/ml

0.64

138

Elevated blood glucose level

190

1.27

0.48

2.5

1.3

0.69

1.35

u/ml

0.35

Cardiomyopathies, Primary/intrinsic

226

1.24

0.48

1.4

1.3

0.63

2.28

u/ml

1.11

106

Ankylosing spondylitis, strict definition

128

1.33

0.47

1.3

1.2

0.06

0.28

u/ml

—

HSIL lesion of the cervix uteri, vagina or vulva

720

0.87

0.47

1.1

1.2

0.12

1.02

u/ml

1.88

278

Fracture of shoulder and upper arm

870

1.11

0.47

1.2

1.3

1.20

1.33

u/ml

0.07

398

Vascular disorders of the intestines

102

1.37

0.47

1.3

3.92

1.45

u/ml

—

Sacrococcygeal disorders, not elsewhere classified

1.42

0.47

1.2

1.3

0.25

0.99

u/ml

—

Mental disorders, not otherwise specified

245

1.23

0.46

1.3

1.2

0.24

0.52

u/ml

0.47

Substance abuse, excluding more controls

180

1457

1.08

0.46

1.2

1.3

1.13

1.45

u/ml

0.24

636

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

236

1.23

0.46

1.1

1.2

0.05

0.60

u/ml

—

Eating disorders

364

1.18

0.46

1.1

1.2

0.44

0.48

u/ml

0.04

114

Renal tubulo-interstitial diseases

314

2270

1.06

0.46

1.3

0.81

1.20

u/ml

0.50

148

1007

Malignant melanoma

299

0.80

0.46

1.4

1.3

0.28

1.18

u/ml

—

150

Polycystic ovarian syndrome

182

1.27

0.46

1.1

1.2

0.02

0.26

u/ml

2.42

Abnormal findings on examination of urine, without diagnosis

1.39

0.46

1.4

1.2

0.14

0.82

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

273

1.21

0.46

1.1

1.2

0.62

1.31

u/ml

—

Chronic tubulo-interstitial nephritis

1.39

0.46

1.3

1.2

0.02

0.33

u/ml

—

Benign leiomyoma with endometriosis

430

1.16

0.46

1.3

1.47

0.97

u/ml

0.24

194

Sequelae of injuries of head

129

1.32

0.45

1.2

1.3

0.50

0.28

u/ml

—

Leiomyoma of uterus

231

1406

0.93

0.45

1.3

0.59

1.16

u/ml

1.08

107

607

Idiopathic gout

156

1.28

0.45

1.0

1.4

0.05

1.58

u/ml

1.50

Viral haemorrhagic fevers, not elsewhere classified/unspecified

201

1.25

0.45

1.2

1.3

0.07

0.78

u/ml

—

Macular pucker

275

0.80

0.44

1.3

0.52

0.86

u/ml

—

143

Cystic kidney disease

1.45

0.44

1.1

1.2

0.02

0.84

u/ml

—

Antepartum haemorrhage, not elsewhere classified

302

1.19

0.44

1.3

0.54

0.93

u/ml

0.21

119

Combinations of oral blood glucose lowering drugs

648

1.13

0.44

1.2

1.4

1.06

1.12

u/ml

0.03

335

Acute pancreatitis

432

1.16

0.44

1.4

1.3

1.85

1.46

u/ml

0.12

206

Femoral hernia

1.37

0.43

1.2

0.26

1.60

u/ml

—

Papillary adenocarcinoma of thyroid gland

148

1.29

0.43

1.3

1.2

0.21

0.56

u/ml

0.50

Ptosis of eyelid

202

1.24

0.43

1.2

1.3

0.19

1.23

u/ml

1.20

104

Pre-eclampsia or eclampsia

772

1.11

0.43

1.4

1.2

0.56

1.01

u/ml

0.54

310

Maternal care for known or suspected malpresentation of fetus

525

1.12

0.43

1.3

1.32

0.94

u/ml

0.13

199

Dislocation, sprain and strain of joints and ligaments of thorax

1.41

0.43

1.0

1.2

0.75

0.32

u/ml

—

Other and unspecified acne

1.62

0.43

1.2

1.5

—

0.10

u/ml

—

Benign neoplasm: Other and unspecified parts of small intestine

1.62

0.43

1.4

1.2

0.14

1.31

u/ml

—

Acute pancreatitis (for exclusion)

433

1.16

0.43

1.4

1.3

1.86

1.11

u/ml

0.24

203

Nontraumatic intracranial haemmorrhage

382

0.84

0.42

1.3

1.4

1.93

1.50

u/ml

0.09

194

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

471

1.15

0.42

1.3

0.58

0.66

u/ml

0.07

186

Deep bite

314

1.17

0.42

1.2

1.4

0.23

0.60

u/ml

0.86

103

Other disorders of optic [2nd] nerve and visual pathways

158

1.27

0.41

1.2

1.4

0.21

1.09

u/ml

—

HSIL lesion of the cervix uteri

669

0.88

0.41

1.1

1.2

0.13

0.94

u/ml

1.60

250

Guttate psoriasis

1.52

0.41

1.4

1.2

—

0.06

u/ml

—

Anuria and oliguria

0.00

0.41

0.0

1.2

—

0.05

—

Ulcerative colitis (strict) with PSC

0.00

0.41

0.0

1.1

—

0.03

—

Carcinoid syndrome

0.00

0.41

0.0

1.3

—

0.06

—

Vascular dementia (multiple infarctions)

0.00

0.41

0.0

1.1

—

0.14

—

Benign neoplasm of ovary

520

0.86

0.41

1.2

1.3

1.53

1.45

u/ml

0.03

244

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

371

2155

1.05

0.41

1.3

1.31

1.29

u/ml

0.02

178

974

Carcinoma in situ of breast, lobular

0.00

0.41

0.0

1.1

—

0.06

—

Exposure to excessive heat of man-made origin

0.00

0.41

0.0

1.4

—

0.12

—

Crystalline deposits in vitreous body

0.00

0.41

0.0

1.3

—

0.10

—

Seminoma of testis

0.00

0.41

0.0

1.3

—

0.56

—

Familial hypercholesterolemia

286

1.19

0.41

1.1

1.3

0.40

1.70

u/ml

1.25

149

Myocardial infarction

130

857

1.09

0.41

1.5

1.3

1.99

1.38

u/ml

0.34

463

Carcinoma in situ of breast, lobular

0.00

0.41

0.0

1.1

—

0.06

—

Other congenital malformations of upper alimentary tract

0.00

0.41

0.0

1.3

—

0.11

—

Cutis laxa senilis

0.00

0.41

0.0

1.1

—

3.42

—

Kela-code for behavioural disturbances in mental retardation

0.00

0.41

0.0

1.2

—

0.07

—

Primary angle-closure glaucoma

1.40

0.40

1.3

1.2

2.36

1.77

u/ml

—

Other obstructive and reflux uropathy

114

1.32

0.40

1.7

1.3

0.14

0.42

u/ml

—

STROKE

196

1270

1.07

0.40

1.3

1.28

u/ml

0.00

111

586

Osteomyelitis

123

1.30

0.40

1.7

1.4

3.83

0.93

u/ml

—

Left ventricular outflow tract obstruction, narrow definition

123

1.30

0.40

1.4

4.64

0.26

u/ml

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

194

0.77

0.40

1.1

1.3

0.07

1.33

u/ml

—

Effects of other external causes

1.34

0.40

1.0

1.3

—

0.51

u/ml

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

121

907

0.92

0.40

1.3

1.96

1.22

u/ml

0.36

475

Other congenital malformations of brain

0.00

0.40

0.0

1.7

—

0.10

—

Malignant neoplasm of eye and adnexa

0.00

0.40

0.0

1.1

—

0.08

—

Other and unspecified acquired haemolytic anaemias

0.00

0.40

0.0

1.3

—

0.07

—

Parkinson's disease, including avohilmo

260

0.81

0.40

1.7

1.4

0.92

1.61

u/ml

0.29

143

Exposure to excessive natural cold

0.00

0.40

0.0

1.3

—

0.05

—

Occlusion and stenosis of arteries, not leading to stroke

0.00

0.40

0.0

1.3

—

0.14

—

Bell's palsy

278

1.19

0.39

1.3

0.56

0.69

u/ml

0.10

120

Alcohol use disorder, Swedish definition

146

1462

0.93

0.39

1.3

1.27

1.39

u/ml

0.07

672

Benign neoplasm: Other and unspecified parts of small intestine

1.43

0.39

1.4

1.2

0.14

1.04

u/ml

—

Other and unspecified injuries of thorax

1.43

0.39

1.8

1.2

1.79

0.12

u/ml

—

Diabetic nephropathy, excluding more controls

253

0.82

0.39

1.3

0.52

0.82

u/ml

0.22

119

Squamous cell neoplasms and carcinoma of cervix

0.00

0.39

0.0

1.1

—

0.08

—

Degenerative myopia

0.00

0.39

0.0

1.2

—

0.08

—

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.3

—

0.41

—

Seminoma of testis, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.3

—

0.43

—

Epidural haemorrhage

0.00

0.39

0.0

1.2

—

0.07

—

Injury of nerves at shoulder and upper arm level

0.00

0.39

0.0

1.3

—

0.60

—

Lymphoid leukaemia

106

1.32

0.39

1.7

1.3

0.27

0.56

u/ml

—

Intestinal stricture

683

1.11

0.39

1.3

1.00

1.40

u/ml

0.23

319

Failed induction of labour

187

1.23

0.39

1.1

1.2

0.05

0.34

u/ml

1.30

Melanocytic naevi of lower limb, including hip

124

1.29

0.38

1.4

1.3

1.08

0.79

u/ml

—

Convergent concomitant strabismus

169

1.24

0.38

1.1

1.3

0.20

0.72

u/ml

0.77

Delirium, not induced by alcohol and other psychoactive substances

170

0.76

0.38

1.2

1.3

0.42

1.65

u/ml

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

170

0.76

0.38

1.0

1.2

2.45

1.60

u/ml

—

Other diseases of the digestive system

675

1.11

0.37

1.2

1.3

0.37

1.43

u/ml

2.16

314

All dysplastic lesions of the cervix uteri, vagina or vulva

101

1096

0.91

0.37

1.2

0.12

0.94

u/ml

2.80

413

Pre-eclampsia

723

1.11

0.37

1.4

1.2

0.59

1.05

u/ml

0.50

287

Benign neoplasm: Skin of eyelid, including canthus

373

1.15

0.37

1.1

1.3

0.10

1.01

u/ml

2.01

185

Intrahepatic Cholestasis of Pregnancy (ICP)

243

1.20

0.37

1.1

1.2

0.05

0.30

u/ml

—

Blepharochalasis

666

1.11

0.37

1.2

1.3

0.20

1.47

u/ml

3.37

350

Ulcerative colitis (strict definition, require KELA)

486

1.13

0.37

1.3

0.58

1.03

u/ml

0.41

196

Diabetes, insulin treatment (Kela reimbursement)

384

2244

1.05

0.37

1.3

1.29

u/ml

0.00

183

1014

Conductive hearing loss, unspecified

188

1.22

0.37

1.3

0.46

1.37

u/ml

0.64

Malignant neoplasm of thyroid gland

179

1.23

0.37

1.3

1.2

0.19

0.54

u/ml

0.61

Arthropod-borne viral fevers and viral haemorrhagic fevers

234

1.20

0.37

1.2

1.3

0.07

0.76

u/ml

—

107

Lymphoid leukaemia

107

1.31

0.37

1.7

1.4

0.27

1.37

u/ml

—

Retained placenta and membranes, without haemorrhage

383

1.15

0.37

1.4

1.2

0.69

0.79

u/ml

0.06

159

Pustulosis palmaris et plantaris

116

1.30

0.37

1.1

1.2

0.22

0.79

u/ml

—

Other and unspecified myopathies

161

1.24

0.37

1.3

0.38

1.36

u/ml

0.76

Other eating disorders

152

1.25

0.37

1.1

1.3

0.13

0.37

u/ml

—

Erectile dysfunction

125

1.28

0.37

1.3

1.5

1.41

0.99

u/ml

0.13

Cyst of kidney

134

1.27

0.37

1.8

1.3

0.18

1.42

u/ml

—

Burn and corrosion of wrist and hand

1.34

0.36

1.0

1.4

2.80

0.40

u/ml

—

Glaucoma-related operations

1.34

0.35

1.2

1.1

0.24

1.54

u/ml

—

Ischaemic Stroke, excluding all haemorrhages

121

989

0.92

0.35

1.2

1.3

0.69

1.47

u/ml

1.31

521

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

526

1.12

0.35

1.2

1.3

0.52

0.97

u/ml

0.45

209

Personal history of certain other diseases

1.43

0.35

2.0

1.1

—

0.18

u/ml

—

Golimumab

1.32

0.35

1.2

1.3

0.01

0.47

u/ml

—

Need for other prophylactic measures

153

1.24

0.35

1.4

1.3

0.38

0.59

u/ml

0.18

Family history of certain disabilities and chronic diseases leading to disablement

126

1.27

0.35

1.4

1.2

0.14

0.75

u/ml

—

Spermatocele

117

1.28

0.35

1.3

1.5

6.16

2.03

u/ml

—

Parkinson's disease

255

0.82

0.35

1.7

1.4

0.92

1.62

u/ml

0.30

142

Benign neoplasm of breast

329

1.16

0.35

1.2

1.3

0.09

1.39

u/ml

2.06

135

Cardiomyopathy (excluding other)

236

1.19

0.34

1.4

1.3

0.63

2.20

u/ml

1.08

110

Diabetic nephropathy

294

0.84

0.34

1.3

0.52

1.72

u/ml

1.02

149

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

200

0.80

0.34

1.3

0.25

1.30

u/ml

—

100

Pure hypercholesterolaemia

226

1434

1.06

0.34

1.2

1.3

0.87

1.62

u/ml

0.95

124

700

Pedal cyclist injured in collision with motor vehicle

1.34

0.34

1.2

1.5

1.88

0.97

u/ml

—

Hyperfunction of pituitary gland

154

1.24

0.34

1.3

1.2

0.11

0.69

u/ml

—

Thyrotoxicosis with toxic multinodular goitre

136

1.25

0.33

1.7

1.2

0.61

1.37

u/ml

—

Delivery, wide proxy

112

645

0.92

0.33

1.2

1.3

0.13

1.31

u/ml

4.49

295

Endometriosis ASRM stages 3,4

758

1.10

0.33

1.2

1.3

0.87

1.01

u/ml

0.08

321

Single delivery by caesarean section

437

1.10

0.33

1.3

1.41

0.68

u/ml

0.29

175

Non-follicular lymphoma, hilmo, excluding all cancers

188

0.80

0.33

1.1

1.3

0.38

1.35

u/ml

—

Diabetes medication

407

2376

1.04

0.33

1.3

1.42

1.25

u/ml

0.15

194

1050

Diabetic retinopathy

488

0.90

0.33

1.2

1.4

1.94

1.12

u/ml

0.34

232

171

1627

0.94

0.33

1.3

1.27

1.39

u/ml

0.08

741

Postpartum care and examination

349

1.12

0.32

1.3

0.83

0.64

u/ml

0.15

118

Parkinson's disease, strict definition

231

0.82

0.32

1.8

1.4

0.99

1.45

u/ml

0.17

125

Postpartum haemorrhage

106

853

1.08

0.32

1.2

1.3

0.33

0.78

u/ml

1.08

317

Personal history of malignant neoplasm

1.35

0.32

1.0

1.2

0.02

2.60

u/ml

—

Abscess of anal and rectal regions

201

1.20

0.32

1.5

1.3

0.34

0.48

u/ml

—

Fall on and from ladder

146

1.23

0.32

1.3

1.4

2.40

0.82

u/ml

0.30

Acne vulgaris

229

1.18

0.32

1.1

1.4

0.02

0.63

u/ml

—

Other vitreous opacities

1.31

0.32

1.3

1.2

9.96

0.67

u/ml

—

Mental and behavioural disorders due to psychoactive substance use

189

1685

1.06

0.32

1.3

1.22

1.31

u/ml

0.06

103

756

Benign neoplasm: Skin, unspecified

101

1.29

0.31

1.7

1.2

1.48

0.73

u/ml

—

Benign neoplasm: Skin of trunk

110

1.28

0.31

1.1

1.2

0.61

0.64

u/ml

—

Benign neoplasm: Skin of trunk

110

1.28

0.31

1.1

1.2

0.61

0.68

u/ml

—

Other specific arthropathies, wide

1.32

0.31

1.1

—

0.50

—

Tobacco use

138

1.23

0.30

1.1

1.2

0.31

0.71

u/ml

—

Diseases of arteries, arterioles and capillaries

181

1276

1.06

0.30

1.3

2.96

1.20

u/ml

1.16

660

Melanocytic naevi of lower limb, including hip

129

1.24

0.30

1.4

1.2

1.08

0.71

u/ml

—

Puerperal sepsis

389

0.87

0.30

1.3

0.15

0.85

u/ml

1.61

165

Twin gestation

315

1.14

0.30

1.3

0.11

0.88

u/ml

0.71

130

Disturbances of smell and taste

102

1.28

0.30

1.2

0.24

0.28

u/ml

—

Other diseases of arteries and capillaries

203

1.18

0.29

1.1

1.2

2.44

0.89

u/ml

0.29

100

Non-follicular lymphoma

185

0.81

0.29

1.1

1.3

0.38

1.23

u/ml

—

Alcoholic liver disease

185

0.81

0.29

1.4

1.3

3.87

0.90

u/ml

—

Presence of cardiac and vascular implants and grafts

690

0.92

0.29

1.3

1.01

1.28

u/ml

0.13

366

Poor fetal growth

477

1.11

0.29

1.2

0.14

0.96

u/ml

0.96

165

Haemangioma, any site

222

1.17

0.29

1.2

1.3

0.24

0.95

u/ml

—

Gestational [pregnancy-induced] hypertension

104

965

1.08

0.29

1.3

1.2

0.23

0.88

u/ml

1.58

367

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

217

0.83

0.29

1.2

1.3

0.03

1.25

u/ml

—

100

Benign lipomatous neoplasm

765

1.09

0.29

1.3

0.93

1.37

u/ml

0.39

367

Other lesions of median nerve

1.23

0.29

1.6

1.2

0.04

0.87

u/ml

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

249

0.84

0.29

1.2

0.20

1.05

u/ml

1.08

128

Cardiac arrest

1.26

0.28

1.9

1.4

3.69

2.60

u/ml

—

Melanocytic naevi

910

1.08

0.28

1.5

1.3

1.67

1.03

u/ml

0.45

382

Lyme disease

650

1.09

0.28

1.3

0.31

1.42

u/ml

2.09

312

Superficial injury of forearm

260

1.15

0.28

1.2

1.3

0.11

0.28

u/ml

—

101

Pregnancy with abortive outcome

281

1406

1.05

0.28

1.3

0.95

1.11

u/ml

0.15

118

585

Multiple gestation

326

1.14

0.28

1.3

0.11

0.85

u/ml

0.71

135

Tooth agenesis EXCLUDE clefts and syndromes

112

1.25

0.28

2.1

1.6

2.06

0.55

u/ml

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

378

0.90

0.28

1.5

1.3

3.25

1.35

u/ml

0.50

221

Major coronary heart disease event

195

1235

1.05

0.28

1.4

1.3

1.81

1.42

u/ml

0.26

108

640

Carcinoma in situ of skin of other and unspecified parts of face

103

1.26

0.28

1.5

1.3

0.04

2.00

u/ml

—

Malignant neoplasm of kidney, except renal pelvis

158

1.20

0.28

1.8

1.4

0.51

1.32

u/ml

0.62

Maternal care for known or suspected fetal abnormality and damage

521

0.90

0.28

1.3

0.20

0.93

u/ml

1.14

208

Other spirochaetal diseases

661

1.09

0.28

1.2

1.3

0.31

1.42

u/ml

2.08

314

Complications of labour and delivery

270

1441

1.04

0.27

1.3

1.20

1.12

u/ml

0.04

111

592

Coronary angioplasty

586

0.92

0.27

1.4

1.3

1.61

1.45

u/ml

0.07

333

Other complications of labour and delivery, not elsewhere classified

402

0.89

0.27

1.2

1.3

0.45

0.75

u/ml

0.27

123

Abnormal findings in secretions and smears from cervix uteri vagina vulva

205

1534

1.05

0.27

1.2

1.3

0.57

0.92

u/ml

0.41

611

Disorders of choroid and retina

253

1763

1.04

0.27

1.3

1.86

1.11

u/ml

0.64

146

832

Infections with a predominantly sexual mode of transmission

117

1096

1.07

0.27

1.3

1.2

0.63

0.98

u/ml

0.48

423

Redundant prepuce, phimosis and paraphimosis

430

1.11

0.27

1.5

1.3

3.62

1.41

u/ml

0.61

196

Haemangioma, any site

224

1.16

0.27

1.2

1.3

0.24

0.53

u/ml

—

Other disorders of amniotic fluid and membranes

504

1.10

0.27

1.2

1.3

0.46

0.93

u/ml

0.41

198

Fracture of skull and facial bones

528

1.10

0.27

1.1

1.3

1.25

1.24

u/ml

0.00

224

Malignant neoplasm of skin

144

1148

0.94

0.27

1.4

1.3

1.94

1.41

u/ml

0.28

612

Type 1 diabetes

729

1.08

0.26

1.4

1.3

0.62

0.97

u/ml

0.42

298

Malignant neoplasm of colon

268

0.86

0.26

1.3

0.20

1.24

u/ml

1.48

140

Other predominantly sexually transmitted diseases, not elsewhere classified

586

1.09

0.26

1.3

1.2

0.50

0.89

u/ml

0.34

214

Viral meningitis

104

1.25

0.26

1.2

1.3

0.23

0.50

u/ml

—

Poisoning by drugs, medicaments and biological substances

750

1.08

0.26

1.3

1.58

1.16

u/ml

0.17

304

In situ neoplasms

991

0.93

0.26

1.4

1.3

1.19

u/ml

0.00

475

Medical abortion

266

1386

1.04

0.26

1.3

0.70

1.12

u/ml

0.58

120

578

Other surgical follow-up care

1.28

0.26

1.0

1.4

1.60

0.15

u/ml

—

Mental and behavioural disorders due to sedatives or hypnotics

178

1.18

0.26

1.2

0.03

0.33

u/ml

—

Disorders of lipoprotein metabolism and other lipidaemias

267

1610

1.04

0.26

1.2

1.3

1.18

1.51

u/ml

0.27

130

767

Retinal detachment with retinal break

253

1.15

0.26

1.2

1.3

0.25

0.99

u/ml

0.96

122

Lesion of sciatic nerve

1.30

0.26

1.2

0.10

0.77

u/ml

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

915

1.07

0.26

1.1

1.2

1.25

1.13

u/ml

0.06

343

Poisoning by medicine

674

1.08

0.25

1.3

1.15

1.22

u/ml

0.03

273

Antenatal screening

574

0.93

0.25

1.2

1.3

1.40

0.76

u/ml

0.25

202

Exclusions for E4_PCOS_CONSORTIUM

309

1865

1.04

0.25

1.3

0.49

1.13

u/ml

1.83

141

749

Meningitis

123

1.22

0.25

1.1

1.3

0.16

0.61

u/ml

—

Benign neoplasm of other and unspecified endocrine glands

330

1.12

0.25

1.2

1.3

0.38

1.01

u/ml

0.83

154

Hypertensive heart and/or renal disease

381

1.10

0.25

1.1

1.4

0.99

2.02

u/ml

0.68

214

Substance abuse

180

1640

1.05

0.24

1.2

1.3

1.13

1.35

u/ml

0.16

741

Chronic nephritic syndrome

1.25

0.24

1.4

1.3

0.06

1.28

u/ml

—

Paralytic strabismus

148

0.81

0.24

1.3

0.23

0.84

u/ml

—

Family history of malignant neoplasm

302

1.13

0.24

1.7

1.2

4.28

1.07

u/ml

0.62

123

Use of biperiden

137

0.80

0.24

1.2

0.08

0.56

u/ml

—

Delivery

139

777

0.95

0.24

1.2

1.3

0.16

1.19

u/ml

4.35

346

Haemangioma and lymphangioma, any site

236

1.15

0.24

1.2

1.3

0.24

0.50

u/ml

—

Unspecified kidney failure

161

1.18

0.24

1.2

1.3

0.56

1.67

u/ml

—

Dental caries 3 and operation codes, only avohilmo

134

636

1.06

0.23

1.4

0.78

1.20

u/ml

0.32

283

Other obstetric trauma

180

1.17

0.23

1.1

1.2

0.05

0.85

u/ml

—

Benign neoplasm of breast

341

1.12

0.23

1.2

1.3

0.09

0.97

u/ml

1.67

144

Secondary uncertain malignant neoplasm

243

0.86

0.23

1.1

1.4

1.09

1.29

u/ml

—

124

Adenocarcinoma and papilloma adenocarcinoma of rectum

168

0.83

0.22

1.1

1.4

0.07

1.67

u/ml

—

Type 1 diabetes, strict definition

263

0.87

0.22

1.9

1.2

0.46

0.49

u/ml

—

Other specified/unspecified dorsopathies

1.25

0.22

1.5

1.3

0.22

0.85

u/ml

—

Ulcerative proctitis

181

1.16

0.22

1.6

1.2

0.32

0.56

u/ml

—

Myeloproliferative diseases (CML excluded)

153

1.18

0.22

1.9

1.3

0.39

1.43

u/ml

0.76

Benign neoplasm of meninges

242

0.87

0.22

1.0

1.2

0.04

1.07

u/ml

—

113

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

295

1.12

0.22

1.1

1.2

0.62

0.47

u/ml

—

Haemangioma and lymphangioma, any site

238

1.14

0.22

1.2

1.3

0.24

0.90

u/ml

—

101

Chalazion

276

1.12

0.22

1.5

1.3

0.59

1.00

u/ml

0.31

120

Otosclerosis

178

0.84

0.22

1.3

0.45

1.06

u/ml

—

Tongue abnormality

144

1.18

0.22

1.5

1.2

1.08

1.21

u/ml

—

Injury of other and unspecified intrathoracic organs

135

0.81

0.22

2.0

1.4

0.50

0.88

u/ml

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

378

0.90

0.21

1.3

0.17

1.02

u/ml

1.77

185

Injury of nerves at hip and thigh level

0.00

0.21

0.0

1.1

—

0.06

—

Blindness or visual impairment, binocular

0.00

0.21

0.0

1.0

—

0.02

—

Benign neoplasm: Ill-defined sites within the digestive system

0.00

0.21

0.0

1.1

—

0.03

—

Cleft lip and palate

0.00

0.21

0.0

1.1

—

0.09

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

0.21

0.0

1.1

—

0.03

—

Exposure to uncontrolled fire in building or structure

0.00

0.21

0.0

1.5

—

0.08

—

Malignant neoplasm of parotid gland

0.00

0.21

0.0

1.5

—

0.07

—

Osteosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

0.06

—

Histrionic personality disorder

0.00

0.21

0.0

1.4

—

0.08

—

Intentional self-harm by jumping from a high place

0.00

0.21

0.0

1.1

—

0.05

—

Benign neoplasm: Ill-defined sites within the digestive system

0.00

0.21

0.0

1.1

—

0.03

—

Other or unspecified paralytic strabismus

0.00

0.21

0.0

1.1

—

0.02

—

Colorectal cancer

440

0.91

0.21

1.3

0.22

1.54

u/ml

2.59

231

Retinal vascular occlusion

201

1.14

0.21

1.2

1.3

0.63

0.83

u/ml

0.19

107

Supervision of normal pregnancy

103

555

1.06

0.21

1.2

1.3

0.10

0.77

u/ml

2.17

198

Carcinoma in situ of breast

0.00

0.21

0.0

1.1

—

0.03

—

Unspecified protein-energy malnutrition

0.00

0.21

0.0

1.0

—

0.07

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

177

0.85

0.21

1.3

0.25

1.62

u/ml

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.21

0.0

1.4

—

0.07

—

Cervical root disorders

0.00

0.21

0.0

1.4

—

0.08

—

GI-bleeding

672

1.07

0.21

1.2

1.3

0.21

1.35

u/ml

3.06

314

Meningococcal infection

0.00

0.21

0.0

1.1

—

0.21

—

Shock, not elsewhere classified

0.00

0.21

0.0

1.5

—

0.86

—

Other and unspecified abdominal hernia

1.24

0.21

1.2

0.10

0.65

u/ml

—

Viral infections of the central nervous system

192

1.15

0.20

1.2

0.16

0.62

u/ml

—

Liposarcoma

0.00

0.20

0.0

1.4

—

0.06

—

Foreign body or object entering through skin

164

1.16

0.20

1.4

0.58

0.64

u/ml

—

Cleft lip and cleft lip and palate

0.00

0.20

0.0

1.4

—

0.12

—

Malignant neoplasm of urinary organs

164

1.16

0.20

1.8

1.4

0.51

1.27

u/ml

0.60

Gestational diabetes (for exclusion)

164

1111

1.04

0.20

1.2

1.3

0.82

0.78

u/ml

0.02

417

Type 1 diabetes, strict (exclude DM2)

323

0.89

0.20

1.7

1.3

0.42

0.63

u/ml

—

103

Postpartum hemorraghe, parous women as controls

106

879

1.06

0.20

1.2

0.33

0.65

u/ml

0.53

324

Bulimia nervosa (incl. atypical)

108

1.21

0.20

1.2

0.04

0.51

u/ml

—

Juvenile arthritis (FINNGEN)

136

1.18

0.20

1.3

1.4

0.18

0.46

u/ml

—

Benign neoplasm: Skin, unspecified

108

1.21

0.20

1.7

1.1

1.48

0.68

u/ml

—

Retinal vascular disorders

202

1.14

0.20

1.2

1.3

0.63

0.83

u/ml

0.19

107

Postpartum hemorraghe, all women as controls

106

1001

1.05

0.19

1.2

0.33

0.80

u/ml

0.96

373

Acute tubulo-interstitial nephritis

200

1708

1.04

0.19

1.3

0.48

1.18

u/ml

2.23

767

Aortic valve malfunction, age under 60 years

212

1.13

0.19

1.1

1.3

0.15

0.80

u/ml

1.14

Carcinoma in situ of breast, intraductal

218

0.87

0.19

1.4

1.3

2.18

1.26

u/ml

0.20

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

356

0.93

0.19

1.5

1.4

3.36

1.40

u/ml

0.50

213

Alcohol dependence

654

0.93

0.19

1.2

1.3

0.92

1.25

u/ml

0.16

303

Other retinal disorders

173

1335

1.04

0.19

1.3

2.32

1.20

u/ml

0.66

651

Abnormal findings on antenatal screening of mother

291

0.89

0.19

1.2

0.02

0.42

u/ml

—

Carcinoma in situ of skin

137

1.17

0.18

1.2

1.3

0.38

1.52

u/ml

—

Other disorders of gingiva or/and edentulous alveolar ridge

109

1.19

0.18

1.1

1.4

0.29

0.65

u/ml

—

Melanocytic naevi, other sites/unspecified

213

1.13

0.18

1.7

1.2

1.30

0.47

u/ml

0.55

Assault by bodily force

213

1.13

0.18

1.1

1.3

3.09

0.50

u/ml

—

Maternal care for other known or suspected fetal problems

100

608

1.06

0.18

1.2

1.3

0.35

1.03

u/ml

0.86

223

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

190

1602

1.04

0.18

1.4

1.2

0.90

0.86

u/ml

0.02

640

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

280

1.11

0.18

1.4

1.3

2.82

1.90

u/ml

0.20

140

Peripheral artery operations in Hilmo

213

1.13

0.18

1.2

1.3

0.22

0.84

u/ml

0.79

113

Total colectomy

100

1.20

0.18

1.2

0.13

0.78

u/ml

—

Total colectomy operation

100

1.20

0.18

1.3

1.2

0.13

0.78

u/ml

—

Invasive ventilation

166

1.15

0.18

1.5

1.3

0.25

0.84

u/ml

0.68

Alcohol abuse, main dg, excluding more controls

352

0.91

0.18

1.3

0.17

1.31

u/ml

1.77

139

Toxic effects of substances chiefly nonmedicinal as to source

300

1.10

0.17

1.1

1.3

0.21

1.12

u/ml

1.28

119

malignant neoplasm of male genital organs

460

0.94

0.17

1.5

1.3

4.16

1.30

u/ml

0.99

275

Dialysis

1.21

0.17

1.2

1.3

0.02

0.25

u/ml

—

Carcinoma in situ of cervix uteri

310

0.90

0.17

1.2

0.15

0.89

u/ml

—

103

Benign mammary dysplasia

368

1.09

0.17

1.6

1.3

1.29

1.13

u/ml

0.08

165

Erythema nodosum

1.22

0.17

1.2

0.45

0.90

u/ml

—

Hypertensive Heart Disease

355

0.92

0.17

1.1

1.4

1.18

1.84

u/ml

0.33

197

Dialysis, with operation codes

272

1.10

0.17

1.6

1.3

0.57

0.64

u/ml

0.05

125

Basal cell carcinoma

121

1007

0.96

0.17

1.3

2.13

1.30

u/ml

0.40

545

Dental caries 1 and operation codes, only avohilmo

112

537

1.05

0.16

1.3

1.4

0.33

1.16

u/ml

1.91

246

Sequelae of cerebrovascular disease

633

0.94

0.16

1.4

1.3

0.62

1.36

u/ml

1.21

332

Alcohol use disorder, ICD-based

109

1140

0.96

0.16

1.3

0.82

1.57

u/ml

0.71

522

Coronary artery bypass grafting

369

0.93

0.16

1.1

1.4

1.88

1.73

u/ml

0.03

214

Type 1 diabetes, definitions combined

318

0.91

0.16

1.7

1.2

0.42

0.61

u/ml

—

101

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

204

0.88

0.16

1.5

1.2

0.42

0.90

u/ml

0.41

Acute alcohol intoxication

597

0.94

0.16

1.3

1.4

0.60

1.52

u/ml

1.02

262

Degenerative macular diseases

206

1.12

0.16

1.6

1.3

7.56

0.82

u/ml

0.83

111

Carcinoma in situ of skin of other and unspecified parts of face

111

1.17

0.15

1.5

1.2

0.04

1.80

u/ml

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

380

0.92

0.15

1.2

1.3

0.15

1.17

u/ml

2.27

208

Benign neoplasm: Adrenal gland

168

1.13

0.15

1.3

0.54

0.98

u/ml

0.31

Obstructed labour due to maternal pelvic abnormality

483

0.93

0.15

1.1

1.2

0.27

0.90

u/ml

1.26

208

Melanocytic naevi, other sites/unspecified

216

1.11

0.15

1.7

1.2

1.30

0.48

u/ml

0.54

Disorders resulting from impaired renal tubular function

1.21

0.15

1.1

1.2

0.03

0.26

u/ml

—

Long labour

815

0.95

0.15

1.3

0.60

0.80

u/ml

0.22

302

Acne

322

1.09

0.15

1.1

1.3

0.02

0.85

u/ml

—

Benign neoplasm: Adrenal gland

169

1.13

0.14

1.3

1.2

0.54

1.02

u/ml

0.33

Malignant neoplasm of corpus uteri

160

0.87

0.14

1.3

1.2

0.03

1.34

u/ml

—

Injury of unspecified body region

179

1.12

0.14

1.2

1.3

0.39

0.58

u/ml

—

Peripheral artery disease

708

1.05

0.14

1.3

1.4

3.86

1.10

u/ml

1.22

395

Foreign body on external eye

357

0.92

0.14

1.2

1.4

3.72

1.12

u/ml

0.36

158

Benign neoplasm of brain and other parts of central nervous system

160

1.13

0.14

1.4

1.3

0.40

0.61

u/ml

0.24

Congenital malformations of cardiac septa

205

0.90

0.14

1.1

1.4

1.97

0.74

u/ml

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

141

1.14

0.14

1.1

1.2

0.20

0.63

u/ml

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

284

0.92

0.13

1.2

1.3

0.39

1.02

u/ml

0.83

144

Placenta praevia

151

1.13

0.13

1.4

1.2

0.18

0.35

u/ml

—

Endometriosis of ovary

528

1.06

0.13

1.1

1.3

1.26

1.55

u/ml

0.12

232

Calcific aortic valvular stenosis, including rheumatic fever

489

1.06

0.13

1.3

1.86

1.41

u/ml

0.15

267

Type 1 diabetes, wide definition, subgroup 1

617

1.05

0.13

1.4

1.3

0.26

0.88

u/ml

1.41

241

Eating disorder

315

1.08

0.13

1.2

1.3

0.47

0.27

u/ml

0.27

Contact with machinery

209

1.10

0.13

1.2

1.3

1.30

1.00

u/ml

0.12

104

Carcinoma in situ of cervix uteri

304

0.92

0.13

1.2

0.15

0.49

u/ml

—

Acute alcohol intoxication, ICD10

489

0.94

0.13

1.3

0.65

1.15

u/ml

0.37

203

Heart failure and coronary heart disease

431

1.06

0.13

1.2

1.3

1.54

1.59

u/ml

0.02

241

Open bite

161

1.12

0.13

1.3

1.4

0.20

0.48

u/ml

—

Other diseases of biliary tract

161

1.12

0.13

1.2

1.3

6.17

1.35

u/ml

—

Myocardial infarction, unclassifiable

316

1.07

0.13

1.6

1.3

4.15

1.68

u/ml

0.55

175

Suicide or other Intentional self-harm

746

1.05

0.12

1.1

1.3

1.48

1.17

u/ml

0.13

311

Benign leiomyoma with endometriosis

472

1.06

0.12

1.3

1.47

1.18

u/ml

0.13

220

Intestinal adhesions without obstruction

171

1.11

0.12

1.1

1.2

0.34

0.95

u/ml

—

Extracorporeal dialysis

127

0.87

0.12

1.4

1.3

0.03

0.98

u/ml

—

Other inflammatory liver diseases

171

1.11

0.12

1.1

1.3

0.02

0.59

u/ml

—

Aneurysms, operations, SAH

375

1.07

0.12

1.6

1.4

1.67

1.21

u/ml

0.12

187

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

104

1.15

0.12

1.1

1.3

1.50

0.32

u/ml

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

313

0.93

0.12

1.4

1.2

0.15

1.07

u/ml

1.52

151

Other keratitis

278

1.08

0.12

1.2

3.16

1.08

u/ml

0.40

110

Other malignant neoplasms of skin (=non-melanoma skin cancer)

128

978

1.03

0.12

1.4

1.3

2.10

1.34

u/ml

0.41

527

Acute appendicitis, with complications

522

1.05

0.12

1.5

1.3

1.52

1.66

u/ml

0.06

237

Other and unspecified vascular occlusions

162

1.11

0.11

1.3

0.80

1.03

u/ml

—

163

1538

0.97

0.11

1.3

1.27

1.40

u/ml

0.08

701

L01XX Other antineoplastic agents

1.16

0.11

1.5

1.2

0.68

0.62

u/ml

—

Hard cardiovascular diseases

240

1575

0.98

0.11

1.4

1.3

1.39

1.47

u/ml

0.05

129

761

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

199

0.90

0.11

1.5

1.2

0.42

0.74

u/ml

0.36

Postpartum haemorrhage due to retained placenta

464

1.06

0.11

1.1

1.2

0.37

0.93

u/ml

0.53

177

Mental and behavioural disorders due to alcohol, excluding acute intoxication

119

1227

0.97

0.11

1.3

0.76

1.57

u/ml

0.90

568

Myocardial infarction, strict

112

790

1.03

0.11

1.5

1.3

1.62

1.29

u/ml

0.17

428

Inguinal hernia, bilateral

182

1.10

0.11

1.3

1.5

4.86

2.55

u/ml

0.27

Parodontitis, under 40 years, or operation codes

291

0.93

0.11

1.5

1.3

0.36

0.77

u/ml

0.51

Peripheral retinal degeneration

1.16

0.11

1.5

1.2

0.09

0.85

u/ml

—

Glucagon-like peptide-1 (GLP-1) analogues

148

1184

1.03

0.11

1.3

2.32

1.31

u/ml

0.53

617

Divergent concomitant strabismus

221

1.09

0.11

1.2

0.04

0.49

u/ml

—

Infections of genitourinary tract in pregnancy

301

0.93

0.10

1.3

1.2

0.15

0.72

u/ml

—

103

Scar conditions and fibrosis of skin

115

1.13

0.10

1.5

1.2

0.18

0.74

u/ml

—

Obstructed labour due to malposition and malpresentation of fetus

859

0.96

0.10

1.3

2.17

0.69

u/ml

0.35

322

Other obstructed labour

241

1.08

0.10

1.0

1.2

0.62

1.10

u/ml

—

Diabetic neuropathy

201

1.09

0.10

1.4

1.3

0.14

2.37

u/ml

2.06

Inguinal hernia

161

1113

0.98

0.10

1.2

1.4

1.81

1.76

u/ml

0.02

506

Basal cell carcinoma, including avohilmo

128

1036

0.97

0.10

1.3

1.99

1.35

u/ml

0.32

557

Other (not insulin) diabetes medications

355

2106

1.02

0.09

1.2

1.3

1.45

1.25

u/ml

0.15

170

960

Carcinoma in situ of breast, intraductal

207

0.92

0.09

1.4

1.2

2.18

1.35

u/ml

0.18

Parodontitis, under 40 years

289

0.93

0.09

1.5

1.2

0.36

0.56

u/ml

0.26

Hydronephrosis

248

0.93

0.09

1.3

1.4

2.47

1.21

u/ml

—

116

Complications predominantly related to the puerperium

950

1.03

0.09

1.3

1.2

0.34

0.78

u/ml

0.84

377

Assault

379

1.06

0.09

1.1

1.2

2.30

0.60

u/ml

0.49

140

Carcinoma in situ of skin

145

1.10

0.09

1.2

0.38

1.57

u/ml

—

Single delivery by forceps and vacuum extractor

362

1.04

0.09

1.2

1.3

0.19

0.75

u/ml

1.52

138

Ulcerative rectosigmoiditis

223

1.08

0.09

1.3

0.39

0.79

u/ml

—

Benign neoplasm of ovary

472

0.95

0.09

1.2

1.3

1.53

0.95

u/ml

0.25

211

Operations 2 for CAVS

487

1.04

0.09

1.3

1.91

1.41

u/ml

0.17

265

Calcific aortic valvular stenosis, diagnosis (helper)

487

1.04

0.09

1.3

1.91

1.41

u/ml

0.17

265

Benign neoplasm of brain and other parts of central nervous system

165

1.09

0.08

1.4

1.3

0.40

1.16

u/ml

0.58

Calcific aortic valvular stenosis, operated

488

1.04

0.08

1.3

1.91

1.41

u/ml

0.17

265

Calcific aortic valvular stenosis

488

1.04

0.08

1.3

1.91

1.41

u/ml

0.17

265

Overjet

0.79

0.08

1.0

1.7

—

0.71

u/ml

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

226

0.93

0.08

1.8

1.2

0.46

1.18

u/ml

0.72

114

Inflammatory disorders of breast

185

1.08

0.08

1.3

1.2

0.03

0.67

u/ml

—

Inguinal or femoral hernia, bilateral

185

1.08

0.08

1.3

1.4

4.86

2.52

u/ml

0.28

Parkinson's disease, excluding more controls

220

0.93

0.08

1.7

1.4

0.92

1.58

u/ml

0.27

115

Injuries to unspecified part of trunk, limb or body region

234

1.07

0.08

1.2

1.4

0.32

1.17

u/ml

—

106

Diabetes mellitus in pregnancy

144

913

1.02

0.08

1.2

1.3

0.96

0.83

u/ml

0.06

335

Mixed specific developmental disorders

1.05

0.08

1.0

1.7

—

1.23

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

244

1.07

0.08

1.3

2.88

0.74

u/ml

0.34

107

Sacroiliitis, not elsewhere classified

127

1.10

0.08

1.2

0.04

0.76

u/ml

—

Spirochaetal infections, other/unspecified

205

1.07

0.07

1.1

1.3

0.06

1.26

u/ml

1.39

Cerebral aneurysm, nonruptured

205

1.07

0.07

1.8

1.3

0.27

1.15

u/ml

0.93

Tubulo-interstitial nephritis, not specified as acute or chronic

166

1.08

0.07

1.1

1.3

0.14

0.98

u/ml

—

Polycythaemia vera

0.86

0.07

1.5

1.2

0.57

1.75

u/ml

—

Other and unspecified injuries of wrist and hand

1.12

0.07

1.5

1.4

0.18

0.95

u/ml

—

Malignant neoplasm of rectum

174

0.92

0.07

1.3

0.25

1.65

u/ml

—

Complications of the puerperium, not elsewhere classified

143

0.91

0.07

1.5

1.2

1.07

0.34

u/ml

—

Atherosclerosis, excluding cerebral and coronary sclerosis

634

0.97

0.07

1.2

1.4

3.86

1.04

u/ml

1.10

353

Benign neoplasm: Pituitary gland, craniopharyngeal duct

147

1.09

0.07

1.1

1.2

0.20

0.64

u/ml

—

Other benign neoplasms of connective and other soft tissue

245

1.06

0.07

1.4

1.3

0.71

0.85

u/ml

0.07

109

Care involving dialysis

157

1.08

0.07

1.2

1.5

0.03

0.89

u/ml

—

Foreign body entering into or through eye or natural orifice

206

1.07

0.07

1.1

1.4

0.09

0.84

u/ml

—

Type 1 diabetes, wide definition

649

1.03

0.06

1.4

1.3

0.25

0.83

u/ml

1.41

261

Kidney transplant status

132

0.91

0.06

1.7

1.4

1.30

0.98

u/ml

—

Visual field defects

177

1.07

0.06

1.3

1.2

0.15

1.00

u/ml

—

Benign lipomatous neoplasm of other sites/unspecified

187

1.07

0.06

1.0

1.3

0.92

1.20

u/ml

—

Dental caries 2 and operation codes, only avohilmo

287

1803

0.99

0.06

1.3

0.61

1.19

u/ml

0.90

125

782

Other benign neoplasms of connective and other soft tissue

246

1.06

0.06

1.4

1.2

0.71

0.87

u/ml

0.08

107

Dysplasia of cervi uteri

641

1.03

0.06

1.2

1.3

0.13

1.55

u/ml

2.67

251

Maternal care for known or suspected disproportion

152

0.92

0.06

1.1

1.2

0.04

1.58

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

345

0.96

0.06

1.1

1.3

0.93

1.08

u/ml

0.08

156

Biomechanical lesions, not elsewhere classified

119

1.09

0.06

1.4

1.2

0.02

0.64

u/ml

—

Other viral hepatitis

172

0.93

0.06

1.2

1.3

0.04

0.40

u/ml

—

Parkinson's disease, strict definition, excluding more controls

198

0.94

0.05

1.8

1.3

0.99

1.33

u/ml

0.12

102

Pedal cyclist injured in other and unspecified transport accidents

287

1.05

0.05

1.5

1.3

1.00

1.11

u/ml

0.04

119

Labour and delivery complicated by umbilical cord complications

159

1.07

0.05

1.4

1.2

0.07

0.76

u/ml

—

Unspecified abortion

159

1.07

0.05

1.1

1.3

0.08

1.95

u/ml

—

Congenital malformations of the urinary system

169

1.07

0.05

1.4

0.11

0.70

u/ml

—

Mental and behavioural disorders due to alcohol

146

1400

1.01

0.05

1.3

0.86

1.42

u/ml

0.61

635

Pyogenic arthritis

120

1.08

0.04

1.2

4.84

0.32

u/ml

—

Subarachnoid haemorrhage

199

1.06

0.04

1.3

2.90

1.51

u/ml

0.19

100

SLE (Finngen)

1.10

0.04

1.3

1.2

0.03

0.18

u/ml

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aspergillus fumigatus IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS